UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, ~~2022~~2023

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-36788

EXELA TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)


Delaware	47-1347291
(State of or other Jurisdiction Incorporation or Organization)	(I.R.S. Employer Identification No.)

2701 E. Grauwyler Rd. Irving, TX	75061
(Address of Principal Executive Offices)	(Zip Code)

Registrant's Telephone Number, Including Area Code: (844) 935-2832

Securities Registered Pursuant to Section 12(b) of the Act:


Title of Each Class	Trading Symbol	Name of Each Exchange on Which Registered
Common Stock, Par Value $0.0001 per share	XELA	The Nasdaq Stock Market LLC
6.00% Series B Cumulative Convertible Perpetual Preferred Stock, par value $0.0001 per share Tandem Preferred Stock, par value of $0.0001 per share	XELAP	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒☐ No ☐☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ☐	Accelerated Filer ☒
Non-Accelerated Filer ☐	Smaller Reporting Company ☒
	Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~November 11, 2022,~~January 5, 2024, the registrant had ~~122,201,119~~6,365,353 shares of Common Stock outstanding.

Table of Contents

Exela Technologies, Inc.

Form 10-Q

For the quarterly period ended September 30, ~~2022~~2023

TABLE OF CONTENTS


PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

Condensed Consolidated Financial Statements

Condensed Consolidated Balance Sheets as of September 30, ~~2022~~2023 (Unaudited) and December 31, ~~2021 (as restated)~~2022	1

Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022 ~~and 2021~~(Unaudited)	2

Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2023 and 2022 ~~and 2021~~(Unaudited)	3

Condensed Consolidated Statements of Stockholders’ Deficit for the three and nine months ended September 30, 2023 and 2022 ~~and 2021~~(Unaudited)	4

Condensed Consolidated Statements of Cash Flows for the ~~three and~~ nine months ended September 30, 2023 and 2022 ~~and 2021~~(Unaudited)	6

Notes to the Condensed Consolidated Financial Statements (Unaudited)	7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	3937

Item 3. Quantitative and Qualitative Disclosures about Market Risk	5756

Item 4. ~~Internal~~ Controls and Procedures	5857

PART II — OTHER INFORMATION

Item 1. Legal Proceedings	6058

Item 1A. Risk Factors	6158

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds, and Issuer Purchases of Equity Securities	6259

Item 3. Defaults Upon Senior Securities	6359

Item 4. Mine Safety Disclosures	6359

Item 5. Other Information	6359

Item 6. Exhibits	6360

Signatures	62

Table of Contents

Exela Technologies, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

As of September 30, ~~2022~~2023 and December 31, ~~2021~~2022

(in thousands of United States dollars except share and per share amounts)

September 30,

December 31,

2022

2021 (Audited)


(Unaudited)

(Restated)

Assets





Current assets





Cash and cash equivalents

$
10,401

$
20,775

Restricted cash

34,402

27,285

Accounts receivable, net of allowance for doubtful accounts of $5,930 and $6,049, respectively

93,600

184,102

Related party receivables and prepaid expenses

504

715

Inventories, net

17,234

15,215

Prepaid expenses and other current assets

28,551

31,799

Total current assets

184,692

279,891

Property, plant and equipment, net of accumulated depreciation of $201,650 and $196,683, respectively

68,788

73,449

Operating lease right-of-use assets, net

44,943

53,937

Goodwill

328,071

358,323

Intangible assets, net

211,659

244,539

Deferred income tax assets

1,279

2,109

Other noncurrent assets

25,839

24,775

Total assets

$
865,271

$
1,037,023

Liabilities and Stockholders' Equity (Deficit)





Liabilities





Current liabilities

Accounts payable

$
80,783

$
61,744

Related party payables

1,698

1,484

Income tax payable

1,178

3,551

Accrued liabilities

52,795

113,519

Accrued compensation and benefits

52,925

60,860

Accrued interest

29,430

10,075

Customer deposits

18,278

17,707

Deferred revenue

15,681

16,617

Obligation for claim payment

50,780

46,902

Current portion of finance lease liabilities

4,902

6,683

Current portion of operating lease liabilities

13,127

15,923

Current portion of long-term debts

195,043

236,775

Total current liabilities

516,620

591,840

Long-term debt, net of current maturities

909,506

1,012,452

Finance lease liabilities, net of current portion

7,276

9,156

Pension liabilities, net

23,165

28,383

Deferred income tax liabilities

14,046

11,594

Long-term income tax liabilities

2,757

3,201

Operating lease liabilities, net of current portion

34,573

41,170

Other long-term liabilities

4,888

5,999

Total liabilities

1,512,831

1,703,795

Commitments and Contingencies (Note 8)





Stockholders' equity (deficit)





Common Stock, par value of $0.0001 per share; 1,600,000,000 shares authorized; 80,173,342 shares issued and 80,050,757 shares outstanding at September 30, 2022 and 13,382,333 shares issued and 13,259,748 shares outstanding at December 31, 2021

142

37

Preferred stock, $0.0001 par value per share, 20,000,000 shares authorized at September 30, 2022 and December 31, 2021, respectively

Series A Preferred Stock, 2,778,111 shares issued and outstanding at September 30, 2022 and December 31, 2021

1

1

Series B Preferred Stock, 3,029,900 shares issued and outstanding at September 30, 2022 and 0 shares issued and outstanding at December 31, 2021

—

—

Additional paid in capital

1,072,322

838,853

Less: Common Stock held in treasury, at cost; 122,585 shares at September 30, 2022 and December 31, 2021

(10,949)

(10,949)

Equity-based compensation

56,676

56,123

Accumulated deficit

(1,753,865)

(1,532,428)

Accumulated other comprehensive loss:

Foreign currency translation adjustment

(2,875)

(7,463)

Unrealized pension actuarial losses, net of tax

(9,012)

(10,946)

Total accumulated other comprehensive loss

(11,887)

(18,409)

Total stockholders’ deficit

(647,560)

(666,772)

Total liabilities and stockholders’ deficit

$
865,271

$
1,037,023


	September 30,		December 31,
	2023		2022
	(Unaudited)		(Audited)
Assets
Current assets
Cash and cash equivalents	$	6,142	$	15,073
Restricted cash		39,352		29,994
Accounts receivable, net of allowance for credit losses of $5,678 and $6,402, respectively		96,867		101,616
Related party receivables and prepaid expenses		117		759
Income tax receivable		129		—
Inventories, net		11,003		16,848
Prepaid expenses and other current assets		21,483		26,206
Total current assets		175,093		190,496
Property, plant and equipment, net of accumulated depreciation of $217,021 and $207,520, respectively		59,604		71,694
Operating lease right-of-use assets, net		38,557		40,734
Goodwill		170,262		186,802
Intangible assets, net		173,931		200,982
Deferred income tax assets		1,417		1,483
Other noncurrent assets		26,509		29,721
Total assets	$	645,373	$	721,912

Liabilities and Stockholders' Equity (Deficit)
Liabilities
Current liabilities
Current portion of long-term debt	$	48,221	$	154,802
Accounts payable		73,742		79,249
Related party payables		2,499		2,473
Income tax payable		—		2,045
Accrued liabilities		61,447		61,340
Accrued compensation and benefits		53,399		54,143
Accrued interest		24,463		60,901
Customer deposits		16,319		16,955
Deferred revenue		13,842		16,405
Obligation for claim payment		60,037		44,380
Current portion of finance lease liabilities		5,048		5,485
Current portion of operating lease liabilities		11,487		11,867
Total current liabilities		370,504		510,045
Long-term debt, net of current maturities		1,043,775		942,035
Finance lease liabilities, net of current portion		6,815		9,448
Pension liabilities, net		16,861		16,917
Deferred income tax liabilities		11,859		11,180
Long-term income tax liabilities		3,835		2,742
Operating lease liabilities, net of current portion		28,684		31,030
Other long-term liabilities		5,923		6,104
Total liabilities		1,488,256		1,529,501
Commitments and Contingencies (Note 8)
Stockholders' equity (deficit)
Common Stock, par value of $0.0001 per share; 1,600,000,000 shares authorized; 6,365,353 shares issued and outstanding at September 30, 2023 and 1,393,889 shares issued and 1,393,276 shares outstanding at December 31, 2022		261		162
Preferred stock, $0.0001 par value per share, 20,000,000 shares authorized at September 30, 2023 and December 31, 2022, respectively
Series A Preferred Stock, 2,778,111 shares issued and outstanding at September 30, 2023 and December 31, 2022		1		1
Series B Preferred Stock, 3,029,900 shares issued and outstanding at September 30, 2023 and December 31, 2022		—		—
Additional paid in capital		1,169,517		1,102,619
Less: Common Stock held in treasury, at cost; 0 shares at September 30, 2023 and 612 shares at December 31, 2022		—		(10,949)
Equity-based compensation		57,524		56,958
Accumulated deficit		(2,058,388)		(1,948,009)
Accumulated other comprehensive loss:
Foreign currency translation adjustment		(8,157)		(4,788)
Unrealized pension actuarial losses, net of tax		(3,641)		(3,583)
Total accumulated other comprehensive loss		(11,798)		(8,371)
Total stockholders’ deficit		(842,883)		(807,589)
Total liabilities and stockholders’ deficit	$	645,373	$	721,912

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

Exela Technologies, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

For the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022

(in thousands of United States dollars except share and per share amounts)

(Unaudited)

Three Months Ended September 30,

Nine Months Ended September 30,


2022

2021

2022

2021
Revenue

$
264,038

$
279,229

$
810,206

$
872,294
Cost of revenue (exclusive of depreciation and amortization)

217,842

211,731

658,623

653,398
Selling, general and administrative expenses (exclusive of depreciation and amortization)

44,369

43,244

137,604

121,519
Depreciation and amortization

17,737

19,094

53,942

58,113
Impairment of goodwill and other intangible assets

29,565

��

29,565

—
Related party expense

2,016

2,744

6,189

7,199
Operating profit (loss)

(47,491)

2,416

(75,717)

32,065
Other expense (income), net:

Interest expense, net

40,897

41,757

122,928

127,755
Debt modification and extinguishment costs (gain), net

(4,696)

(28,070)

4,305

(28,070)
Sundry expense (income), net

781

136

347

(438)
Other expense (income), net

(1,115)

366

12,419

1,169
Net loss before income taxes

(83,358)

(11,773)

(215,716)

(68,351)
Income tax expense

(1,924)

(1,441)

(5,721)

(3,430)
Net loss

$
(85,282)

$
(13,214)

$
(221,437)

$
(71,781)
Dividend equivalent on Series A Preferred Stock related to beneficial conversion feature

Cumulative dividends for Series A Preferred Stock

(908)

(822)

(2,648)

(724)
Cumulative dividends for Series B Preferred Stock

(1,136)

—

(2,528)

—
Net loss attributable to common stockholders

$
(87,326)

$
(14,036)

$
(226,613)

$
(72,505)
Loss per share:

Basic and diluted

$
(1.38)

$
(1.86)

$
(6.41)

$
(16.49)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue	$	253,125	$	264,038	$	799,683	$	810,206
Cost of revenue (exclusive of depreciation and amortization)		198,450		217,842		626,976		658,623
Selling, general and administrative expenses (exclusive of depreciation and amortization)		35,367		44,369		111,774		137,604
Depreciation and amortization		14,398		17,737		45,848		53,942
Impairment of goodwill and other intangible assets		—		29,565		—		29,565
Related party expense		2,845		2,016		8,696		6,189
Operating profit (loss)		2,065		(47,491)		6,389		(75,717)
Other expense (income), net:
Interest expense, net		24,708		40,897		113,980		122,928
Debt modification and extinguishment costs (gain), net		(571)		(4,696)		(16,129)		4,305
Sundry expense, net		298		781		2,546		347
Other expense (income), net		(1,069)		(1,115)		(1,583)		12,419
Net loss before income taxes		(21,301)		(83,358)		(92,425)		(215,716)
Income tax expense		(1,807)		(1,924)		(7,005)		(5,721)
Net loss	$	(23,108)	$	(85,282)	$	(99,430)	$	(221,437)
Cumulative dividends for Series A Preferred Stock		(1,002)		(908)		(2,923)		(2,648)
Cumulative dividends for Series B Preferred Stock		(1,188)		(1,136)		(3,512)		(2,528)
Net loss attributable to common stockholders	$	(25,298)	$	(87,326)	$	(105,865)	$	(226,613)
Loss per share:
Basic and diluted	$	(3.97)	$	(276.59)	$	(18.08)	$	(1,281.20)

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

Exela Technologies, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Loss

For the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022

(in thousands of United States dollars except share and per share amounts)

(Unaudited)

	��
	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021		2023		2022		2023		2022
Net loss	$	(85,282)	$	(13,214)	$	(221,437)	$	(71,781)	$	(23,108)	$	(85,282)	$	(99,430)	$	(221,437)
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments		1,978		99		4,588		(1,245)		(3,165)		1,978		(3,369)		4,588
Unrealized pension actuarial gains (losses), net of tax		824		472		1,934		230		147		824		(58)		1,934
Total other comprehensive loss, net of tax	$	(82,480)	$	(12,643)	$	(214,915)	$	(72,796)	$	(26,126)	$	(82,480)	$	(102,857)	$	(214,915)

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

Exela Technologies, Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders’ Deficit

For the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022

(in thousands of United States dollars except share and per share amounts)

(Unaudited)

Accumulated Other
Comprehensive Loss

Unrealized

Foreign

Pension

Currency

Actuarial

Total

Common Stock

Series A Preferred Stock

Series B Preferred Stock

Treasury Stock

Additional

Equity-Based

Translation

Losses,

Accumulated

Stockholders'


Shares

Amount

Shares

Amount

Shares

Amount

Shares

Amount

Paid in Capital

Compensation

Adjustment

net of tax

Deficit

Deficit
Balances at January 1, 2021

2,462,111

$
15

3,290,050

$
1

—

$
—

122,585

$
(10,949)

$
446,739

$
52,183

$
(7,419)

$
(17,064)

$
(1,390,038)

$
(926,532)
Net loss January 1 to March 31, 2021

—

—

—

—

—

—

—

—

—

—

—

—

(39,200)

(39,200)
Equity-based compensation

—

—

—

—

—

—

—

—

—

387

—

—

—

387
Foreign currency translation adjustment

—

—

—

—

—

—

—

—

—

—

100

—

—

100
Net realized pension actuarial gains, net of tax

—

—

—

—

—

—

—

—

—

—

—

(157)

—

(157)
Series A Preferred Stock converted to Common Stock

11,171

—

(510,681)

—

—

—

—

—

—

—

—

—

—

—
Payment for fractional shares on Reverse Stock Split

(272)

—

—

—

—

—

—

—

(14)

—

—

—

—

(14)
Issuance of Common Stock

486,591

1

—

—

—

—

—

—

25,079

—

—

—

—

25,080
Balances at March 31, 2021

2,959,601

$
16

2,779,369

$
1

—

$
—

122,585

$
(10,949)

$
471,804

$
52,570

$
(7,319)

$
(17,221)

$
(1,429,238)

$
(940,336)
Net loss April 1, 2021 to June 30, 2021

—

—

—

—

—

—

—

—

—

—

—

—

(19,367)

(19,367)
Equity-based compensation

—

—

—

—

—

—

—

—

—

593

—

—

—

593
Foreign currency translation adjustment

—

—

—

—

—

—

—

—

—

—

(1,444)

—

—

(1,444)
Net realized pension actuarial gains, net of tax

—

—

—

—

—

—

—

—

—

—

—

(85)

—

(85)
Series A Preferred Stock converted to Common Stock

28

—

(1,258)

—

—

—

—

—

—

—

—

—

—

—
Issuance of Common Stock from at the market offerings, net of offering costs

560,835

1

—

—

—

—

—

—

17,372

—

—

—

—

17,373
Balances at June 30, 2021

3,520,464

$
17

2,778,111

$
1

—

$
—

122,585

$
(10,949)

$
489,176

$
53,163

$
(8,763)

$
(17,306)

$
(1,448,605)

$
(943,266)
Net loss July 1, 2021 to September 30, 2021

—

—

—

—

—

—

—

—

—

—

—

—

(13,214)

(13,214)
Equity-based compensation

—

—

—

—

—

—

—

—

—

348

—

—

—

348
Foreign currency translation adjustment

—

—

—

—

—

—

—

—

—

—

99

—

—

99
Net realized pension actuarial gains, net of tax

—

—

—

—

—

—

—

—

—

—

—

472

—

472
Issuance of Common Stock from at the market offerings, net of offering costs

4,789,373

9

—

—

—

—

—

—

222,717

—

—

—

—

222,726
Balances at September 30, 2021

8,309,837

$
26

2,778,111

$
1

—

$
—

122,585

$
(10,949)

$
711,893

$
53,511

$
(8,664)

$
(16,834)

$
(1,461,819)

$
(732,835)

~~Table of Contents~~


																	Accumulated Other Comprehensive Loss																								Accumulated Other Comprehensive Loss
																			Unrealized																								Unrealized
																	Foreign		Pension																						Foreign		Pension
																	Currency		Actuarial				Total																		Currency		Actuarial				Total
	Common Stock			Series A Preferred Stock			Series B Preferred Stock			Treasury Stock			Additional		Equity-Based		Translation		Losses,		Accumulated		Stockholders'		Common Stock			Series A Preferred Stock			Series B Preferred Stock			Treasury Stock			Additional		Equity-Based		Translation		Losses,		Accumulated		Stockholders'
	Shares	Amount		Shares	Amount		Shares	Amount		Shares	Amount		Paid in Capital		Compensation		Adjustment		net of tax		Deficit		Deficit		Shares	Amount		Shares	Amount		Shares	Amount		Shares	Amount		Paid in Capital		Compensation		Adjustment		net of tax		Deficit		Deficit
Balances at January 1, 2022	13,259,748	$	37	2,778,111	$	1	—	$	—	122,585	$	(10,949)	$	838,853	$	56,123	$	(7,463)	$	(10,946)	$	(1,532,428)	$	(666,772)	66,300	$	37	2,778,111	$	1	—	$	—	612	$	(10,949)	$	838,853	$	56,123	$	(7,463)	$	(10,946)	$	(1,532,428)	$	(666,772)
Net loss January 1 to March 31, 2022	—		—	—		—	—		—	—		—		—		—		—		—		(56,956)		(56,956)
Net loss																									—		—	—		—	—		—	—		—		—		—		—		—		(56,956)		(56,956)
Equity-based compensation	—		—	—		—	—		—	—		—		—		302		—		—		—		302	—		—	—		—	—		—	—		—		—		302		—		—		—		302
Foreign currency translation adjustment	—		—	—		—	—		—	—		—		—		—		1,477		—		—		1,477	—		—	—		—	—		—	—		—		—		—		1,477		—		—		1,477
Net realized pension actuarial gains, net of tax	—		—	—		—	—		—	—		—		—		—		—		308		—		308	—		—	—		—	—		—	—		—		—		—		—		308		—		308
Common Stock exchanged for Series B Preferred Stock	(900,328)		(2)	—		—	900,328		—	—		—		2		—		—		—		—		—	(4,502)		(2)	—		—	900,328		—	—		—		2		—		—		—		—		—
Issuance of Common Stock from at the market offerings, net of offering costs	11,814,075		24	—		—	—		—	—		—		114,509		—		—		—		—		114,533	59,070		24	—		—	—		—	—		—		114,509		—		—		—		—		114,533
Withholding of employee taxes on vested RSUs	—		—	—		—	—		—	—		—		—		(190)		—		—		—		(190)	—		—	—		—	—		—	—		—		—		(190)		—		—		—		(190)
Common Stock issued for vested RSUs	54,360		—	—		—	—		—	—		—		—		—		—		—		—		—	272		—	—		—	—		—	—		—		—		—		—		—		—		—
Balances at March 31, 2022	24,227,855	$	59	2,778,111	$	1	900,328	$	—	122,585	$	(10,949)	$	953,364	$	56,235	$	(5,986)	$	(10,638)	$	(1,589,384)	$	(607,298)	121,140	$	59	2,778,111	$	1	900,328	$	—	612	$	(10,949)	$	953,364	$	56,235	$	(5,986)	$	(10,638)	$	(1,589,384)	$	(607,298)
Net loss April 1 to June 30, 2022	—		—	—		—	—		—	—		—		—		—		—		—		(79,199)		(79,199)
Net loss																									—		—	—		—	—		—	—		—		—		—		—		—		(79,199)		(79,199)
Equity-based compensation	—		—	—		—	—		—	—		—		—		528		—		—		—		528	—		—	—		—	—		—	—		—		—		528		—		—		—		528
Foreign currency translation adjustment	—		—	—		—	—		—	—		—		—		—		1,133		—		—		1,133	—		—	—		—	—		—	—		—		—		—		1,133		—		—		1,133
Net realized pension actuarial gains, net of tax	—		—	—		—	—		—	—		—		—		—		—		802		—		802	—		—	—		—	—		—	—		—		—		—		—		802		—		802
Dividend declared and paid on Series B Preferred Stock ($0.46 per share)	—		—	—		—	—		—	—		—		(1,396)		—		—		—		—		(1,396)	—		—	—		—	—		—	—		—		(1,396)		—		—		—		—		(1,396)
Common Stock exchanged for Series B Preferred Stock	(2,129,572)		(4)	—		—	2,129,572		—	—		—		4		—		—		—		—		—	(10,648)		(4)	—		—	2,129,572		—	—		—		4		—		—		—		—		—
Issuance of Common Stock from at the market offerings, net of offering costs	18,189,580		36	—		—	—		—	—		—		56,328		—		—		—		—		56,364	90,948		36	—		—	—		—	—		—		56,328		—		—		—		—		56,364
Withholding of employee taxes on vested RSUs	—		—	—		—	—		—	—		—		—		(2)		—		—		—		(2)	—		—	—		—	—		—	—		—		—		(2)		—		—		—		(2)
Common Stock issued for vested RSUs	2,494		—	—		—	—		—	—		—		—		—		—		—		—		—	12		—	—		—	—		—	—		—		—		—		—		—		—		—
Agreed cancellation of Common Stock issued for Director's vested RSUs	(31,082)		—	—		—	—		—	—		—		—		—		—		—		—		—	(155)		—	—		—	—		—	—		—		—		—		—		—		—		—
Balances at June 30, 2022	40,259,275	$	91	2,778,111	$	1	3,029,900	$	—	122,585	$	(10,949)	$	1,008,300	$	56,761	$	(4,853)	$	(9,836)	$	(1,668,583)	$	(629,068)	201,297	$	91	2,778,111	$	1	3,029,900	$	—	612	$	(10,949)	$	1,008,300	$	56,761	$	(4,853)	$	(9,836)	$	(1,668,583)	$	(629,068)
Net loss July 1, 2022 to September 30, 2022	—		—	—		—	—		—	—		—		—		—		—		—		(85,282)		(85,282)
Net loss																									—		—	—		—	—		—	—		—		—		—		—		—		(85,282)		(85,282)
Equity-based compensation	—		—	—		—	—		—	—		—		—		(142)		—		—		—		(142)	—		—	—		—	—		—	—		—		—		(142)		—		—		—		(142)
Foreign currency translation adjustment	—		—	—		—	—		—	—		—		—		—		1,978		—		—		1,978	—		—	—		—	—		—	—		—		—		—		1,978		—		—		1,978
Net realized pension actuarial gains, net of tax	—		—	—		—	—		—	—		—		—		—		—		824		—		824	—		—	—		—	—		—	—		—		—		—		—		824		—		824
Dividend declared and paid on Series B Preferred Stock ($0.375 per share)	—		—	—		—	—		—	—		—		(1,136)		—		—		—		—		(1,136)	—		—	—		—	—		—	—		—		(1,136)		—		—		—		—		(1,136)
Common Stock repurchased and retired	(357,461)		—	—		—			—	—		—		(487)		—		—		—		—		(487)	(1,787)		—	—		—			—	—		—		(487)		—		—		—		—		(487)
Issuance of Common Stock from at the market offerings, net of offering costs	40,093,528		51	—		—	—		—	—		—		65,590		—		—		—		—		65,641	200,468		51	—		—	—		—	—		—		65,590		—		—		—		—		65,641
Reversal of excess withholding of employee taxes on vested RSUs	—		—	—		—	—		—	—		—		—		57		—		—		—		57	—		—	—		—	—		—	—		—		—		57		—		—		—		57
Issuance of Common Stock to Executive Chairman under certain subscription agreement	70,921		—	—		—	—		—	—		—		100		—		—		—		—		100	355		—	—		—	—		—	—		—		100		—		—		—		—		100
Cancellation of fractional Common Stock on Reverse Stock Split	(15,506)		—	—		—	—		—	—		—		(45)		—		—		—		—		(45)	(78)		—	—		—	—		—	—		—		(45)		—		—		—		—		(45)
Balances at September 30, 2022	80,050,757	$	142	2,778,111	$	1	3,029,900	$	—	122,585	$	(10,949)	$	1,072,322	$	56,676	$	(2,875)	$	(9,012)	$	(1,753,865)	$	(647,560)	400,255	$	142	2,778,111	$	1	3,029,900	$	—	612	$	(10,949)	$	1,072,322	$	56,676	$	(2,875)	$	(9,012)	$	(1,753,865)	$	(647,560)

Table of Contents

Exela Technologies, Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders’ Deficit (Continued)

For the three and nine months ended September 30, 2023 and 2022

(in thousands of United States dollars except share and per share amounts)

(Unaudited)


																	Accumulated Other Comprehensive Loss
																			Unrealized
																	Foreign		Pension
																	Currency		Actuarial				Total
	Common Stock			Series A Preferred Stock			Series B Preferred Stock			Treasury Stock			Additional		Equity-Based		Translation		Losses,		Accumulated		Stockholders'
	Shares	Amount		Shares	Amount		Shares	Amount		Shares	Amount		Paid in Capital		Compensation		Adjustment		net of tax		Deficit		Deficit
Balances at January 1, 2023	1,393,276	$	162	2,778,111	$	1	3,029,900	$	—	612	$	(10,949)	$	1,102,619	$	56,958	$	(4,788)	$	(3,583)	$	(1,948,009)	$	(807,589)
Net loss	—		—	—		—	—		—	—		—		—		—		—		—		(45,436)		(45,436)
Equity-based compensation	—		—	—		—	—		—	—		—		—		111		—		—		—		111
Foreign currency translation adjustment	—		—	—		—	—		—	—		—		—		—		(2,105)		—		—		(2,105)
Net realized pension actuarial loss, net of tax	—		—	—		—	—		—	—		—		—		—		—		(89)		—		(89)
Issuance of Common Stock from at the market offerings, net of offering costs	4,977,744		99	—		—	—		—	—		—		66,929		—		—		—		—		67,028
Balances at March 31, 2023	6,371,020	$	261	2,778,111	$	1	3,029,900	$	—	612	$	(10,949)	$	1,169,548	$	57,069	$	(6,893)	$	(3,672)	$	(1,993,445)	$	(788,080)
Net loss	—		—	—		—	—		—	—		—		—		—		—		—		(30,886)		(30,886)
Equity-based compensation	—		—	—		—	—		—	—		—		—		203		—		—		—		203
Foreign currency translation adjustment	—		—	—		—	—		—	—		—		—		—		1,901		—		—		1,901
Net realized pension actuarial loss, net of tax	—		—	—		—	—		—	—		—		—		—		—		(116)		—		(116)
Payment for fractional shares on reverse stock split in May 2023	(5,667)		—	—		—	—		—	—		—		(31)		—		—		—		—		(31)
Balances at June 30, 2023	6,365,353	$	261	2,778,111	$	1	3,029,900	$	—	612	$	(10,949)	$	1,169,517	$	57,272	$	(4,992)	$	(3,788)	$	(2,024,331)	$	(817,009)
Net loss	—		—	—		—	—		—	—		—		—		—		—		—		(23,108)		(23,108)
Equity-based compensation	—		—	—		—	—		—	—		—		—		252		—		—		—		252
Foreign currency translation adjustment	—		—	—		—	—		—	—		—		—		—		(3,165)		—		—		(3,165)
Net realized pension actuarial gains, net of tax	—		—	—		—	—		—	—		—		—		—		—		147		—		147
Treasury stock retired	—		—	—		—	—		—	(612)		10,949		—		—		—		—		(10,949)		—
Balances at September 30, 2023	6,365,353	$	261	2,778,111	$	1	3,029,900	$	—	—	$	—	$	1,169,517	$	57,524	$	(8,157)	$	(3,641)	$	(2,058,388)	$	(842,883)

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

Exela Technologies, Inc. and Subsidiaries

Condensed Consolidated ~~Statement~~Statements of Cash Flows

For the nine months ended September 30, ~~2022~~2023 and ~~2021~~2022

(in thousands of United States dollars except share and per share amounts)

(Unaudited)

Nine Months Ended September 30,


2022

2021

Cash flows from operating activities

Net loss

$
(221,437)

$
(71,781)

Adjustments to reconcile net loss

Depreciation and amortization

53,942

58,113

Original issue discount and debt issuance cost amortization

10,383

11,684

Debt modification and extinguishment costs (gain), net

(1,803)

(28,070)

Impairment of goodwill and other intangible assets

29,565

—

Provision for doubtful accounts

704

2,427

Deferred income tax provision

2,492

484

Share-based compensation expense

694

1,519

Unrealized foreign currency losses

(1,503)

(604)

Loss (Gain) on sale of assets

548

(112)

Fair value adjustment for interest rate swap

—

(125)

Change in operating assets and liabilities, net of effect from acquisitions

Accounts receivable

83,282

14,440

Prepaid expenses and other assets

(6,910)

(4,329)

Accounts payable and accrued liabilities

(37,004)

(57,433)

Related party payables

426

604

Additions to outsource contract costs

(330)

(405)

Net cash used in operating activities

(86,951)

(73,588)

Cash flows from investing activities





Purchase of property, plant and equipment

(14,208)

(6,950)

Additions to patents

(15)

—

Additions to internally developed software

(2,710)

(951)

Proceeds from sale of assets

194

4,252

Net cash used in investing activities

(16,739)

(3,649)

Cash flows from financing activities





Proceeds from issuance of Common Stock from private placement

—

25,065

Proceeds from issuance of Common Stock from at the market offerings

245,073

249,169

Dividend paid on Series B Preferred Stock

(2,532)

—

Repurchases of Common Stock for retirement

(487)

—

Cash paid for equity issuance costs from at the market offerings

(8,480)

(9,060)

Borrowings under factoring arrangement and Securitization Facility

93,867

102,141

Principal repayment on borrowings under factoring arrangement and Securitization Facility

(186,245)

(105,112)

Cash paid for withholding taxes on vested RSUs

(138)

—

Lease terminations

3

(125)

Cash paid for debt issuance costs

(7,125)

—

Principal payments on finance lease obligations

(4,342)

(8,446)

Borrowings from senior secured revolving facility and BRCC revolver

20,000

3,000

Repayments on senior secured revolving facility

(49,477)

(55)

Proceeds from issuance of 2026 Notes

80,620

—

Borrowings from other loans

7,500

8,537

Cash paid for debt repurchases

(4,712)

(58,607)

Repayment of BRCC term loan

(59,209)

—

Principal repayments on senior secured term loans and other loans

(22,829)

(28,512)

Net cash provided by financing activities

101,487

177,995

Effect of exchange rates on cash

(1,054)

(78)

Net increase (decrease) in cash and cash equivalents

(3,257)

100,680

Cash, restricted cash, and cash equivalents

Beginning of period

48,060

70,309

End of period

$
44,803

$
170,989

Supplemental cash flow data:

Income tax payments, net of refunds received

$
5,267

$
2,766

Interest paid

93,405

137,862

Noncash investing and financing activities:

Assets acquired through right-of-use arrangements

958

2,754

Leasehold improvements funded by lessor

—

125

Accrued capital expenditures

1,916

2,495


	Nine Months Ended September 30,
	2023		2022
Cash flows from operating activities
Net loss	$	(99,430)	$	(221,437)
Adjustments to reconcile net loss
Depreciation and amortization		45,848		53,942
Original issue discount, debt premium and debt issuance cost amortization		9,976		10,383
Debt modification and extinguishment gain, net		(17,534)		(1,803)
Impairment of goodwill and other intangible assets		—		29,565
Credit loss expense		1,818		704
Deferred income tax provision		680		2,492
Share-based compensation expense		566		694
Unrealized foreign currency gain		(143)		(1,503)
(Gain) loss on sale of assets		(6,579)		548
Change in operating assets and liabilities
Accounts receivable		2,954		83,282
Prepaid expenses and other current assets		8,732		(6,910)
Accounts payable and accrued liabilities		23,667		(37,004)
Related party payables		668		426
Additions to outsource contract costs		(443)		(330)
Net cash used in operating activities		(29,220)		(86,951)
Cash flows from investing activities
Purchase of property, plant and equipment		(5,585)		(14,208)
Additions to patents		—		(15)
Additions to internally developed software		(2,967)		(2,710)
Proceeds from sale of assets		29,811		194
Net cash provided by (used in) investing activities		21,259		(16,739)
Cash flows from financing activities
Proceeds from issuance of Common Stock from at the market offerings		69,260		245,073
Cash paid for equity issuance costs from at the market offerings		(2,232)		(8,480)
Dividend paid on Series B Preferred Stock		—		(2,532)
Payment for fractional shares on reverse stock split		(31)		—
Repurchases of Common Stock for retirement		—		(487)
Borrowings under factoring arrangement and Securitization Facility		87,653		93,867
Principal repayment on borrowings under factoring arrangement and Securitization Facility		(90,358)		(186,245)
Cash paid for withholding taxes on vested RSUs		—		(138)
Lease terminations		—		3
Cash paid for debt issuance costs		(8,273)		(7,125)
Principal payments on finance lease obligations		(3,477)		(4,342)
Borrowings from senior secured revolving facility and BRCC revolver		9,600		20,000
Repayments on senior secured revolving facility		—		(49,477)
Proceeds from issuance of 2026 Notes		—		80,620
Borrowings from other loans		41,843		7,500
Cash paid for debt repurchases		(11,858)		(4,712)
Proceeds from Senior secured term loan		40,000		—
Proceeds from Second Lien Note		31,500		—
Repayment of BRCC term loan		(48,529)		(59,209)
Principal repayments on senior secured term loans and other loans		(106,657)		(22,829)
Net cash provided by financing activities		8,441		101,487
Effect of exchange rates on cash, restricted cash and cash equivalents		(53)		(1,054)
Net increase in cash, restricted cash and cash equivalents		427		(3,257)
Cash, restricted cash, and cash equivalents
Beginning of period		45,067		48,060
End of period	$	45,494	$	44,803
Supplemental cash flow data:
Income tax payments, net of refunds received	$	3,369	$	5,267
Interest paid		80,156		93,405
Noncash investing and financing activities:
Assets acquired through right-of-use arrangements		405		958
Issuance of new notes in exchange of 2026 notes		764,800		—
Issuance of new notes in exchange of 2023 term loan		2,963		—
Accrued PIK interest paid through issuance of PIK Notes		44,146		—
Accrued capital expenditures	$	1,778	$	1,916

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

Exela Technologies, Inc. and Subsidiaries

Notes to the Condensed Consolidated Financial Statements

(in thousands of United States dollars except share and per share amounts or unless otherwise noted)

(Unaudited)

1. General

These condensed consolidated financial statements should be read in conjunction with the notes to the consolidated financial statements as of and for the year ended December 31, ~~2021~~2022 included in the Exela Technologies, Inc. (the “Company,” “Exela,” “we,” “our” or “us”) annual report on Form 10-K ~~as amended on November 14, 2022,~~ for such period ~~(the “2021~~(as amended, the “2022 Form 10-K”)., filed with the Securities and Exchange Commission (“SEC”) on April 3, 2023 and May 1, 2023 and available at the SEC’s website at http://www.sec.gov.

The accompanying condensed consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America (“GAAP”) and in accordance with the instructions to Form 10-Q and Rule 10-01 of ~~Securities and Exchange Commission (“SEC”)~~ Regulation S-X under the Securities Act of 1933, as amended (the “Securities Act”), as they apply to interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. These accounting principles require us to use estimates and assumptions that impact the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. Actual results may differ from our estimates.

The condensed consolidated financial statements are unaudited, but in our opinion include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the results for the interim period. The interim financial results are not necessarily indicative of results that may be expected for any other interim period or the fiscal year.

On ~~July 25, 2022,~~May 12, 2023, we effected a ~~one-for-twenty~~one-for-two hundred reverse stock split (the “Reverse Stock Split”) of our issued and outstanding shares of common stock, par value $0.0001 per share (“Common Stock”). As a result of the Reverse Stock Split, every ~~twenty (20)~~two hundred (200) shares of Common Stock issued and outstanding were automatically combined into one (1) share of issued and outstanding Common Stock, without any change in the par value per share. All information related to Common Stock, stock options, restricted stock units, warrants and earnings per share have been retroactively adjusted to give effect to the Reverse Stock Split for all periods presented.

~~Restatement~~

As described in additional detail in the Explanatory Note to its 2021 Form 10-K/A, the Company restated its audited consolidated financial statements in the 2021 Form 10-K for the year ended December 31, 2021. Previously filed quarterly reports on Form 10-Q for the first two fiscal quarters in the fiscal year ended December 31, 2022 have not been amended for the restated consolidated balance sheet as of December 31, 2021 as affected by the restatement. See Note 21, Restatement of Previously Issued Financial Statements, of the Notes to the consolidated financial statements in the 2021 Form 10-K/A for the impact of the restatement. These condensed consolidated financial statements include restated consolidated balance sheet as of December 31, 2021.

Going Concern

In accordance with ASC Subtopic 205-40, Presentation of Financial Statements—Going Concern (“ASC 205-40”), the Company has the responsibility to evaluate whether conditions and/or events raise substantial doubt about its ability to meet its obligations as they become due within one year after the date that the financial statements are issued. As required under ASC 205-40, management’s evaluation should initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.

In performing this evaluation, wethe Company concluded that under the standards of ASC 205-40 the following conditions raised substantial doubt about ~~our~~its ability to continue as a going concern: a

●

history of net losses, including net losses of $99.4 million for the nine months ended September 30, 2023;

●

net operating cash outflow of $29.2 million for the nine months ended September 30, 2023;

●

working capital deficit of $195.4 million as of September 30, 2023; and

●

an accumulated deficit of $2,058.4 million as of September 30, 2023.

The Company has undertaken and/or completed the following plans and actions to improve its available cash ~~outflows,~~balances, liquidity or cash generated from operations:

Table of Contents

working capital deficits and significant cash payments for interest on our long-term debt in addition to $22.8 million principal amount of 2023 Notes and $133.6 million principal amount of senior secured term loans (all as defined in Note 5) both of which mature within the next twelve months from the filing date of this report. Management considered the Company’s current financial condition and liquidity sources, including current funds available, forecasted future cash flows and the Company’s obligations due before November 15, 2023. As required under ASC 205-40, management’s evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company, such as access to equity financing (despite the Company’s track record in raising nearly $639.7 million of such funds).

The Company has undertaken and completed the following plans and actions to improve our available cash balances, liquidity or cash generated from operations, over the twelve month period from the date these financial statements are issued:

●

~~completed~~identified and in the ~~Revolver Exchange (see Note 5);~~process of executing on significant cost savings for fiscal year 2024;

●

~~paid off its remaining obligations relating~~issued approximately $764.8 million aggregate principal amount of New Notes (as defined in Note 5 – Long-Term Debt and Credit Facilities) in exchange for $956.0 million aggregate principal amount of existing 2026 Notes that provide flexibility to ~~the settlement~~pay up to 50% of the ~~Appraisal Action (see Note 8);~~

●

amended the BRCC Facility to provide up to $51.0 million of additional liquidity through a revolving credit facility which becomes available as the Company pays down the term portion of the facility (which the Company expects to do over the next twelve months);interest payments in 2024 in New Notes.

●

executed a ~~$150.0~~$40.0 million financing agreement with ~~PNC Bank~~certain lenders with Blue Torch Finance LLC acting as an administrative agent and used proceeds to ~~replace the~~repay existing ~~securitization facility that generated annual interest rate savings~~debt;

●

fully discharged $48.4 million of ~~approximately $6.0~~outstanding principal amount of 2023 Term Loans by issuing $3.0 million aggregate principal amount of New Notes and making cash payment of $44.8 million resulting in a debt extinguishment gain of $0.6 million;

●

fully repaid $9.0 million of outstanding principal amount of 2023 Notes in cash (see Note 5 – Long-Term Debt and Credit Facilities); and

●

~~raised proceeds~~completed the merger of ~~$310.1 million from the sale of equity and debt during the nine months ended September 30, 2022.~~its European business with CFFE on November 29, 2023 (see Note 14 – Subsequent Events for further details).

~~Despite~~In addition to these actions, management has reviewed the Company's operational plans which include executing on price increases, projected growth of margins and cost containment activities. The Company will have to continue to restore positive operating cash flows and profitability over the next twelve months and otherwise execute its business plan. The Company believes that the effective execution of management’s plans, as described above, will provide sufficient liquidity to meet its financial obligations and allievate substantial doubt. However, there can be no assurance that it will be successful in continuing to restore positive cash flows, or that it can raise additional financing when needed, and obtain it on terms acceptable or favorable to the Company. These factors and the execution risk currently raise substantial doubt about our ability to continue as a going concern for at least twelve months from the date that the financial statements were issued.

The Company’s plans to further enhance liquidity include the potential sale of certain non-core assets that are not central to the Company’s long-term strategic vision, and any potential action with respect to these operations would be intended to allow the Company ~~will need~~ to ~~take further action~~better focus on its core businesses. The Company has retained financial advisors to ~~raise additional funds in the capital markets. In order to access the capital markets, the Company filed registration statements providing for~~assist with the sale of ~~common stock, preferred stock, warrants, debt securities and/or units. Based on our experience with~~select assets. The Company expects to use the ~~at-the-market programs~~potential net proceeds from this initiative for the pay down of debt. These plans are subject to inherent risks and ~~our knowledge of the Company~~uncertainties and the financial market, we believe that we will be able to raise additional funds from the sale of equity and debt in the future. However, the Company’s ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions ~~the Company’s performance and investor sentiment with respect to the Company and its industry and considering these factors~~that are outside of the Company’s ~~control, substantial doubt about~~control. Accordingly, there can be no assurance that these plans can be effectively implemented and, therefore, that the Company’s ability to continue as a going concern exists under the standards of ASC 205-40. The consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that mayconditions can be ~~necessary if the Company were unable to continue as a going concern.~~effectively mitigated.

Net Loss per Share

Earnings per share (“EPS”) is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of ~~Common Stock~~common stock outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to the potential dilution that could occur if securities or other contracts to issue ~~Common Stock~~common stock were exercised or converted into ~~Common Stock,~~common stock, using the more dilutive of the two-class method and the if-converted method in the period of earnings. The two class method is an earnings allocation method that determines earnings per share (when there are earnings) for ~~Common Stock~~common stock and participating securities. The if-converted method assumes all convertible securities are converted into ~~Common Stock.~~common stock. Diluted EPS excludes all dilutive potential shares of ~~Common Stock~~common stock if their effect is anti-dilutive.

As the Company experienced net losses for the periods presented, the impact of the Company’s Series A Perpetual Convertible Preferred Stock (“Series A Preferred Stock”) and Series B Cumulative Convertible Perpetual Preferred Stock (the “Series B Preferred Stock”), was calculated using the if-converted method. As of September 30, ~~2022,~~2023, the outstanding shares of the Company’s Series A Preferred Stock and Series B Preferred Stock, if converted would have resulted in an additional ~~71,256~~393 shares and ~~3,029,900~~16,079 shares of our Common Stock outstanding, respectively, however, they were not included in the computation of diluted loss per share as their effects were anti-dilutive (i.e., if included, would reduce the net loss per share).

~~Table of Contents~~

Similarly, the Company also did not include the effect of ~~486,591~~2,433 shares of Common Stock issuable upon exercise of 9,731,819 warrants sold in a private placement of securities on March 18, 2021 or the effect of the aggregate number

Table of Contents

of shares issuable pursuant to outstanding restricted stock units, performance units and options ~~(497,283~~(2,471 and ~~531,987~~2,486 as of September 30, ~~2022~~2023 and ~~2021,~~2022, respectively) in the calculation of diluted loss per share for the three and nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, because their effects were also anti-dilutive.


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021		2023		2022		2023		2022
Net loss attributable to common stockholders (A)	$	(87,326)	$	(14,036)	$	(226,613)	$	(72,505)	$	(25,298)	$	(87,326)	$	(105,865)	$	(226,613)
Weighted average common shares outstanding - basic and diluted (B)		63,145,001		7,532,751		35,375,045		4,397,908
Weighted average common shares outstanding – basic and diluted (B)										6,365,353		315,725		5,854,840		176,875
Loss Per Share:
Basic and diluted (A/B)	$	(1.38)	$	(1.86)	$	(6.41)	$	(16.49)	$	(3.97)	$	(276.59)	$	(18.08)	$	(1,281.20)

~~Impact of COVID-19~~Merger Agreement

The COVID-19 pandemic remains a threat and certain countries, such as China, are still subject to restrictions related to COVID-19. While the threat level has declined to a significant extent in the U.S. and globally, any resurgence could have a material adverse effect on our business operations, results of operations, cash flows and financial position.

In fiscal year 2022 to date, we continue to see impacts of global supply chain challenges, availability of staff at some of our key operating centers and pending customers’ decision to resume work from office. However, all of our production-related facilities remain operational and are continuing to provide ongoing services to our customers.

~~Network Outage~~

~~In late June~~On October 9, 2022, the Company ~~experienced~~entered into a ~~network security incident impacting certain~~definitive merger agreement to merge its European business with CF Acquisition Corp. VIII (“CFFE”), a special purpose acquisition company, to form a new publicly-traded company which will be called XBP Europe, Inc. (“XBP Europe”). Following the closing of the ~~Company’s operational and information technology systems.~~transaction, which occurred on November 29, 2023, the Company indirectly owns a majority of the outstanding capital stock of XBP Europe. The effects of these transactions are not reflected in these condensed consolidated financial statements (see Note 14 – Subsequent Events for further details).

Sale of Non-core Assets

On June 8, 2023, the Company ~~immediately took steps to isolate~~completed the ~~impact and prevent additional systems from being affected, including taking large parts~~sale of its ~~network offline as~~high-speed scanner business, which was a ~~precaution and thereby disrupting some access~~part of its ITPS segment (as defined in Note 3 – Significant Accounting Policies), for a purchase price of approximately $30.1 million, subject to our applications and services by our employees and customers. Promptly upon our detection of this incident, we initiated response and containment protocols and our security teams, supplemented by leading cyber defense firms, worked to remediate this incident. We notified law enforcement, contacted our customers to apprise themfinal working capital adjustments. The sale of the ~~situation and~~high-speed scanner business does not represent a strategic shift that will ~~provide any notices that may be required by applicable law.~~

~~We undertook extensive efforts to identify, contain and recover from this incident quickly and securely. We systematically brought our information systems back online in~~have a ~~controlled, phased approach. Our teams worked to maintain our business operations and minimize the impact~~major effect on ~~our customers, operating partners, and employees. The Company’s systems recovery efforts are substantially complete, and~~ the Company’s operations ~~are fully functional, however, the incident did~~and financial results. As a result ~~in some loss of revenue as well as certain incremental costs, some of which is expected to continue. The impact~~ of this ~~security incident has continued~~transaction, the Company disposed of $16.5 million of goodwill based on the relative fair value of the high-speed scanner business to ~~persist into third quarter~~the total fair value of ~~2022.~~

~~We maintain~~the ITPS reporting unit. This transaction resulted in a ~~variety~~total pre-tax gain of ~~insurance policies, including cyber insurance~~$7.2 million included in selling, general and ~~business interruption insurance that~~administrative expenses (exclusive of depreciation and amortization) in the condensed consolidated statements of operations for the nine months ended September 30, 2023. Per the terms of the sales agreement, the Company may ~~partially off-set~~receive additional cash consideration (“Contingent Consideration”) upon the ~~costs related to this incident.~~future occurrence of certain earn out events described in the sales agreement. The Contingent Consideration, if any, will be recognized in the period the earn out event occurs, and the Contingent Consideration is realizable.

2. New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Effective January 1, ~~2022,~~2023, the Company adopted Accounting Standards Update (“ASU”) ~~no. 2021-05,~~No. 2016-13, ~~Leases~~Financial Instruments – Credit Losses (Topic ~~842)~~326): ~~Lessors — Certain Leases~~Measurement of Credit Losses on Financial Instruments, to replace the incurred loss impairment methodology under current GAAP with ~~Variable Lease Payments~~.a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company is required to use a forward-looking expected credit loss model for accounts receivables, loans, and other financial instruments. This ASU ~~requires a lessor~~along with related additional clarificatory guidance in the ASU No. 2019-05, “Financial Instruments—Credit Losses (Topic 326)” and ASU No. 2019-11, “Codification Improvements to ~~classify a lease with variable lease payments that do not depend on an index or rate as an operating lease on the commencement date~~Topic 326, Financial Instruments—Credit Losses”, was also adopted. Adoption of the ~~lease if specified criteria are met.~~standard was applied using a modified retrospective approach through a cumulative-effect adjustment to retained earnings as of the effective date. The ~~adoption had no material~~Company has performed its analysis of the impact on its financial instruments that are within the ~~Company's~~scope of this guidance, primarily cash equivalents, restricted cash and accounts receivable, based on class of financing receivables which share the same or similar risk characteristics such as customer type and geographic location, among others. For accounts receivable, the Company applied this methodology using aging schedules reflecting how long the receivables have been outstanding, historical collection experience, current and future economic and market conditions. There was no impact to the Company’s opening retained earnings or its condensed consolidated ~~results of operations, cash flows, financial position or disclosures.~~

balance sheet upon adoption and as a result, the

Table of Contents

~~Effective January 1,~~balances presented for December 31, 2022, which were derived under the ~~Company adopted ASU no. 2021-04,~~ ~~Earnings Per Share (Topic 260), Debt — Modifications and Extinguishments (Subtopic 470-50), Compensation — Stock Compensation (Topic 718), and Derivatives and Hedging — Contracts~~incurred loss model, are comparable to September 30, 2023.

The following table describes the changes in ~~Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting~~the allowance for ~~Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the Emerging Issues Task Force)~~. The ASU requires issuers to account for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after the modification or exchange based on the economic substance of the modification or exchange. Under the ASU, an issuer determines the accountingexpected credit losses for the ~~modification or exchange based on whether the transaction was done~~nine months ended September 30, 2023 (all related to ~~issue equity, to issue or modify debt, or for other reasons. The adoption had no material impact on the Company's consolidated results of operations, cash flows, financial position or disclosures.~~accounts receivables):


Balance at January 1, 2023 of the allowance for expected credit losses	$	6,402
Change in the provision for expected credit losses for the period		(724)
Balance at September 30, 2023 of the allowance for expected credit losses	$	5,678

Effective January 1, ~~2022,~~2023, the Company adopted ASU ~~no. 2020-06,~~ Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU eliminates two models in ASC 470-20 for convertible instruments that require separate accounting for embedded conversion features namely cash conversion model and beneficial conversion feature model. The guidance also requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of share settlement for instruments that may be settled in cash or shares. The adoption had no material impact on the Company's consolidated results of operations, cash flows, financial position or disclosures.

~~Recently Issued Accounting Pronouncements~~

~~In September 2022, the FASB issued ASU 2022-04,~~ ~~Liabilities – Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations~~. This ASU requires that a buyer in a supplier finance program disclose the key terms of supplier finance programs, the amount of obligations outstanding at the end of the reporting period that the entity has confirmed as valid to the finance provider, where these obligations are recorded in the balance sheet, and a roll forward of the obligations. The new standard is effective for fiscal years beginning after December 15, 2022, on a retrospective basis, including interim periods within those fiscal years. The Company is currently evaluating the impact that adopting this standard will have on the consolidated financial statements.

~~In October 2021, the FASB issued ASU no.~~No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. While primarily related to contract assets and contract liabilities that were accounted for by the acquiree in accordance with ASC 606, the amendments also apply to contract assets and contract liabilities from other contracts to which the provisions of Topic 606 apply, such as contract liabilities from the sale of nonfinancial assets within the scope of Subtopic 610-20. The ASU was applied prospectively. The adoption had no material impact on the Company’s condensed consolidated results of operations, cash flows, financial position or disclosures.

Recently Issued Accounting Pronouncements

In March 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-01, Leases (Topic 842): Common Control Arrangements. The FASB-issued guidance clarifies the accounting for leasehold improvements associated with common control leases by requiring that leasehold improvements associated with common control leases be amortized by the lessee over the useful life of the leasehold improvements to the common control group (regardless of the lease term), as long as the lessee controls the use of the underlying asset through a lease. Additionally, leasehold improvements associated with common control leases should be ~~applied prospectively~~accounted for as a transfer between entities under common control through an adjustment to equity, if, and iswhen, the lessee no longer controls the use of the underlying asset. The amendments in this ASU are effective for ~~the Company for fiscal years~~annual and interim periods beginning after December 15, ~~2022, and interim periods within those fiscal years. Early adoption is permitted.~~2023. The Company is currently evaluating the impact that adopting this standard will have on ~~the~~its condensed consolidated financial statements.

~~In June 2016, the FASB issued ASU no. 2016-13,~~ ~~Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,~~ to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The Company will be required to use a forward-looking expected credit loss model for accounts receivables, loans, and other financial instruments. This ASU along with related additional clarificatory guidance in the ASU No. 2019-05, “~~Financial Instruments—Credit Losses (Topic 326)~~~~” and ASU No. 2019-11, “~~~~Codification Improvements to Topic 326, Financial Instruments—Credit Losses~~”, is effective for the Company for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. Adoption of the standard will be applied using a modified retrospective approach through a cumulative-effect adjustment to retained earnings as of the effective date. The Company is currently evaluating the impact that adopting this standard will have on the consolidated financial statements.

~~Table of Contents~~

3. Significant Accounting Policies

The information presented below supplements the Significant Accounting Policies information presented in ~~our 2021~~the 2022 Form 10-K.

Revenue Recognition

We account for revenue in accordance with ASC 606, Revenue from Contracts with Customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC 606. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The contract transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. All of our material sources of revenue are derived from contracts with customers, primarily relating to the provision of business and transaction processing services within each of our segments. We do not have any significant extended payment terms, as payment is received shortly after goods are delivered or services are provided.

Nature of Services

Our primary performance obligations are to stand ready to provide various forms of business processing services, consisting of a series of distinct services, but that are substantially the same, and have the same pattern of

Table of Contents

transfer over time, and accordingly are combined into a single performance obligation. Our promise to our customers is typically to perform an unknown or unspecified quantity of tasks and the consideration received is contingent upon the customers’ use (i.e., number of transactions processed, requests fulfilled, etc.); as such, the total transaction price is variable. We allocate variable fees to the single performance obligation charged to the distinct service period in which we have the contractual right to bill under the contract.

Disaggregation of Revenues

The Company is organized into three segments: Information & Transaction Processing Solutions (“ITPS”), Healthcare Solutions (“HS”), and Legal & Loss Prevention Services (“LLPS”) (See Note ~~13)~~13 – Segment and Geographic Area Information). The following tables disaggregate revenue from contracts by segment and by geographic region for the three and nine months ended September 30, ~~2022~~2023 and ~~2021:~~2022:


	Three Months Ended September 30,																Three Months Ended September 30,
	2022								2021								2023								2022
		ITPS		HS		LLPS		Total		ITPS		HS		LLPS		Total		ITPS		HS		LLPS		Total		ITPS		HS		LLPS		Total
U.S.A.	$	141,904	$	60,955	$	17,774	$	220,633	$	157,207	$	53,995	$	16,930	$	228,132	$	127,074	$	62,090	$	18,885	$	208,049	$	141,904	$	60,955	$	17,774	$	220,633
EMEA		39,053		—		—		39,053		46,561		—		—		46,561		40,035		—		—		40,035		39,053		—		—		39,053
Other		4,352		—		—		4,352		4,536		—		—		4,536		5,041		—		—		5,041		4,352		—		—		4,352
Total	$	185,309	$	60,955	$	17,774	$	264,038	$	208,304	$	53,995	$	16,930	$	279,229	$	172,150	$	62,090	$	18,885	$	253,125	$	185,309	$	60,955	$	17,774	$	264,038


	Nine Months Ended September 30,																Nine Months Ended September 30,
	2022								2021								2023								2022
		ITPS		HS		LLPS		Total		ITPS		HS		LLPS		Total		ITPS		HS		LLPS		Total		ITPS		HS		LLPS		Total
U.S.A.	$	429,979	$	173,940	$	55,946	$	659,865	$	492,620	$	161,292	$	53,564	$	707,476	$	410,598	$	188,740	$	60,095	$	659,433	$	429,979	$	173,940	$	55,946	$	659,865
EMEA		136,722		—		—		136,722		150,662		—		—		150,662		125,107		—		—		125,107		136,722		—		—		136,722
Other		13,619		—		—		13,619		14,156		—		—		14,156		15,143		—		—		15,143		13,619		—		—		13,619
Total	$	580,320	$	173,940	$	55,946	$	810,206	$	657,438	$	161,292	$	53,564	$	872,294	$	550,848	$	188,740	$	60,095	$	799,683	$	580,320	$	173,940	$	55,946	$	810,206

~~Table of Contents~~

Contract Balances

The following table presents contract assets, contract liabilities and contract costs recognized at September 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


	September 30,		December 31,		September 30,		December 31,		January 1,
	2022		2021		2023		2022		2022
Accounts receivable, net	$	93,600	$	184,102	$	96,867	$	101,616	$	184,102
Deferred revenues		16,726		17,518		14,881		17,585		17,518
Customer deposits		18,278		17,707		16,319		16,955		17,707
Costs to obtain and fulfill a contract		1,835		2,328	$	1,485	$	1,674	$	2,328

Accounts receivable, net includes ~~$24.3~~$29.7 million and ~~$22.6~~$25.7 million as of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively, representing amounts not yet billed to customers. We have accrued the unbilled receivables for work performed in accordance with the terms of contracts with customers.

Deferred revenues relate to payments received in advance of performance under a contract. A significant portion of this balance relates to maintenance contracts or other service contracts where we received payments for upfront conversions or implementation activities which do not transfer a service to the customer but rather are used in fulfilling the related performance obligations that transfer over time. The advance consideration received from customers is deferred over the contract term. We recognized revenue of ~~$15.3~~$1.6 million and $16.4 million during the three and nine months ended September 30, ~~2022~~2023, respectively that had been deferred as of December 31, ~~2021.~~2022. We recognized revenue of $1.8 million and $15.3 million during the three and nine months ended September 30, 2022, respectively that

Table of Contents

had been deferred as of January 1, 2022. We recognized revenue of $16.5 million during the year ended December 31, 2022 that had been deferred as of January 1, 2022.

Costs incurred to obtain and fulfill contracts are deferred and presented as part of intangible assets, net and expensed on a straight-line basis over the estimated benefit period. We recognized $0.2 million and $0.2 million of amortization for these costs for the three months ended September 30, 2023 and 2022, respectively, within depreciation and amortization expense. We recognized $0.6 million and $0.8 million of amortization for these costs for the nine months ended September 30, 2023 and 2022, respectively, within depreciation and amortization expense. We recognized $1.1 million of amortization for these costs in 2022 within depreciation and amortization expense. These costs represent incremental external costs or certain specific internal costs that are directly related to the contract acquisition or fulfillment and can be separated into two principal categories: contract commissions and fulfillment costs. Applying the practical expedient in ASC 340-40-25-4, we recognize the incremental costs of obtaining contracts as an expense when incurred, if the amortization period would have been one year or less. These costs are included in ~~Selling,~~selling, general and administrative expenses. The effect of applying this practical expedient was not material.

Customer deposits consist primarily of amounts received from customers in advance for postage. These advanced postage deposits are used to cover the costs associated with postage, with the corresponding postage revenue being recognized as services are performed.

Performance Obligations

At the inception of each contract, we assess the goods and services promised in our contracts and identify each distinct performance obligation. The majority of our contracts have a single performance obligation, as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts. For the majority of our business and transaction processing service contracts, revenues are recognized as services are provided based on an appropriate input or output method, typically based on the related labor or transactional volumes.

~~A certain number~~Certain of our contracts have multiple performance obligations, including contracts that combine software implementation services with post-implementation customer support. For contracts with multiple performance obligations, we allocate the contract’s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. The primary method used to estimate standalone selling price is the expected cost plus a margin approach, under which we estimate our expected costs of satisfying a performance obligation and add an appropriate margin for that distinct good or service. We also use the adjusted market approach whereby we estimate the price that customers in the market would be willing to pay. In assessing whether to allocate variable consideration to a specific part of the contract, we consider the nature of the variable payment and whether it relates specifically to its efforts to satisfy a specific part of the contract. ~~A certain number~~Certain of our software implementation performance obligations are satisfied at a point in time, typically when customer acceptance is obtained.

~~Table of Contents~~

When evaluating the transaction price, we analyze, on a contract-by-contract basis, all applicable variable consideration. The nature of our contracts ~~give~~gives rise to variable consideration, including volume discounts, contract penalties, and other similar items that generally decrease the transaction price. We estimate these amounts based on the expected amount to be provided to customers and reduce revenues recognized. We do not anticipate significant changes to our estimates of variable consideration.

We include reimbursements from customers, such as postage costs, in revenue, while the related costs are included in cost of revenue.

Table of Contents

Transaction Price Allocated to the Remaining Performance Obligations

In accordance with optional exemptions available under ASC 606, we did not disclose the value of unsatisfied performance obligations for (a) contracts with an original expected length of one year or less, and (b) contracts for which variable consideration relates entirely to an unsatisfied performance obligation, which comprise the majority of our contracts. We have certain non-cancellable contracts where we receive a fixed monthly fee in exchange for a series of distinct services that are substantially the same and have the same pattern of transfer over time, with the corresponding remaining performance obligations as of September 30, ~~2022~~2023 in each of the future periods below:


Estimated Remaining Fixed Consideration for Unsatisfied Performance Obligations	Estimated Remaining Fixed Consideration for Unsatisfied Performance Obligations			Estimated Remaining Fixed Consideration for Unsatisfied Performance Obligations

Remainder of 2022		$	10,559
2023			35,904
Remainder of 2023					$	10,169
2024			31,804			35,699
2025			28,332			30,338
2026			570			3,663
2027 and thereafter			—
2027						2,041
2028 and thereafter						1,226
Total		$	107,169		$	83,136

~~Table of Contents~~

4. Intangible Assets and Goodwill

Intangible Assets

Intangible assets are stated at cost or acquisition-date fair value less accumulated amortization and consists of the following:


	September 30, 2022						September 30, 2023
	Gross Carrying		Accumulated		Intangible		Gross Carrying		Accumulated		Intangible
	Amount (a)		Amortization		Asset, net		Amount (a)		Amortization		Asset, net
Customer relationships	$	507,396	$	(342,244)	$	165,152	$	507,675	$	(373,656)	$	134,019
Developed technology		88,553		(87,912)		641		88,553		(88,026)		527
Patent								15		(14)		1
Trade names (b)		8,415		(3,104)		5,311		8,400		(3,100)		5,300
Outsource contract costs		17,053		(15,217)		1,836		17,616		(16,131)		1,485
Internally developed software		51,305		(32,927)		18,378		55,107		(40,786)		14,321
Assembled workforce		4,473		(4,194)		279
Purchased software		26,749		(6,687)		20,062		26,749		(8,471)		18,278
Intangibles, net	$	703,944	$	(492,285)	$	211,659	$	704,115	$	(530,184)	$	173,931


	December 31, 2021						December 31, 2022
	Gross Carrying		Accumulated		Intangible		Gross Carrying		Accumulated		Intangible
	Amount (a)		Amortization		Asset, net		Amount (a)		Amortization		Asset, net
Customer relationships	$	508,241	$	(316,084)	$	192,157	$	507,723	$	(351,240)	$	156,483
Developed technology		88,553		(87,612)		941		88,553		(88,000)		553
Patent								15		(6)		9
Trade names (b)		8,400		(3,100)		5,300		8,400		(3,100)		5,300
Outsource contract costs		16,814		(14,486)		2,328		17,184		(15,509)		1,675
Internally developed software		49,108		(27,812)		21,296		52,441		(35,095)		17,346
Assembled workforce		4,473		(3,355)		1,118
Purchased software		26,749		(5,350)		21,399		26,749		(7,133)		19,616
Intangibles, net	$	702,338	$	(457,799)	$	244,539	$	701,065	$	(500,083)	$	200,982

(a)	Amounts include intangible assets acquired in business combinations and asset acquisitions.

(b)	The carrying amount of trade names for ~~2022~~2023 and ~~2021~~2022 is net of accumulated impairment losses of $44.1 million. Carrying amount of $5.3 million as at September 30, ~~2022~~2023 represents indefinite-lived intangible ~~asset.~~assets.

~~Goodwill~~

The Company’s operating segments are significant strategic business units that align its products and services with how it manages its business, approach the markets and interacts with customers. The Company is organized into three segments: ITPS, HS, and LLPS (See Note 13).

1413

Table of Contents

Goodwill

The Company’s operating segments are significant strategic business units that align its products and services with how it manages its business, approaches the markets and interacts with customers. The Company is organized into three segments: ITPS, HS, and LLPS (See Note 13 – Segment and Geographic Area Information).

Goodwill by reporting segment consists of the following:




	Balances as at January 1, 2021 (a)			Additions		Deletions		Impairments		Currency Translation Adjustments		Balances as at December 31, 2021 (a)	Balances as at January 1, 2023 (a)			Additions		Deletions			Impairments		Currency Translation Adjustments		Balances as at September 30, 2023 (a)
ITPS	$	254,130	$	—	$	(825)	$	—	$	(633)	$	252,672	$	81,151	$	—	$	(16,500)	(b)	$	—	$	(40)	$	64,611
HS		86,786		—		—		—		—		86,786		86,786		—		—			—		—		86,786
LLPS		18,865		—		—		—		—		18,865		18,865		—		—			—		—		18,865
Total	$	359,781	$	—	$	(825)	$	—	$	(633)	$	358,323	$	186,802	$	—	$	(16,500)		$	—	$	(40)	$	170,262

	Balances as at January 1, 2022 (a)			Additions		Deletions		Impairments		Currency Translation Adjustments		Balances as at September 30, 2022 (a)	Balances as at January 1, 2022 (a)			Additions		Deletions			Impairments		Currency Translation Adjustments		Balances as at December 31, 2022 (a)
ITPS	$	252,672	$	—	$	—	$	(29,565)	$	(687)	$	222,420	$	252,672	$	—	$	—		$	(171,182)	$	(339)	$	81,151
HS		86,786		—		—		—		—		86,786		86,786		—		—			—		—		86,786
LLPS		18,865		—		—		—		—		18,865		18,865		—		—			—		—		18,865
Total	$	358,323	$	—	$	—	$	(29,565)	$	(687)	$	328,071	$	358,323	$	—	$	—		$	(171,182)	$	(339)	$	186,802

(a)

The goodwill amount for all periods presented is net of accumulated impairment amounts. Accumulated impairment relating to ITPS ~~is $346.1~~was $487.7 million, ~~$316.5~~$487.7 million and ~~$317.5~~$316.5 million as at September 30, ~~2022,~~2023, December 31, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively. Accumulated impairment relating to LLPS iswas $243.4 million as at September 30, 2023, December 31, 2022 and December 31, 2021, ~~and December 31, 2020.~~respectively.

(b)	The deletion in goodwill is due to derecognition of allocated goodwill on sale of the high-speed scanner business in the second quarter of 2023. Refer to Note 1—General.

The Company tests for goodwill impairment at the reporting unit level on October 1 of each year and between annual tests if a triggering event indicates the possibility of an impairment. The Company monitors changing business conditions as well as industry and economic factors, among others, for events which could trigger the need for an interim impairment analysis. The Company concluded that a sustained decline in its stock price and its debt price, consistent with broad trends in the global financial markets during the first half of 2022 represented triggering event for impairment. Accordingly, the Company performed an interim impairment analysis at June 30, 2022, and concluded that no impairment relating to goodwill existed at June 30, 2022.

During the three months ended September 30, 2022, the Company assessed the fair value of the reporting units based upon a combination of the income and market approaches, which are standard valuation methodologies. The income approach uses discounted estimated future cash flows, whereas the market approach or guideline public company method utilizes market data of similar publicly traded companies. Our evaluation incorporated factors such as changes in the Company’s growth rate and recent trends in the Company’s market capitalization, and concluded that a triggering event for an interim impairment analysis had occurred in the third quarter of 2022. As part of the assessment, long-term projections were revised resulting in lower than previously projected long-term future cash flows for the reporting units which reduced the estimated fair value to below carrying value. As a result of the interim impairment analysis at September 30, 2022, the Company recorded an impairment charge of $29.6 million, including taxes to goodwill relating to ITPS. The impairment charges are included within Impairment of goodwill and other intangible assets in the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022.

5. Long-Term Debt and Credit Facilities

Senior Credit Facilities

On July 12, 2017, subsidiaries of the Company entered into a First Lien Credit Agreement with Royal Bank of Canada, Credit Suisse AG, Cayman Islands Branch, Natixis, New York Branch and KKR Corporate Lending LLC (the “Credit Agreement”) providing Exela Intermediate LLC, a wholly owned subsidiary of the Company, upon the terms

~~Table of Contents~~

and subject to the conditions set forth in the Credit Agreement, (i) a $350.0 million senior secured term loan ~~maturing~~scheduled to mature July 12, 2023 with an original issue discount of $7.0 million, and (ii) a $100.0 million senior secured revolving facility ~~that matured~~scheduled to mature on July 12, 2022 (the “Revolving Credit Facility”).

The Credit Agreement provided for the following interest rates for borrowings under the senior secured term facility and the Revolving Credit Facility: at the borrower’s option, either (1) an adjusted LIBOR, subject to a 1.0% floor in the case of term loans, or (2) a base rate, in each case plus an applicable margin. The initial applicable margin for the senior secured term facility was 7.5% with respect to LIBOR borrowings and 6.5% with respect to base rate borrowings. The initial applicable margin for the Revolving Credit Facility was 7.0% with respect to LIBOR borrowings and 6.0% with respect to base rate borrowings. The applicable margin for borrowings under the Revolving Credit Facility is subject to step-downs based on leverage ratios. The senior secured term loan is subject to amortization payments, commencing on the last day of the first full fiscal quarter of the Company following the closing date, of 0.6% of the aggregate principal amount for each of the first eight payments and 1.3% ~~of the aggregate original principal amount for payments thereafter, with any balance due at maturity.~~

~~Term Loan Repricing~~

On July 13, 2018, ~~Exela executed a transaction~~subsidiaries of the Company were able to ~~reprice~~refinance the $343.4 million of term loans then outstanding under ~~its senior secured credit facilities (the “Repricing”). The Repricing was accomplished pursuant to a First Amendment to~~ the ~~First Lien~~ Credit Agreement (the “First Amendment”), dated as of July 13, 2018, by and among the Company’s subsidiaries Exela Intermediate Holdings LLC, Exela Intermediate, LLC, each “Subsidiary Loan Party” listed on the signature pages thereto, Royal Bank of Canada, as administrative agent, and each of the lenders party thereto, whereby such subsidiaries borrowed $343.4 million of refinancing term loans (the “Repricing Term Loans”) and borrowed an additional $30.0 million pursuant to ~~refinance their existing senior secured~~incremental term ~~loans.~~loans (the “2018 Incremental Term Loans”). On April 16, 2019, subsidiaries of the Company borrowed a further $30.0 million pursuant to incremental term loans (the “2019 Incremental Term Loans”, and, together with the 2018 Incremental Terms Loans and Repricing Term Loans, referred to herein as the “2023 Term Loans”). The subsidiaries of the Company made periodic interest and principal repayments on the 2023 Term Loan under the terms of the loan agreements.

Table of Contents

On December 9, 2021, in a private exchange transaction, subsidiaries of the Company exchanged $212.1 million of 2023 Term Loans for $84.3 million in cash and $127.8 million principal amount of new 11.500% First-Priority Senior Secured Notes scheduled to mature July 12, 2026 (the “2026 Notes”) issued by Exela Intermediate LLC and Exela Finance Inc., wholly-owned subsidiaries of the Company (together, the “Issuers”).

~~In accordance with ASC 470~~ ~~– Debt – Modifications and Extinguishments,~~ asAs a result of ~~certain lenders that participated in Exela’s debt structure prior to~~ the ~~Repricing~~private exchange, repurchases (as discussed below) and ~~the Company’s debt structure after the Repricing, it was determined that a portion~~periodic principal repayments, $48.4 million aggregate principal amount of the ~~refinancing~~2023 Term Loans were outstanding as of ~~Exela’s senior secured credit facilities would be accounted for as~~July 11, 2023, the date the Company fully repaid and discharged the remaining outstanding balance of the 2023 Term Loans by making a cash payment of $44.8 million and by issuance of $3.0 million principal amount of new 11.500% First-Priority Senior Secured Notes scheduled to mature on April 15, 2026 (the “New Notes”) and issued by the Issuers in an exchange transaction (as discussed below). The Company recorded $0.6 million debt extinguishment gain on repayment of the 2023 Term Loans under ASC 470-50 and reported within debt modification and ~~the remaining would be accounted for as an extinguishment. The Company incurred $1.0 million~~extinguishment costs (gain), net in ~~new debt issuance costs related to the refinancing,~~our condensed consolidated statements of which $1.0 million was expensed pursuant to modification accounting. The proportion of debt that was extinguished resulted in a write off of previously recognized debt issue costs of $0.1 million. Additionally,operations for the ~~new lenders who exceeded the 10% test, less than $0.1 million was recorded as additional debt issue costs. All unamortized costs~~three and ~~discounts will be amortized over the life of the new term loan using the effective interest rate of the term loan.~~

nine months ended September 30, 2023.

The ~~Repricing~~2023 Term Loans ~~will bear~~bore interest at a rate per annum of, at the borrower’s option, either (a) a LIBOR rate determined by reference to the costs of funds for Eurodollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs, subject to a 1.0% floor, or (b) a base rate determined by reference to the highest of (i) the federal funds rate plus 0.5%, (ii) the prime rate and (iii) the one-month adjusted LIBOR plus 1.0%, in each case plus an applicable margin of 6.5% for LIBOR loans and 5.5% for base rate loans. The interest rates applicable to the Repricing Term Loans are 100 basis points lower than the interest rates applicable to the existing senior secured term loans that were incurred on July 12, 2017 pursuant to the Credit Agreement. The Repricing Term Loans will mature on July 12, 2023, the same maturity date as the prior senior secured term loans.

~~2018 Incremental Term Loans~~

On July 13, 2018, the Company’s subsidiaries borrowed an additional $30.0 million pursuant to incremental term loans (the “Incremental Term Loans”) under the First Amendment. The proceeds of the Incremental Term Loans may be used by the Company for general corporate purposes and to pay fees and expenses in connection with the First Amendment. The interest rates applicable to the Incremental Term Loans are the same as those for the Repricing Term Loans.

The borrower may voluntarily repay the Repricing Term Loans and the Incremental Term Loans at any time, without prepayment premium or penalty, subject to customary “breakage” costs with respect to LIBOR rate loans. The

~~Table of Contents~~

~~Incremental Term Loans will mature on July 12, 2023, the same maturity date as the Repricing Term Loans and prior senior secured term loans.~~

Other than as described above, the terms, conditions and covenants applicable to the Repricing Term Loans and the Incremental Term Loans are consistent with the terms, conditions and covenants that were applicable to the existing senior secured loans under the Credit Agreement.

~~2019 Incremental Term Loan~~

On April 16, 2019, the Company’s subsidiaries borrowed an additional $30.0 million pursuant to incremental term loans (the “2019 Incremental Term Loans”) under the Second Amendment to First Lien Credit Agreement (the “Second Amendment”). The proceeds of the 2019 Incremental Term Loans were used to replace the cash spent for acquisitions, pay related fees, expenses and related borrowings and for general corporate purposes. The 2019 Incremental Term Loans will mature on July 12, 2023, the same maturity date as the Incremental Term Loans, Repricing Term Loans and prior senior secured term loans under the Credit Agreement (collectively, the “Term Loans”).

The 2019 Incremental Term Loans will bear interest at a rate per annum that is the same as the Repricing Term Loans under the senior credit facility. The 2019 Incremental Term Loans will mature on July 12, 2023, the same maturity date as the Term Loans. The borrower may voluntarily repay the 2019 Incremental Term Loans at any time, without prepayment premium or penalty, subject to customary “breakage” costs with respect to LIBOR rate loans.

Other than as described above, the terms, conditions and covenants applicable to the 2019 Incremental Term Loans are consistent with the terms, conditions and covenants that are applicable to the Repricing Term Loans and 2018 Incremental Term Loans under the Credit Agreement. The Repricing and issuance of the 2018 and 2019 Incremental Term Loans resulted in a partial debt extinguishment, for which Exela recognized $1.4 million in debt extinguishment costs during the year ended December 31, 2019, reported within Debt modification and extinguishment costs (gain), net within our consolidated statements of operations.

~~Third Amendment~~

On May 18, 2020, subsidiaries of the Company amended the Credit Agreement (the Third Amendment to First Lien Credit Agreement (the “Third Amendment”)) to, among other things, extend the time for delivery of its audited financial statements for the year ended December 31, 2019 and its financial statements for the quarter ended March 31, 2020. Upon the Company’s delivery of the annual and quarterly financial statements within the time frames stated therein (which the Company satisfied during the month of June 2020), the borrower became in compliance with respect to the financial statement delivery requirements set forth in the Credit Agreement. Pursuant to the Third Amendment, the borrowers also amended the Credit Agreement to, among other things: restrict the borrower and its subsidiaries’ ability to designate or invest in unrestricted subsidiaries; incur certain debt; create certain liens; make certain investments; pay certain dividends or other distributions on account of its equity interests; make certain asset sales or other dispositions (or utilize the proceeds of certain asset sales to reinvest in the business); or enter into certain affiliate transactions pursuant to the negative covenants under the Credit Agreement. Further, pursuant to the amendment, the borrower under the Credit Agreement was also required to maintain a minimum Liquidity (as defined in the amendment) of $35.0 million. In connection with this amendment, the borrower paid a forbearance fee of $5.0 million to the consenting lenders. The Company concluded that the amendment represents modification of debt under ASC 470-50. Accordingly, the forbearance fee paid was added to unamortized debt issuance cost which shall be amortized using updated effective interest rate based on modified cash flows.

~~Private Exchange~~

On December 9, 2021, in a separate transaction referred to here as the “Private Exchange” (as distinguished from the “Public Exchange” described below), subsidiaries of the Company agreed with three (3) of their Term Loan lenders to exchange $212.1 million of Term Loans under the Credit Agreement for $84.3 million in cash and in $127.8 million principal amount of new 11.500% First-Priority Senior Secured Notes due 2026 (the “2026 Notes”). In connection with the Private Exchange, the exchanging lenders provided consents to amend the Credit Agreement to (i)

~~Table of Contents~~

~~eliminate all affirmative covenants, (ii) eliminate all negative covenants and (iii) eliminate certain events of default (other than events of default relating to payment obligations).~~

As a result of the Private Exchange, repurchases (as discussed below) and periodic principal repayments, $77.8 million aggregate principal amount of the Term Loans maturing July 12, 2023 remains outstanding as of September 30, 2022.

Revolving Credit Facility; Letters of Credit

As of December 31, 2021, ~~our~~the $100 million Revolving Credit Facility was fully drawn taking into account approximately $0.5 million in letters of credit issued ~~thereunder.~~thereunder as of such date. As of December 31, ~~2021, there were outstanding irrevocable letters of credit totaling approximately $0.5 million under the Revolving Credit Facility. As of September 30,~~ 2022, the Revolving Credit Facility had been prepaid and terminated as described below.

On March 7, 2022, subsidiaries of the Company entered into a Revolving Loan Exchange and Prepayment Agreement with Royal Bank of Canada, Credit Suisse AG, Cayman Islands Branch, KKR Corporate Lending LLC, Granite State Capital Master Fund LP, Credit Suisse Loan Funding LLC and Revolvercap Partners Fund LP exchanging $100.0 million of outstanding Revolving Credit Facility owed by Exela Intermediate LLC, upon the terms and subject to the conditions set forth in the Revolver Exchange agreement, for (i) $50.0 million in cash, and (ii) $50.0 million of 2026 Notes (such exchange, the “Revolver Exchange” and such 2026 Notes, the “Exchange Notes”). Prepayment of Revolving Credit Facility was treated as an extinguishment of debt under ASC 470-50. Accordingly, the Company wrote off the unamortized balance of $0.2 million of debt issuance costs related to Revolving Credit Facility and reported it within ~~Debt~~debt modification and extinguishment costs (gain), net in our condensed consolidated statements of operations for the nine months ended September 30, 2022.

The Exchange Notes were subject to a guarantee in the form of a true-up mechanism whereby subsidiaries of the Company ~~was~~were responsible to make a payment to the holders of the Exchange Notes to true-up the shortfall below certain agreed thresholds, if holders of the Exchange Notes sold their notes at a price below that threshold during agreed periods in 2022. As security for the true-up obligation under the Revolver Exchange, subsidiaries of the Company issued $10.0 million of principal amount of 2026 Notes as collateral (the “Collateral Notes”). The Collateral Notes were not reflected in the ~~condensed~~ consolidated financial statements unless and until they were sold to third parties. On March 7, 2022, we recognized $17.4 million (the fair value of the true-up obligation as accounted for under ASC 450, Contingencies and ASC 460, Guarantees) as a true-up liability with an offsetting debit to the original issuance discount of the issued Exchange Notes on the closing date of the Revolver Exchange. We remeasured our obligation under the true-up mechanism as of March 31, 2022 and accrued an additional $6.2 million liability based on fair value of our obligation in Other expense, net on the condensed consolidated statements of operations for the three months ended March 31, 2022.

On May 6, 2022, subsidiaries of the Company amended the true-up mechanism and placed an additional $20.0 million of principal amount of Collateral Notes and paid $5.0 million asagainst the true-up ~~advance.~~amount payable. We remeasured our obligation under the ~~amended terms of the~~ true-up mechanism as of ~~June~~September 30, 2022 and accrued an additional ~~$7.4~~$13.6 million of true-up liability based on the fair value of our obligation ~~as of such date~~ in ~~Other~~other expense, net in the condensed consolidated statements of operations for the ~~three~~nine months ended ~~June~~September 30, 2022. As of June 30, 2022, there was a net accrued liability balance of $26.0 million for the true-up obligation included in Accrued liabilities on the condensed consolidated balance sheet after adjusting $5.0 million of true-up advance paid for this liability during the second quarter of 2022.

In July 2022, $9.0 million of principal amount of the Collateral Notes were sold by the holders of the Exchange Notes for net proceeds of $2.6 million and the proceeds were ~~adjusted~~applied against the true-up amount payable. Additionally, in July 2022, the Company made a cash payment of $2.1 million which was applied against the true-up amount payable.

Table of Contents

In August 2022, the remaining balance of $20.2 million of net true-up liability was settled with cash payments of $9.9 million and by permitting the holders of the Exchange Notes to keep the $21.0 million of principal amount of 2026 Notes previously placed as Collateral Notes constituting an issuance. The Company made a net reversal of $1.1 million of accrued true-up liability in ~~Other~~other expense (income), net in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022.

~~Table of Contents~~

~~Senior Secured~~ 2023 Notes

On July 12, 2017, ~~subsidiaries of~~ the ~~Company~~Issuers issued $1.0 billion in aggregate principal amount of 10.0% First Priority Senior Secured Notes due 2023 (the “2023 Notes”). The 2023 Notes ~~are~~were guaranteed by ~~certain~~nearly all U.S. subsidiaries of ~~the Company.~~Exela Intermediate LLC. The 2023 Notes ~~bear~~bore interest at a rate of 10.0% per year. The issuers ~~pay~~paid interest on the 2023 Notes on January 15 and July 15 of each year, commencing on January 15, 2018. The 2023 Notes mature on July 15, 2023. As a result of the Public Exchange and repurchases (as discussed below), $22.8 million aggregate principal amount of the 2023 Notes remains outstanding as of September 30, 2022 maturing on July 15, 2023.

~~Public Exchange~~

On October 27, 2021, the Company launched an offer to exchange (the “Public Exchange”) up to $225.0 million in cash and new 2026 Notes for the Company’s outstanding 2023 Notes. The Public Exchange was for $900 in cash per $1,000 principal amount of 2023 Notes tendered subject to proration. The maximum amount of cash to be paid was $225.0 million and the offer was not subject to any minimum participation condition. In case of oversubscription to the cash offer, tendered 2023 Notes would be accepted for cash on a pro rata basis (as a single class). The balance of any tendered 2023 Notes not accepted for cash would be exchanged into 2026 Notes on the basis of $1,000 principal amount of new 2026 Notes for each $1,000 principal amount of outstanding 2023 Notes tendered.

~~As of the expiration time of the Public Exchange, $912.7 million aggregate principal amount, or approximately 91.3%, of the 2023 Notes had been validly tendered pursuant to the Public Exchange.~~ On December 9, 2021, upon the settlement of ~~the Public Exchange,~~a public exchange, $662.7 million aggregate principal amount of the 2026 Notes were issued and an aggregate $225.0 million in cash (plus accrued but unpaid interest) was paid to participating holders in respect of the validly tendered ~~2023 Notes.~~

~~Third Supplemental Indenture~~

In conjunction with the Public Exchange, the Company also solicited consents to amend certain provisions in the indenture governing the 2023 Notes (“Notes Amendments”). On December 1, 2021, on receipt$912.7 million principal amount of the requisite consents to the Notes Amendments, the Company, and Wilmington Trust, National Association, as trustee (the “2023 Notes Trustee”), entered into a third supplemental indenture (the “Third Supplemental Indenture”) to the indenture, dated as of July 12, 2017 (as amended and supplemented by (i) the first supplemental indenture, dated as of July 12, 2017 and (ii) the second supplemental indenture, dated as of May 20, 2020, the “2023 Notes Indenture”) governing the outstanding 2023 Notes. The ~~Third Supplemental Indenture amends~~Company concluded that the public exchange of notes represented modification of debt under ASC 470-50.

As a result of the public exchange and repurchases (as discussed below), $9.0 million aggregate principal amount of the 2023 Notes ~~Indenture and~~remained outstanding as of July 11, 2023, the date the Company fully repaid the remaining outstanding balance of the 2023 Notes to eliminate substantially all of the restrictive covenants, eliminate certain events of default, modify covenants regarding mergers and consolidations and modify or eliminate certain other provisions, including certain provisions relating to future guarantors and defeasance, contained in ~~the 2023 Notes Indenture and the 2023 Notes. In addition, all of the collateral securing the 2023 Notes was released pursuant to the Third Supplemental Indenture.~~cash.

~~Senior Secured~~ 2026 Notes

As of December 31, ~~2021, subsidiaries of~~2022, the ~~Company~~Issuers had ~~$795.0~~$980.0 million aggregate principal amount of the 2026 Notes ~~outstanding including $790.5 million in aggregate principal amount issued under the Public Exchange and Private Exchange transactions described above.~~

outstanding. During the nine months ended September 30, ~~2022,~~2023, no 2026 Notes were sold by subsidiaries of the Company sold $150.0 million in aggregate of principal amount of the 2026 Notes generating net proceeds of $75.0 million. On March 18, 2022, the subsidiaries of the Company issued $50.0 million of the 2026 Notes to satisfy the exchange obligation under the Revolver Exchange.Company. The 2026 Notes are guaranteed by ~~certain~~nearly all U.S. subsidiaries of ~~the Company.~~Exela Intermediate LLC. The 2026 Notes bear interest at a rate of 11.5% per year. ~~The issuers shall~~We are required to pay interest on the 2026 Notes on January 15 and July 15 of each year, ~~commencing~~and commenced making such interest payments on July 15, 2022. The 2026 Notes are scheduled to mature on July 12, 2026.

~~On or after December 1, 2022, the issuers~~ The Issuers may redeem the 2026 Notes in whole or in part from time to time, at a redemption price of 100%, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date.

On July 11, 2023, the Issuers, certain guarantors and U.S. Bank Trust Company, National Association, as trustee, entered into an indenture (the “New Notes Indenture”) governing the Company’s New Notes and issued approximately $764.8 million aggregate principal amount of the New Notes as consideration for the exchange of $956.0 million aggregate principal amount of the Issuers’ existing 2026 Notes pursuant to a public exchange offer (the “2023 Exchange”), which was equivalent to issuing $800 of the New Notes per $1,000 principal amount of the existing 2026 Notes. The Company performed an assessment of the 2023 Exchange and determined that it met the criteria to be accounted for as a troubled debt restructuring under ASC 470-60. The undiscounted cash flows associated with the New Notes issued were compared to the carrying value of the exchanged 2026 Notes and since the undiscounted cash flows of the New Notes exceeded the carrying value of the exchanged 2026 Notes, the carrying value of the New Notes was established at the carrying value of the exchanged 2026 Notes and the Company established new effective interest rates based on the carrying value of the exchanged 2026 Notes prior to the 2023 Exchange. The difference between the principal amount of the issued New Notes and their carrying value was recorded as a premium and is included in long-term debt on the Company’s condensed consolidated balance sheets. The Company recorded a premium of $142.3 million on the notes exchange, which will be reduced as contractual interest payments are made on the New Notes.

On July 11, 2023, we entered into a seventh supplemental indenture to the 2026 Notes Indenture which eliminated substantially all of the restrictive covenants, eliminated certain events of default, modified covenants regarding mergers and consolidations and modified or eliminated certain other provisions, including certain provisions relating to future guarantors and defeasance, contained in the 2026 Notes Indenture and the 2026 Notes. In addition, all of the collateral securing the 2026 Notes was released pursuant to the seventh supplemental indenture.

1916

Table of Contents

~~In addition, prior~~The July 11, 2023 transaction resulted in cancellation of debt income (“CODI”) for tax purposes. Absent an exception, a debtor recognizes CODI upon discharge of its outstanding indebtedness for an amount of consideration that is less than the outstanding debt. The Internal Revenue Code of 1986, as amended, (the “Code”), provides that a debtor may exclude CODI from taxable income but must reduce certain of its tax attributes by the amount of CODI. Pursuant to the US tax rules, the Company computes the final CODI calculation based on the tax basis as of the last day of the fiscal tax year (i.e., December ~~1, 2022,~~31, 2023) which includes the date in which the debt transaction occurred. As such, the Company applied its best estimate as of July 12, 2023 (transaction date) to compute the CODI impact knowing that certain amounts will change based on regular business operations. For the period ended September 30, 2023, the Company estimated CODI in the amount of $600 million will be excluded from taxable income and result in a partial reduction in the gross U.S. federal and state net operating losses. The Company will finalize the tax effects of CODI, including the estimated tax effects of tax basis and attribute reduction recognized as a result of the debt transaction in the final December 31, 2023 financial statements and subsequent tax return filings.

As a result of the 2023 Exchange and repurchases (as discussed below), $24.0 million aggregate principal amount of the 2026 Notes maturing July 12, 2026 remained outstanding as of September 30, 2023.

Senior Secured New Notes

On July 11, 2023, the Issuers issued approximately $767.8 million aggregate principal amount of the New Notes under the New Notes Indenture, which includes the New Notes issued under the 2023 Exchange (as described above) and as consideration for the exchange of certain of the Company’s outstanding 2023 Term Loans (as described above). The New Notes are scheduled to mature on April 15, 2026.

Interest on the New Notes will accrue at 11.500% per annum and will be paid semi-annually, in arrears, on January 15 and July 15 of each year, beginning July 15, 2023. Interest will be payable in cash or in kind by issuing additional New Notes (or increasing the principal amount of the outstanding New Notes) (“PIK Interest”) as described below: (A) for the July 15, 2023 interest payment date, such interest was paid in kind as PIK Interest, (B) for each interest payment date from and including the January 15, 2024 interest payment date through and including the July 15, 2024 interest payment date, such interest shall be paid in cash in an amount equal to (i) 50% of such interest plus (ii) an amount not to exceed an amount that, pro forma for such payment, would leave the issuers with Unrestricted Cash (as defined in the New Notes Indenture) of at least $15.0 million, with the remaining interest paid in kind as PIK Interest, and (C) for interest payment dates falling on or after January 15, 2025, such interest shall be paid in cash.

On July 15, 2023, the Company issued $44.1 million in aggregate principal amount of the New Notes as a payment for PIK Interest due on July 15, 2023. $811.9 million aggregate principal amount of the New Notes maturing April 15, 2026 remained outstanding as of September 30, 2023.

The Issuers’ obligations under the New Notes and the New Notes Indenture are irrevocably and unconditionally guaranteed, jointly and severally, by the same guarantors (the “Guarantors”) that guarantee the 2026 Notes (other than certain guarantors that have ceased to have operations or assets) and by certain of the Issuers’ other affiliates (the “Affiliated Guarantors”). The New Notes and the related guarantees are first-priority senior secured obligations of the Issuers, the Guarantors and Affiliated Guarantors.

The issuers may redeem the ~~2026~~New Notes at their option, in whole at any time or in part from time to time, at a redemption price ~~equal to~~of 100% ~~of the principal amount of the 2026 Notes redeemed,~~, plus ~~the Applicable Premium as of, and~~ accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. ~~“Applicable Premium” means,~~In addition, the New Notes will be mandatorily redeemable in part upon the sale of certain assets that constitute additional credit support.

The New Notes Indenture contains covenants that limit the Issuers’ and the Affiliated Guarantors (as defined below) and their respective subsidiaries’ ability to, among other things, (i) incur or guarantee additional indebtedness, (ii) pay dividends or distributions on, or redeem or repurchase, capital stock and make other restricted payments, (iii) make investments, (iv) consummate certain asset sales, (v) engage in certain transactions with ~~respect~~affiliates, (vi) grant or assume certain liens and (vii) consolidate, merge or transfer all or substantially all of their assets. These covenants are subject to a number of important limitations and exceptions. In addition, upon the occurrence of specified change of

Table of Contents

control events, the Issuers must offer to repurchase the New Notes at 101% of the principal amount, plus accrued and unpaid interest, if any, ~~2026 Note~~to, but excluding, the applicable repurchase date. The New Notes Indenture also provides for events of default, which, if any of them occurs, would permit or require the principal, premium, if any, interest and any other monetary obligations on ~~any applicable redemption date, as determined by the issuers, the greater of: (1) 1%~~all of the then outstanding ~~principal amount of the 2026 Note;~~New Notes to be due and (2) the excess of: (a) the present value at such redemption date of (i) the redemption price of the 2026 Note, at December 1, 2022 plus (ii) all required interest payments due on the 2026 Note through December 1, 2022 (excluding accrued but unpaid interest), computed using a discount rate equal to the treasury rate as of such redemption date plus 50 basis points; over (b) the then outstanding principal amount of the 2026 Note.

~~$980.0 million aggregate principal amount of 2026 Notes were outstanding as of September 30, 2022.~~payable immediately.

Repurchases

In July 2021, the Company commenced a debt buyback program to repurchase senior secured indebtedness, which is ongoing. During the three and nine months ended September 30, 2021, we repurchased $54.5 million of our 2023 Notes for a net cash consideration of $40.2 million. The gain on early extinguishment of debt for the 2023 Notes during the three and nine months ended September 30, 2021 totaled $13.7 million and is inclusive of $0.5 million and $0.2 million write off of original issue discount and debt issuance costs, respectively. During the three and nine months ended September 30, 2021, we also repurchased $35.1 million of the outstanding principal amount of our senior secured term loan under the Credit Agreement for a net cash consideration of $19.0 million. The gain on early extinguishment of debt for the senior secured term loan during the three and nine months ended September 30, 2021 totaled $14.4 million and is inclusive of $0.4 million and $1.4 million write off of original issue discount and debt issuance costs, respectively.

~~During the three and nine months ended September 30,~~ 2022, we repurchased $15.0 million principal amount of the Exchange Notes issued under the Revolver Exchange (as discussed above) for a net cash consideration of $4.7 million. The gain on early extinguishment of debt for the Exchange Notes during the three and nine months ended September 30, 2022 totaled $5.3 million and is inclusive of $5.0 million and $0.1 million write off of original issue discount and debt issuance costs, respectively.

During the nine months ended September 30, 2023, we repurchased $13.8 million principal amount of the 2023 Notes for a cash consideration of $4.4 million. The gain on early extinguishment of debt for the 2023 Notes during the nine months ended September 30, 2023 totaled $9.9 million and is inclusive of less than $0.1 million write off of original issue discount and debt issuance costs. During the nine months ended September 30, 2023, we repurchased $15.1 million principal amount of the 2023 Term Loans for a cash consideration of $8.0 million. The gain on early extinguishment of debt for the 2023 Term Loans during the nine months ended September 30, 2023 totaled $7.1 million and is inclusive of less than $0.1 million write off of original issue discount and debt issuance costs. Gain on the early extinguishment of debt ~~and debt extinguishment costs during the three and nine months ended September 30, 2022 and 2021 are~~is reported within ~~Debt~~debt modification and extinguishment costs (gain), net within our condensed consolidated statements of operations.

BRCC Facility

On November 17, 2021, GP2 XCV, LLC, a subsidiary of the Company (“GP2 XCV”), entered into a borrowing facility with B. Riley Commercial Capital, LLC (which was subsequently assigned to BRF Finance Co., LLC (“BRF Finance”)) pursuant to which ~~the Company~~such subsidiary was able to borrow an original principal amount of $75.0 million, which was later increased to $115.0 million as of December 7, 2021 (as the same may be amended from time to time, the “BRCC Term Loan”). On March 31, 2022, GP2 XCV ~~entered into an amendment to the borrowing facility with~~and B. Riley Commercial Capital, LLC ~~pursuant~~amended this facility to ~~which the Company will be able~~permit GP2 XCV to borrow up to $51.0 million under a separate revolving loan (the “BRCC Revolver”, collectively with the BRCC Term Loan, the “BRCC Facility”).

The BRCC Facility is secured by a lien on all the assets of GP2 XCV and by a pledge of the equity of GP2 XCV. GP2 XCV is a bankruptcy-remote entity, and as such its assets are not available to other creditors of the Company or any of its subsidiaries other than GP2 XCV. The BRCC Facility will mature on June 10, 2023. However, the BRCC Revolver is subject to certain automatic maturity extensions of six months, unless B. Riley Commercial Capital, LLC or the Company notifies the other party about its election not to extend. In such event, the outstanding principal amount of the BRCC Revolver as of the maturity shall be due and payable in 12 equal installments on the last business day of each calendar month thereafter. Interest under the BRCC Facility accrues at a rate of 11.5% per annum (13.5% per annum default rate) and is payable quarterly on the last business day of each March, June, September and December. The purpose of BRCC Term Loan was to fund certain repurchases of the secured indebtedness and to provide funding for ~~the Public Exchange transaction and Private Exchange transaction described above.~~certain debt exchange transactions. The purpose of BRCC Revolver is to fund general corporate purposes.

~~Table of Contents~~

During the nine months ended September 30, ~~2022,~~2023, we borrowed $9.6 million of principal amount under the BRCC Revolver. During the nine months ended September 30, 2023, we repaid ~~$59.2~~$48.5 million and $3.7 million of outstanding principal amount under the BRCC Term Loan and the BRCC Revolver, respectively along with ~~$1.8~~$1.6 million of exit ~~fees.~~fees on the BRCC Term Loan. The exit fees paid on the ~~partial~~ prepayment of the BRCC Term Loan were treated as a debt extinguishment cost under ASC 470-50 and reported within ~~Debt~~debt modification and extinguishment costs (gain), net in our condensed consolidated statements of operations. The BRCC Facility matured on June 10, 2023. As of September 30, ~~2022,~~2023, the Company had fully repaid the outstanding balance under the BRCC Term Loan. As of September 30, 2023, there were borrowings of ~~$55.8 million and $20.0~~$25.9 million outstanding under the BRCC ~~Term Loan and BRCC Revolver, respectively, maturing June 10, 2023. There was no availability~~Revolver. The outstanding principal amount under the BRCC Revolver is payable in eleven (11) monthly installments of $2.0 million commencing October 31, 2023, with the remaining outstanding principal balance of $3.9 million payable on September 30, 2024.

Table of Contents

Senior Secured Term Loan

On July 11, 2023, Exela Intermediate LLC and Exela Finance Inc., wholly-owned subsidiaries of the Company, entered into a financing agreement with certain lenders and Blue Torch Finance LLC, as administrative agent, pursuant to which the lenders extended a term loan of principal amount of $40.0 million (“Senior Secured Term Loan”). On the same date, the Company used proceeds of this term loan and cash on hand to repay its outstanding 2023 Notes and 2023 Term Loans.

The Senior Secured Term Loan shall be, at the option of the Company, either a Reference Rate Loan, or a SOFR Rate Loan. Each portion of the Senior Secured Term Loan that is a Reference Rate Loan bears interest on the principal amount outstanding from the date of the Senior Secured Term Loan until repaid, at a rate per annum equal to the Reference Rate plus the Applicable Margin. “Reference Rate” for any period means the greatest of (i) 4.00% per annum, (ii) the federal funds rate plus 0.50% per annum, (iii) the Adjusted Term SOFR (which rate shall be calculated based upon an interest period of 1 month and shall be determined on a daily basis) plus 1.00% per annum, and (iv) the rate last quoted by the Wall Street Journal as the "Prime Rate" in the United States. “Applicable Margin,” with respect to the interest rate of (a) any Reference Rate Loan is 10.39% per annum, and (b) any SOFR Rate Loan is 11.39% per annum. SOFR Rate Loans shall bear interest on the principal amount outstanding, at a rate per annum equal to the Adjusted Term SOFR rate for the Interest Period in effect for the Term Loan plus Applicable Margin. “Adjusted Term SOFR” means the rate per annum equal to Term SOFR for such calculation, plus 0.26161%. “Term SOFR,” for calculation with respect to a SOFR Rate Loan, is the per annum forward-looking term rate based on secured overnight financing rate for a tenor comparable to the applicable interest period on the day that is two business days prior to the first day of such interest period. However, with respect to a Reference Rate Loan, “Term SOFR” means the per annum forward-looking term rate based on secured overnight financing rate for a tenor of three months on the day that is two business days prior to such day. If Term SOFR as so determined shall ever be less than 4.00%, then Term SOFR shall be deemed to be 4.00%.

The Company may, at any time, elect to have interest on all or a portion of the loans be charged at a rate of interest based upon Term SOFR (the “SOFR Option”) by notifying the administrative agent at least 3 business days. Such notice needs to be provided in the case of the continuation of a SOFR Rate Loan as a SOFR Rate Loan on the last day of the then current interest period. The Company shall have not more than 5 SOFR Rate Loans in effect at any given time, and only may exercise the SOFR Option for SOFR Rate Loans of at least $500,000 and integral multiples of $100,000 in excess thereof.

The outstanding principal amount of the Senior Secured Term Loan shall be repaid in eleven (11) equal quarterly installments of $0.5 million commencing December 31, 2023, with the remaining outstanding principal amount of $34.5 million payable at maturity along with accrued and unpaid interest. The maturity date of the Senior Secured Term Loan shall be the earlier of July 11, 2026 and the date that is 91 days prior to the earliest maturity of any of the New Notes or the 2026 Notes (after giving effect to any refinancing indebtedness).

The Company may, at any time, prepay the principal of the Senior Secured Term Loan. Each prepayment shall be accompanied by the payment of accrued interest and the applicable premium, if any. Each prepayment shall be applied against the remaining installments of principal due on the Senior Secured Term Loan in the inverse order of maturity. The applicable premium shall be payable in the form of a make-whole amount if prepayment is made within one year of the borrowing date (the “First Period”). If optional prepayment is made after the year one anniversary of the borrowing date to the date of the two-year anniversary (the “Second Period”), the applicable premium shall be an amount equal to 1% times the amount of the principal amount of the Senior Secured Term Loan being paid on such date. The applicable premium shall be zero in case of prepayment after the date of the two-year anniversary of the borrowing date. Further, during the Second Period, if the prepayment is because of an event of default or termination of contract for any reason, the applicable premium shall be 1% times the aggregate principal amount of the Senior Secured Term Loan outstanding on such date.

The Senior Secured Term Loan contains customary events of default, affirmative and negative covenants, including limitation on the Company’s and certain of its subsidiaries’ ability to create, incur or allow certain liens; enter

Table of Contents

into sale and lease-back transactions; make any restricted payments; undergo fundamental changes, as well as certain financial covenants. The Company was in compliance with all financial covenants as of September 30, ~~2022.~~2023.

Securitization Facility

On December 17, 2020, certain subsidiaries of the Company entered into a $145.0 million securitization facility with a five year term (the “Securitization Facility”) with certain lenders and Alter Domus (US), LLC, as administrative agent (the “Securitization Administrative Agent”). Borrowings under the Securitization Facility were subject to a borrowing base definition that consists of receivables and, subject to contribution, further supported by inventory and intellectual property, in each case, subject to certain eligibility criteria, concentration limits and reserves.

The Securitization Facility provided for an initial funding of approximately $92.0 million supported by ~~the~~ receivables, ~~portion of the borrowing base~~ and, subject to contribution, a further funding of approximately $53.0 million to be supported by inventory and intellectual property. On December 17, 2020, Exela Receivables 3, LLC (the “Securitization Borrower”) made the initial borrowing of approximately $92.0 million under the Securitization Facility and used a portion of the proceeds to repay $83.0 million of the aggregate outstanding principal amount of loans as of December 17, 2020 under a previous $160.0 million accounts receivable securitization facility (“A/R Facility”) and used the remaining proceeds for general corporate purposes. On April 11, 2021, the Company amended the Securitization ~~Loan Agreement and agreed~~Facility to, among other things, extend the ~~option to~~period during which the Company could access ~~further funding of~~the approximately $53.0 million in additional borrowings ~~from April 10, 2021 to September 30, 2021~~ upon the contribution of inventory and intellectual property to support the borrowing ~~base.~~base from April 10, 2021 to September 30, 2021.

The ~~documentation for the Securitization Facility included (i) a Loan and Security Agreement (the “Securitization Loan Agreement”), dated as of December 10, 2020, by and among the~~ Securitization Borrower, a wholly-owned indirect subsidiary of the Company, the lenders (each, a “Securitization Lender” and collectively the “Securitization Lenders”), Alter Domus (US), LLC, as administrative agent (the “Securitization Administrative Agent”) and the Company, as initial servicer, pursuant to which the Securitization Lenders will make loans to the Securitization Borrower to be used to purchase receivables and related assets from the Securitization Parent SPE (as defined below), (ii) a First Tier Receivables Purchase and Sale Agreement (dated as of December 17, 2020, by and among Exela Receivables 3 Holdco, LLC (the “Securitization Parent ~~SPE”)~~SPE,” and together with the Securitization Borrower, the “SPEs”), ~~a wholly-owned indirect subsidiary of~~ the Company, and certain ~~other indirect, wholly-owned~~of our operating subsidiaries ~~of the Company listed therein (collectively, the “Securitization Originators”), and the Company, as initial servicer, pursuant~~that agreed to ~~which each Securitization Originator has sold or contributed and will~~ sell ~~or contribute to the Securitization Parent SPE certain~~ receivables and related assets in consideration for a combination of cash and equity in the Securitization Parent SPE, (iii) a Second Tier Receivables Purchase and Sale Agreement, dated as of December 17, 2020, by and among, the Securitization Borrower, the Securitization Parent SPE and the Company, as initial servicer, pursuant to which Securitization Parent SPE has sold or contributed and will sell or contribute to the Securitization Borrower certain receivables and related assets in consideration for a combination of cash and equity in the Securitization Borrower, (iv) the Sub-Servicing Agreement, dated as of December 17, 2020, by and among the Company and each Securitization Originator, (v) the Pledge and Guaranty, dated as of the December 10, 2020, between the Securitization Parent SPE and the Administrative Agent, and (vi) the Performance Guaranty, dated as of December 17, 2020, between the Company, as performance guarantor, and the Securitization Administrative Agent (and together with all other certificates, instruments, UCC financing statements, reports, notices, agreements and documents executed or delivered in connection with the Securitization ~~Loan Agreement, the~~Facillity (the “Securitization ~~Agreements”~~Originators”).

~~The Securitization Borrower, the Company, the Securitization Parent SPE and the Securitization Originators provide~~ provided customary representations and covenants under the agreements underlying the Securitization ~~Agreements.~~Factility. The Securitization ~~Loan Agreement provides for~~Facility identified certain events of default upon the occurrence of which the Securitization Administrative Agent may declare the facility’s termination date to have occurred and declare the outstanding Securitization Loan and all other obligations of the Securitization Borrower to be immediately due and payable, however the Securitization Facility does

~~Table of Contents~~

not include an ongoing liquidity covenant like the A/R Facility and aligns reporting obligations with the Company’s other material indebtedness agreements.

The Securitization Borrower and Securitization Parent SPE were formed in December 2020, and are identified as ~~VIEs~~variable interest entities (“VIE”) and consolidated into the Company’s financial statements following VIE consolidation model under ASC 810. The Securitization Borrower and Securitization Parent SPE are bankruptcy remote entities and as such their assets are not available to creditors of the Company or any of its subsidiaries. Each loan under the Securitization Facility ~~bears~~bore interest on the unpaid principal amount as follows: (i) if a Base Rate Loan, at a rate per annum equal to (x) the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate in effect on such day plus 0.50% and (c) the Adjusted LIBOR Rate (as defined in the Securitization Loan Agreement) plus 1.00%, plus (y) 8.75%; or (ii) if a LIBOR Rate Loan, at the Adjusted LIBOR Rate plus 9.75%.

On June 17, 2022, the Company repaid in full the approximately $91.9 million principal amount of loans outstanding under the Securitization ~~Facility. The aggregate outstanding principal amount of loans under the Securitization~~ Facility, ~~as of such date was approximately $91.9 million. The early termination of the Securitization Facility~~ triggered a prepayment premium of $2.7 million and a required payment of approximately $0.5 million and $1.3 million in respect of accrued interest and fees, respectively. All obligations under the Securitization Facility (other than contingent indemnification obligations that expressly survive termination) terminated upon repayment. The Securitization Facility was replaced by the Amended Receivables Purchase Agreement and related agreements described below. Repayment of the Securitization Facility was treated as an extinguishment of debt under ASC 470-50. Accordingly, the Company wrote off the unamortized balance of $3.3 million of debt issuance costs related to the Securitization Facility. These early termination charges and unamortized balance of the debt issuance cost written off during the nine months ended September 30, 2022 are reported within Debt modification and extinguishment costs (gain), net within our condensed consolidated statements of operations.

On June 17, 2022, the Company entered into an amended and restated receivables purchase agreement ~~(the~~(as amended, the “Amended Receivables Purchase Agreement”) under ~~its accounts receivable securitization facility~~the Securitization Facility among certain of the ~~Company's~~Company’s subsidiaries, ~~its wholly-owned, “bankruptcy remote” special purpose subsidiaries (“SPEs”)~~the SPEs and certain global financial institutions (“Purchasers”). The Amended Receivables Purchase Agreement extends the term of the ~~securitization facility~~Securitization Facility such that the ~~SPE~~SPEs may sell certain receivables to the Purchasers until June 17, 2025. Under the Amended Receivables Purchase Agreement, transfers of accounts receivable from the SPEs are treated as sales and are accounted for as a reduction in accounts receivable, because the agreement transfers effective control over and risk related to the accounts receivable to the Purchasers. The Company and related subsidiaries have no continuing involvement in the transferred accounts receivable, other than collection and

Table of Contents

administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors of the Company, the Securitization Originators, or ~~the related~~any other relevant subsidiaries. ~~As of September 30,~~

On June 17, 2022, the Company ~~has~~ sold ~~$90.2~~$85.0 million of its accounts ~~receivable.~~receivable and used the whole proceeds from this sale to repay part of the $91.9 million borrowings under the Securitization Facility (as discussed above). These sales were transacted at 100% of the face value of the relevant accounts receivable, resulting in derecognition of the accounts receivable from the ~~Company's~~Company’s condensed consolidated balance sheet. The Company de-recognized $408.9 million of accounts receivable under this agreement during the year ended December 31, 2022. The amount remitted to the Purchasers during fiscal year 2022 was $308.7 million. The Company de-recognized $119.3 million and $382.2 million of accounts receivable under this agreement during the three and nine months ended September 30, 2023, respectively. The amount remitted to the Purchasers during the three and nine months ended September 30, 2023 was $119.0 million and $385.5 million, respectively. Unsold accounts receivable of ~~$42.1~~$47.1 million and $46.5 million were pledged by the SPEs as collateral to the Purchasers as of September 30, ~~2022.~~2023 and December 31, 2022, respectively. These pledged accounts receivables are included in accounts receivable, net in the condensed consolidated balance sheets. The program resulted in a pre-tax loss of $2.0 million and $5.9 million for the three and nine months ended September 30, 2023, respectively.

The fair value of the sold accounts receivable approximated their book value due to their short-term nature. Sold accounts receivable are presented as a change in receivables within operating activities in the condensed consolidated statements of cash flows.

Second Lien Note

On February 27, 2023, the SPEs and B. Riley Commercial Capital, LLC entered into a new Secured Promissory Note (which was subsequently assigned to BRF Finance) pursuant to which B. Riley Commercial Capital, LLC agreed to lend up to $35.0 million secured by a second lien pledge of the Securitization Borrower (the “Second Lien Note”). The Second Lien Note is scheduled to mature on June 17, 2025 and bears interest at a per annum rate of one-month Term SOFR plus 7.5%. The SPEs are party to the Amended Receivables Purchase Agreement, thus the transactions necessitated amendments to that agreement and related documents to permit the addition of subordinated debt and additional borrowing capacity into that transaction structure, in addition to providing for a $5.0 million fee to the lenders for facilitating the transaction. In connection with the above-described facility, we also amended the BRCC Term Loan and BRCC Revolver to provide for $9.6 million of borrowing capacity, which was drawn as described above.

2221

Table of Contents

As of September 30, 2023, there were borrowings of $31.5 million outstanding under the Second Lien Note payable at maturity.

Long-Term Debt Outstanding

As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the following long-term debt instruments were outstanding:

December 31,

September 30,

2021

2022

(Restated)
Other (a)
$
24,771

29,296
Term loan under first lien credit agreement (b)

76,031

89,585
2023 notes (c)

22,724

22,616
2026 notes (d)

905,232

801,306
Secured borrowings under BRCC Facility

75,791

115,000
Secured borrowings under Securitization Facility

—

91,947
Revolving Credit Facility

—

99,477
Total debt

1,104,549

1,249,227
Less: Current portion of long-term debt

(195,043)

(236,775)
Long-term debt, net of current maturities
$
909,506

$
1,012,452



	September 30,		December 31,
	2023		2022
Other (a)	$	34,561	$	25,117
2023 term loans (b)		—		71,470
Senior secured term loan maturing July 11, 2026 (c)		38,264		—
2023 notes (d)		—		22,762
2026 notes maturing July 12, 2026 (e)		22,693		908,959
New notes maturing April 15, 2026 (f)		943,642		—
Secured borrowings under BRCC Facility matured on June 10, 2023		25,899		68,529
Second lien note maturing June 17, 2025 (g)		26,937		—
Total debt		1,091,996		1,096,837
Less: Current portion of long-term debt		(48,221)		(154,802)
Long-term debt, net of current maturities	$	1,043,775	$	942,035

(a)	Other debt represents outstanding loan balances associated with various hardware, software purchases, maintenance and leasehold improvements along with loans and receivables factoring arrangement entered into by subsidiaries of the Company.

(b)	Net of unamortized original issue discount and debt issuance costs of ~~$0.4~~$0.2 million and ~~$1.4~~$0.9 million as of December 31, 2022.

(c)	Net of unamortized debt issuance costs of $1.7 million as of September 30, ~~2022 and $0.8 million and $2.8 million as of December 31, 2021.~~2023.

~~(c)~~(d)

Net of unamortized original issue discount and debt issuance costs of $0.1 million and less than $0.1 million as of ~~September 30, 2022 and $0.2 million and $0.1 million as of~~ December 31, ~~2021.~~2022.

~~(d)~~(e)

Net of unamortized net original issue discount and debt issuance costs of ~~$61.9~~$0.3 million and ~~$12.8~~$1.0 million as of September 30, ~~2022;~~2023, respectively; and unamortized net original issue discount and debt issuance costs of $58.8 million and $12.1 million as of December 31, 2022, respectively.

(f)	Net of unamortized net debt exchange premium ~~and carried forward~~of $131.7 million as of September 30, 2023.

(g)	Net of unamortized debt issuance costs of ~~$15.4 million and $9.0~~$4.6 million as of ~~December 31, 2021.~~September 30, 2023.

6. Income Taxes

The Company applies an estimated annual effective tax rate (“ETR”) approach for calculating a tax provision for interim periods, as required under GAAP. The Company recorded an income tax expense of ~~$1.9~~$1.8 million and ~~$1.4~~$1.9 million for the three months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The Company recorded an income tax expense of ~~$5.7~~$7.0 million and ~~$3.4~~$5.7 million for the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively.

The Company's ETR of ~~(2.3)~~(8.5)% and ~~(2.7)~~(7.6)% for the three and nine months ended September 30, ~~2022~~2023, respectively, differed from the expected U.S. statutory tax rate of 21.0% and was primarily impacted by permanent tax adjustments, state and local current expense, foreign operations, and valuation allowances, including valuation allowances on a portion of the Company’s deferred tax assets on U.S. disallowed interest expense carryforwards created by the provisions of The Tax Cuts and Jobs Act (“TCJA”).

For the three and nine months ended September 30, ~~2021,~~2022, the ~~Company’s~~Company's ETR of ~~(12.2%)~~(2.3)% and ~~(5.0%)~~(2.7)%, respectively, differed from the expected U.S. statutory tax rate of 21.0%, and was primarily impacted by permanent tax adjustments, state and local current expense, foreign operations, and valuation allowances, including valuation allowances on a portion of the Company’s deferred tax assets on U.S. disallowed interest expense carryforwards created by the provisions of the TCJA.

Table of Contents

As of September 30, ~~2022,~~2023, there were no material changes to either the nature or the amounts of the uncertain tax positions previously determined for the year ended December 31, ~~2021.~~2022.

During the three months ended September 30, 2023, the Company entered into an indenture agreement for the Company's New Notes resulting in cancelation of debt income (CODI). Absent an exception, a debtor recognizes CODI upon discharge of its outstanding indebtedness for an amount of consideration that is less than the outstanding debt. The Code provides that a debtor may exclude CODI from taxable income but must reduce certain of its tax attributes by the amount of CODI. Pursuant to the US tax rules, the Company computes the final CODI calculation based on the tax basis as of the last day of the fiscal tax year (i.e., December 31, 2023) which includes the date in which the debt transaction occurred. As such, the Company applied its best estimate as of July 12, 2023 (transaction date) to compute the CODI impact knowing that certain amounts will change based on regular business operations. For the period ended September 30, 2023, the Company estimated CODI in the amount of $600 million will be excluded from taxable income and result in a partial reduction in the gross U.S. federal and state net operating losses, on which there is a full valuation allowance and as such there is no financial statement impact. The Company will finalize the tax effects of CODI, including the estimated tax effects of tax basis and attribute reduction recognized as a result of the debt transaction in the final December 31, 2023 financial statements and subsequent tax return filings.

7. Employee Benefit Plans

~~Table of Contents~~

German Pension Plan

The Company’s subsidiary in Germany provides pension benefits to certain retirees. Employees eligible for participation include all employees who started working for the Company or its predecessors prior to September 30, 1987 and have finished a qualifying period of at least 10 years. The Company accrues the cost of these benefits over the service lives of the covered employees based on an actuarial calculation. The Company uses a December 31 measurement date for this plan. The German pension plan is an unfunded plan and therefore has no plan assets. No new employees are registered under this plan and the participants who are already eligible to receive benefits under this plan are no longer employees of the Company.

U.K. Pension Plan

The Company’s subsidiary in the United Kingdom provides pension benefits to certain retirees and eligible dependents. Employees eligible for participation include all full-time regular employees who were more than three years from retirement prior to October 2001. A retirement pension or a lump-sum payment may be paid dependent upon length of service at the mandatory retirement age. The Company accrues the cost of these benefits over the service lives of the covered employees based on an actuarial calculation. The Company uses a December 31 measurement date for this plan. No new employees are registered under this plan and the pension obligation for the existing participants of the plan is calculated based on actual salary of the participants as at the earlier of two dates, the participants leaving the Company or December 31, 2015.

Norway Pension Plan

The Company’s subsidiary in Norway provides pension benefits to eligible retirees and eligible dependents. Employees eligible for participation include all employees who were more than three years from retirement prior to March 2018. The Company accrues the cost of these benefits over the service lives of the covered employees based on an actuarial calculation. The Company uses a December 31 measurement date for this plan. No new employees are registered under this plan and the pension obligation for the existing participants of the plan is calculated based on actual salary of the participants as at the later of two dates, the participants leaving the Company or April 30, 2018.

Asterion Pension Plan

In April 2018, through its acquisition of Asterion International Group, the Company became obligated to provide pension benefits to eligible retirees and eligible dependents of Asterion. Employees eligible for participation include all full-time regular employees who were more than three years from retirement prior to July 2003. A retirement

Table of Contents

pension or a lump-sum payment may be paid dependent upon length of service at the mandatory retirement age. The Company accrues the cost of these benefits over the service lives of the covered employees based on an actuarial calculation. The Company uses a December 31 measurement date for this plan. No new employees are registered under this plan and the pension obligation for the existing participants of the plan is calculated based on actual salary of the participants as at the earlier of two dates, the participants leaving the Company or April 10, 2018.

Tax Effect on Accumulated Other Comprehensive Loss

As of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 the Company recorded actuarial losses of ~~$9.0~~$3.6 million and ~~$10.9~~$3.6 million in accumulated other comprehensive loss on the condensed consolidated balance sheets, respectively, which is net of a deferred tax benefit of $2.0 million for each period.

~~Table of Contents~~

Pension Expense

The components of the net periodic benefit cost are as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021		2023		2022		2023		2022
Service cost	$	15	$	19	$	45	$	57	$	10	$	15	$	30	$	45
Interest cost		486		425		1,458		1,275		766		486		2,275		1,458
Expected return on plan assets		(724)		(606)		(2,172)		(1,818)		(682)		(724)		(2,025)		(2,172)
Amortization:
Amortization of prior service cost		53		45		159		135		89		53		266		159
Amortization of net loss		646		840		1,938		2,520		395		646		1,171		1,938
Net periodic benefit cost	$	476	$	723	$	1,428	$	2,169	$	578	$	476	$	1,717	$	1,428

The Company records pension interest cost within ~~Interest~~interest expense, net. Expected return on plan assets, amortization of prior service costs, and amortization of net losses are recorded within ~~Other income,~~other expense (income), net. Service cost is recorded within ~~Cost~~cost of revenue.

Employer Contributions

The Company’s funding of employer contributions is based on governmental requirements and differs from those methods used to recognize pension expense. The Company made contributions of $1.9 million and ~~$2.4~~$1.9 million to its pension plans during the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The Company has funded the pension plans with the required contributions for ~~2022~~2023 based on current plan provisions.

8. Commitments and Contingencies

~~Appraisal Action~~

~~On March 26, 2020, the Delaware Court of Chancery entered a judgment against the Company’s subsidiary SourceHOV Holdings, Inc. (“SourceHOV”) in the amount of $57.7~~ million inclusive of costs and interest arising out of the petition for appraisal pursuant to 8 Del. C. § 262 in the Delaware Court of Chancery, captioned Manichaean Capital, LLC, et al. v. SourceHOV Holdings, Inc., C.A. No. 2017 0673 JRS (the “Appraisal Action”). The Appraisal Action arose out of a preliminary transaction in connection with the acquisition of SourceHOV and Novitex Holdings, Inc., by Quinpario in July 2017 (“Novitex Business Combination”), and the petitioners sought, among other things, a determination of the fair value of their SourceHOV shares at the time of the Novitex Business Combination; an order that SourceHOV pay that value to the petitioners, together with interest at the statutory rate; and an award of costs, attorneys’ fees, and other expenses. On December 31, 2021, the Company agreed to settle the Appraisal Action along with a separate case brought by the same plaintiffs for $63.4 million. Accordingly as of December 31, 2021, the Company accrued a liability of $63.4 million for these matters, all of which had been paid as of September 30, 2022, and accordingly the Company has no further liability under the Appraisal Action.

Adverse Arbitration Order

In April 2020, one of the Company's Nordic subsidiaries commenced an arbitration in Finland against a customer alleging breach of contract and other damages in connection with an outsourcing services agreement and transition services agreement executed in 2017. In September 2020, the customer submitted counterclaims against the Company in an aggregate amount in excess of €10.0 million. Following an expedited arbitration, in late November 2020, the arbitrator awarded the customer approximately $13.0 million in the aggregate for the counterclaimed damages and costs. The Company filed an application to annul the award in late January 2021 with the relevant court asserting, among other bases, that the arbitrator violated due process and procedural rules by disallowing the Company’s witness and expert testimony and maintaining the expedited format following the assertion of significant counterclaims which would ordinarily have required the application of normal rather than expedited rules. On May 28, 2021, the parties entered into a settlement agreement resolving this dispute for a total of $8.8 million including the reimbursement of certain third party charges. As of September 30, 2023, there was a net outstanding balance of $0.9 million for this matter included in accrued liabilities on the condensed consolidated balance sheet.

2524

Table of Contents

~~party charges. As~~Class Action

On March 23, 2020, the Plaintiff, Bo Shen, filed a putative class action against the Company, Ronald Cogburn, the Company’s former Chief Executive Officer, and James Reynolds, the Company’s former Chief Financial Officer and current member of the Company’s board of directors (the “Board”). Plaintiff claims to have been a holder of 4,000 shares of Company stock, purchased on October 4, 2019 at $1.34/share (in the case of the number of shares and share price without adjusting for any of the reverse stock splits occurring after that date). Plaintiff asserts two claims covering the purported class period of March 16, 2018 to March 16, 2020: (1) a violation of Section 10(b) and Rule 10b-5 of the Exchange Act against all defendants; and (2) a violation of Section 20(a) of the Exchange Act against Mr. Cogburn and Mr. Reynolds. The allegations stem from the Company’s press release, dated March 16, 2020 (announcing the postponement of the earnings call and delay in filing of its annual report on Form 10-K for the fiscal year ended December 31, 2019), and press release and related SEC filings, dated March 17, 2020 (announcing its intent to restate its financial statements for 2017, 2018 and interim periods through September 30, ~~2022, there~~2019) and certain other matters. On July 27, 2023, the parties submitted a settlement agreement to the Court that, if approved, will result in the dismissal of the action with prejudice in exchange for a settlement payment of $5.0 million, which the Company anticipates will be funded by the Company’s insurance carrier to the extent the payment exceeds any remaining deductible under the applicable insurance policy. The settlement agreement was preliminary approved by the Court on August 21, 2023 and the final approval hearing took place on December 7, 2023. The court granted the settlement in full and entered a ~~net outstanding balance~~final judgment of ~~$1.8 million for this matter included in Accrued liabilities on~~dismissal and final orders approving the ~~Condensed Consolidated Balance Sheet.~~plan of allocation and plaintiffs’ attorneys’ fee award, which will be paid entirely out of the existing settlement fund.

Contract-Related Contingencies

Certain customers have asserted claims as a result of the network outage (described in Note 2), but no litigation has been filed. Currently, the Company is assessing these claims and whether they arise from contractual commitments and intends to honor its agreements, however, at this time the Company is not able to conclude on the validity and aggregate impact of these claims or the impact of expected insurance coverage to offset any liabilities for such claims.

The Company has certain contingent obligations that arise in the ordinary course of providing services to its customers. These contingencies are generally the result of contracts that require the Company to comply with certain performance measurements or the delivery of certain services to customers by a specified deadline. The Company believes the adjustments to the transaction price, if any, under these contract provisions will not result in a significant revenue reversal or have a material adverse effect on the Company’s condensed consolidated balance sheets, condensed consolidated statements of operations or condensed consolidated statements of cash flows.

9. Fair Value Measurement

Assets and Liabilities Measured at Fair Value

The carrying amount of assets and liabilities including ~~cash and cash equivalents, accounts receivable, accounts payable and~~ current portion of ~~long-term~~other debt approximated their fair value as of September 30, ~~2021,~~2023 and December 31, ~~2021,~~2022, due to the relative short maturity of these instruments. Management estimates the fair values of the ~~secured term loan,~~2026 Notes and New Notes at approximately 17.0% and 17.0%, respectively, of the respective principal balances outstanding as of September 30, 2023. Management estimated the fair values of the 2023 ~~notes~~Term Loans, 2023 Notes and 2026 ~~notes~~Notes at approximately ~~67.3%~~64.0%, 65.0% and ~~28.0%~~15.5%, respectively, of the respective principal balance outstanding as of ~~September 30,~~December 31, 2022. The fair values of secured borrowings under the Company’s securitization facility, BRCC Facility, Second Lien Note and ~~BRCC facility~~Senior Secured Term Loan are equal to the respective carrying values. Other debt represents the ~~Company's~~Company’s outstanding loan balances associated with various hardware, software purchases, maintenance and leasehold improvements along with loans and receivables factoring arrangement entered into by subsidiaries of the Company and as such, the cost incurred would approximate fair value. Property and equipment, intangible assets, capital lease obligations, and goodwill are not required to be re-measured to fair value on a recurring basis. These assets are evaluated for impairment if certain triggering events occur. If such evaluation indicates that impairment exists, the respective asset is written down to its fair value.

The Company determined the fair value of its long-term debt and current portion of long-term debts using Level 2 inputs, including ~~the~~any recent issuance of the debt, the Company’s credit rating, and the current risk-free rate.

2625

Table of Contents

The following table provides the carrying amounts and estimated fair values of the Company’s financial instruments as of September 30, ~~2022,~~2023 and December 31, ~~2021:~~2022:


	Carrying		Fair		Fair Value Measurements						Carrying		Fair		Fair Value Measurements
As of September 30, 2022	Amount		Value		Level 1		Level 2		Level 3
As of September 30, 2023											Amount		Value		Level 1		Level 2		Level 3
Recurring assets and liabilities:
Long-term debt	$	909,506	$	247,051	$	—	$	247,051	$	—	$	1,043,775	$	219,537	$	—	$	219,537	$	—
Nonrecurring assets and liabilities:
Goodwill		328,071		328,071		—		—		328,071
Current portion of long-term debts												48,221		48,221		—		48,221		—

Carrying

Fair


Amount

Value

Fair Value Measurements (Restated)
As of December 31, 2021

(Restated)

(Restated)

Level 1

Level 2

Level 3
Recurring assets and liabilities:

Long-term debt

$
1,012,452

$
803,668

$
—

$
803,668

$
—
Nonrecurring assets and liabilities:

Goodwill

358,323

358,323

—

—

358,323


	Carrying		Fair		Fair Value Measurements
As of December 31, 2022	Amount		Value		Level 1		Level 2		Level 3
Recurring assets and liabilities:
Long-term debt	$	942,035	$	184,968	$	—	$	184,968	$	—
Current portion of long-term debts		154,802		121,893		—		121,893		—

10. Stock-Based Compensation

Exela 2018 Stock Incentive Plan

On January 17, 2018, Exela’s 2018 Stock Incentive Plan (the “2018 Plan”) became effective. The 2018 Plan provides for the grant of incentive and nonqualified stock options, restricted stock, restricted stock units, stock appreciation rights, performance awards, and other stock-based compensation to eligible participants. The Company was initially authorized to issue up to ~~138,729~~694 shares of Common Stock under the 2018 Plan. On June 27, 2022, the shareholders of the Company approved our Amended and Restated 2018 Stock Incentive Plan increasing the number of shares of Common Stock reserved for issuance from an original ~~138,729~~694 shares to ~~892,404.~~4,462.

Restricted Stock Unit

Restricted stock unit awards generally vest ratably over a one to two year period. Restricted stock units are subject to forfeiture if employment or service terminates prior to vesting and are expensed ratably over the vesting period.

A summary of restricted stock unit activities under the 2018 Plan for the nine months ended September 30, ~~2022~~2023 is summarized in the following table:


				Average						Average
		Weighted		Remaining				Weighted		Remaining
	Number	Average Grant		Contractual Life	Aggregate		Number	Average Grant		Contractual Life
	of Units	Date Fair Value		(Years)	Intrinsic Value		of Units	Date Fair Value		(Years)
Outstanding Balance as of December 31, 2021	68,450	$	34.95	0.11	$	2,393
Outstanding Balance as of December 31, 2022							8	$	6,600.00	1.00
Granted	—		—				—		—
Forfeited	—		—				—		—
Vested	(66,935)		35.00				—		—
Outstanding Balance as of September 30, 2022	1,515	$	33.00	0.67	$	50
Outstanding Balance as of September 30, 2023							8	$	6,600.00	0.25

~~Table of Contents~~

Certain RSUs that vested during the nine months ended September 30, 2022 were net-share settled such that the Company withheld shares with value equivalent to the employee’s minimum statutory obligation for applicable income and other employment taxes, and remitted the cash to the appropriate taxing authorities. The total shares withheld were 8,998 shares and were based on the value of the RSUs on their respective vesting dates as determined by the Company’s closing stock price. Total payment for the employee’s tax obligations to taxing authorities were $0.1 million and is reflected as a financing activity within the Condensed Consolidated Statements of Cash Flows.

Options

Under the 2018 Plan, stock options are granted at a price per share not less than 100% of the fair market value per share of the underlying stock at the grant date. The vesting period for each option award is established on the grant date, and the options generally expire 10 years from the grant date. Options granted under the 2018 Plan generally

Table of Contents

require no less than a two or four year ratable vesting period. Stock option activity for the nine months ended September 30, ~~2022~~2023 is summarized in the following table:


						Average								Average
		Weighted		Weighted		Remaining				Weighted		Weighted		Remaining
		Average Grant		Average		Vesting Period	Aggregate			Average Grant		Average		Vesting Period
	Outstanding	Date Fair Value		Exercise Price		(Years)	Intrinsic Value (2)		Outstanding	Date Fair Value		Exercise Price		(Years)
Outstanding Balance as of December 31, 2021	72,265	$	112.60	$	235.69	0.69	$	—
Outstanding Balance as of December 31, 2022									352	$	22,554.25	$	47,117.77	0.20
Granted	—		—						—		—
Exercised	—		—						—		—
Forfeited	(1,497)		120.23						(14)		27,703.04
Expired	—		—						—		—
Outstanding Balance as of September 30, 2022 (1)	70,768	$	112.44	$	234.73	0.27	$	—
Outstanding Balance as of September 30, 2023 (1)									338	$	22,347.33	$	46,554.52	0.03

(1) ~~51,967~~329 of the outstanding options are exercisable as of September 30, ~~2022.~~

~~(2) Exercise prices of all of the outstanding options as of September 30, 2022 were higher than the market price of the shares of the Company. Therefore, aggregate intrinsic value is zero.~~2023.

As of September 30, ~~2022,~~2023, there was approximately ~~$0.3~~less than $0.1 million of total unrecognized compensation expense related to non-vested restricted stock unit awards and stock option awards under the 2018 Plan, which will be recognized over the respective service period. Stock-based compensation expense is recorded within ~~Selling,~~selling, general and administrative expenses. The Company recorded compensation expense of less than $0.1 million and net reversal of compensation expense of $0.1 million related to restricted stock unit awards and stock option awards under the 2018 Plan for the three and nine months ended September 30, 2023, respectively, due to forfeiture of options. The Company incurred total compensation expense of $0.2 million and $0.6 million related to restricted stock unit awards and stock option awards under the 2018 Plan for the three and nine months ended September 30, 2022, ~~respectively, and $0.4 million and $1.3 million for the three and nine months ended September 30, 2021,~~ respectively. The Company reversed compensation expense of $0.6 million on account of agreed cancellation of Common Stock issued for Director's vested restricted stock units during the three and nine months ended September 30, 2022.

Market Performance Units

On September 14, 2021, the Company granted its Executive Chairman performance units with a market performance condition, which are notional units representing the right to receive one share of Common Stock (or the cash value of one share of Common Stock). Until such time that the Company obtained the approval of the stockholders of the Company regarding an increase to the number of shares authorized for issuance under its 2018 Plan in accordance with Nasdaq Listing Rule 5635(a), these performance units would be settled in cash, and following such shareholder approval, atAt the election of the compensation committee of the Company, these performance units might be settled in cash or in shares of Common Stock. The performance units provide that until an increase to the share reserve is approved, such performance units are subject to the terms and conditions of the 2018 Plan as though granted thereunder, but not be considered an award that is outstanding under the plan, and following such time that the plan amendment is approved, constitute an award under the 2018 Plan.

Fifty percent of the performance units covered by the award will vest if, at any time during the period commencing September 14, 2021 and ending June 30, 2024, the volume weighted average of the reported closing price of the ~~Company’s~~ Common Stock is ~~$200~~$40,000 per share or greater on (x) 60 consecutive trading days or (y) 90 non-consecutive trading days in any 180 day period (the “Tranche 1”). In addition, the remaining 50% of the performance

~~Table of Contents~~

units will vest if, at any time during the period commencing September 14, 2021 and ending June 30, 2025, the volume weighted average of the reported closing prices of the ~~Company’s~~ Common Stock is ~~$400~~$80,000 per share or greater on (x) 60 consecutive trading days or (y) 90 non-consecutive trading days in any 180 day period (the “Tranche 2”). Any Tranche 1 and Tranche 2 units that are not earned by June 30, 2024 and June 30, 2025, respectively, will be forfeited for no consideration and will no longer be eligible to vest. In addition, if a change in control occurs prior to the applicable expiration date, if the performance units are assumed by the acquirer, the units will remain outstanding and eligible to vest based solely on his continued service to the Company. If in connection with such change in control the performance units are not assumed by an acquirer, a number of performance units will vest based on the per share price paid in the transaction, with 0% vesting if the per share price is equal to or less than ~~$40.00~~$8,000 per share, and 100% of the Tranche 1 vesting if the per share price is equal to or greater than ~~$200~~$40,000 and 100% of the Tranche 2 vesting if the per share price is equal to or greater than ~~$400,~~$80,000, and a number of Tranche 1 and Tranche 2 vesting determined based on a straight line interpolation if the share price is between ~~$40.00~~$8,000 and ~~$200.00~~$40,000 or ~~$400.00,~~$80,000, respectively. In addition, if there is a change in control that is principally negotiated and approved by, and recommended to the Company’s shareholders by, a special committee of independent directors which committee does not include the Executive Chairman, and neither he nor any of his affiliates is directly or indirectly an equity holder of the acquiring Company, and the Tranche 1 are not assumed by an acquirer in connection with such transaction, all of his then unvested Tranche 1 will vest, and the Tranche 2 would be eligible for the pro rata vesting described above. The Executive Chairman will remain eligible to earn his performance units so long as he remains ~~employed with the Company as Executive Chairman through December 31, 2023 and following such date he remains~~ engaged with the Company in any capacity, including as a non-employee director.

On June 27, 2022, the Company obtained the approval of the stockholders of the Company for the 2018 Plan amendment regarding an increase to the number of shares authorized for issuance under its 2018 Plan. After approval of the amended and restated 2018 Plan, the performance units are an award that is outstanding under the amended and restated 2018 Plan. Therefore, the performance units may be settled in cash or in shares of Common Stock of the Company at the election of the compensation committee of the Company.

The fair value of per unit of the awards was determined to be ~~$29.60~~$5,920 and ~~$30.20~~$6,040 for Tranche 1 and Tranche 2, respectively, on the grant date by application of the Monte Carlo simulation model. Until December 31, 2021, the performance units were cash-settled awards and therefore accounted for as a liability classified award. On December 31, 2021, upon the approval of the amended and restated 2018 Plan, the performance units may be settled in cash or in shares of Common Stock of the Company at the election of the compensation committee of the Company, therefore the award was reclassified to equity. On December 31, 2021, the

Table of Contents

modification date fair value of per unit of the awards was determined to be ~~$8.80~~$1,760 and ~~$9.40~~$1,880 for Tranche 1 and Tranche 2, respectively, by application of the Monte Carlo simulation model.

The following table summarizes the activity for the market performance restricted stock units for the nine months ended September 30, ~~2022:~~2023:


				Weighted Average				Weighted Average
		Weighted		Period Over		Weighted		Period Over
	Number	Average		Which Expected	Number	Average		Which Expected
	of Units	Fair Value		to be Recognized	of Units	Fair Value		to be Recognized
Outstanding Balance as of December 31, 2021	425,000	$	9.10	2.98
Outstanding Balance as of December 31, 2022					2,125	$	1,820.00	2.98
Granted	—		—		—		—
Forfeited	—		—		—		—
Vested	—		—		—		—
Outstanding Balance as of September 30, 2022	425,000	$	9.10	2.98
Outstanding Balance as of September 30, 2023					2,125	$	1,820.00	2.98

As of September 30, ~~2022,~~2023, there was approximately ~~$2.0~~$1.1 million of total unrecognized compensation expense related to non-vested performance unit awards, which will be recognized over the requisite service period. We recognized $0.2 million and $0.7 million compensation expense associated with the performance unit award for the three and nine months ended September 30, ~~2022, respectively. We recognized~~2023, respectively, and $0.2 million ~~compensation expense associated with the performance unit award~~and $0.7 million for the three and nine months ended September 30, ~~2021.~~2022, respectively.

~~Table of Contents~~

11. Stockholders’ Equity

The following description summarizes the material terms and provisions of the securities that the Company has authorized.

Common Stock

The Company is authorized to issue 1,600,000,000 shares of Common Stock. Except as otherwise required by law or as otherwise provided in any certificate of designation for any series of preferred stock, the holders of our Common Stock and Tandem Preferred Stock (that provides a vote to holders of our Series B Preferred Stock, as described below) possess all voting power for the election of ~~our~~the Board ~~of Directors (the “Board”)~~ and all other matters requiring stockholder action and will at all times vote together as one class on all matters submitted to a vote of Exela stockholders. Holders of our Common Stock are entitled to one vote per share on matters to be voted on by stockholders. Holders of our Common Stock will be entitled to receive such dividends and other distributions, if any, as may be declared from time to time by the Board in its discretion out of funds legally available therefor and shall share equally on a per share basis in such dividends and distributions. The holders of the Common Stock have no conversion, preemptive or other subscription rights and there are no sinking fund or redemption provisions applicable to the Common Stock. As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, there were ~~80,050,757~~6,365,353 and ~~13,259,748~~1,393,276 shares of Common Stock outstanding, respectively.

Reverse Stock Split

On ~~July 25, 2022,~~May 12, 2023, we effected the ~~one-for-twenty~~ Reverse Stock Split of our issued and outstanding shares of Common Stock. As a result of the Reverse Stock Split every ~~twenty (20)~~two hundred (200) shares of Common Stock issued and outstanding were automatically combined into one (1) share of issued and outstanding Common Stock, without any change in the par value per share. All information related to Common Stock, stock options, restricted stock units, warrants and earnings per share have been retroactively adjusted to give effect to the Reverse Stock Split for all periods presented.

Giving effect to the Reverse Stock Split ~~the Company’s~~ issued and outstanding ~~stock~~Common Stock decreased from ~~265,194,961~~278,655,235 to ~~13,259,748 as~~1,393,276 at December 31, ~~2021.~~2022.

Table of Contents

Common Stock At-The-Market Sales Program

On May 27, 2021, the Company entered into an At Market Issuance Sales Agreement (“First ATM Agreement”) with B. Riley Securities, Inc. (“B. Riley”) and Cantor Fitzgerald & Co. (“Cantor”), as distribution agents, under which the Company may offer and sell shares of the ~~Company’s~~ Common Stock from time to time through the Distribution Agents, acting as sales agent or principal. On September 30, 2021, the Company entered into a second At Market Issuance Sales Agreement with B. Riley, BNP Paribas Securities Corp., Cantor, Mizuho Securities USA LLC and Needham & Company, LLC, as distribution agents (together with the First ATM Agreement, the “ATM Agreement”).

Sales of the shares of Common Stock under the ATM Agreement ~~will be~~have been in “at the market offerings” as defined in Rule 415 under the Securities Act, including, without limitation, sales made directly on or through the Nasdaq or on any other existing trading market for the Common Stock, as applicable, or to or through a market maker or any other method permitted by law, including, without limitation, negotiated transactions and block trades. Shares of Common Stock sold under the ATM Agreement ~~are~~have been offered pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-255707), filed with the SEC on May 3, 2021 and declared effective on May 12, 2021, ~~(the “2021 Registration Statement”),~~ and the ~~prospectus dated May 12, 2021 included in the 2021~~Company’s Registration Statement on Form S-3 (File No. 333-263909), filed with the SEC on March 28, 2022 and declared effective on May 10, 2022, and the prospectuses and related prospectus supplements included therein for sales of shares of Common Stock as follows:


Supplement	Period	Number of Shares Sold	Weighted Average Price Per Share	Gross Proceeds	Net Proceeds
Prospectus supplement dated May 27, 2021 with an aggregate offering price of up to $100.0 million (“Common ATM Program–1”)	May 28, 2021 through July 1, 2021	12,356	$8,032.74	$99.3 million	$95.7 million
Prospectus supplement dated June 30, 2021 with an aggregate offering price of up to $150.0 million (“Common ATM Program–2”)	June 30, 2021 through September 2, 2021	14,395	$10,413.79	$149.9 million	$144.4 million
Prospectus supplement dated September 30, 2021 with an aggregate offering price of up to $250.0 million (“Common ATM Program–3”)	October 6, 2021 through March 31, 2022	83,719	$2,986.18	$250.0 million	$241.0 million
Prospectus supplement dated May 23, 2022 with an aggregate offering price of up to $250.0 million (“Common ATM Program–4”)	May 24, 2022 through March 31, 2023	6,262,182	$36.15	$226.4 million	$219.3 million

~~Table~~Due to the late filing of ~~Contents~~

Supplement
Period
Number of Shares Sold
Weighted Average Price Per Share
Gross Proceeds
Net Proceeds
Prospectus supplement dated May 27, 2021 with an aggregate offering price of up to $100.0 million (“Common ATM Program–1”)
May 28, 2021 through July 1, 2021
2,471,185
$40.164
$99.3 million
$95.7 million
Prospectus supplement dated June 30, 2021 with an aggregate offering price of up to $150.0 million (“Common ATM Program–2”)
June 30, 2021 through September 2, 2021
2,879,023
$52.069
$149.9 million
$144.4 million
Prospectus supplement dated September 30, 2021 with an aggregate offering price of up to $250.0 million (“Common ATM Program–3”)
October 6, 2021 through March 31, 2022
16,743,797
$14.931
$250.0 million
$241.0 million
Prospectus supplement dated May 23, 2022 with an aggregate offering price of up to $250.0 million (“Common ATM Program–4”)
May 24, 2022 through September 30, 2022
58,283,108
$2.159
$125.8 million
$122.0 million

the 2022 Form 10-K, the Company lost eligibility to use Form S-3 (and thereby the ability to conduct at the market offerings). As a result of subsequent delinquent quarterly reports on Form 10-Q, including for the period ended September 30, 2023 (the “Q3 Form 10-Q”), the Company will not regain eligibility to use Form S-3 until twelve full calendar months following the date the Q3 Form 10-Q was due. Any future delinquency with respect to the filing of a Form 10-K, Form 10-Q, or certain Form 8-Ks will cause the Company to lose Form S-3 eligibility for at least 12 calendar months from the due date of the delinquent filing.

Share Buyback Program

On August 10, 2022, the ~~Company’s~~ Board authorized a share buyback program (the “2022 Share Buyback Program”), pursuant to which the Company ~~was~~is permitted to repurchase up to ~~10,000,000~~50,000 shares of Common Stock over the next two-year period. The 2022 Share Buyback Program does not obligate the Company to repurchase any shares of Common Stock. ~~During~~No shares were repurchased under the ~~three~~2022 Share Buyback Program during the nine months ended September 30, ~~2022,~~2023. As of September 30, 2023, we had repurchased and concurrently retired ~~357,461~~a total of 1,787 shares of Common Stock ~~at an average share price of $1.348 per share~~ pursuant to the 2022 Share Buyback Program.

The Company records such stock repurchases as a reduction to stockholders’ equity. The Company allocates the excess of the repurchase price over the par value of shares acquired to ~~Accumulated Deficit~~accumulated deficit and ~~Additional Paid-in Capital.~~additional paid-in

Table of Contents

capital. The portion allocated to ~~Additional Paid-in Capital~~additional paid-in capital is determined by dividing the number of shares to be retired by the number of shares issued multiplied by the balance of ~~Additional Paid-in Capital~~additional paid-in capital as of the retirement date.

Series A Preferred Stock

The Company is authorized to issue 20,000,000 shares of preferred stock with such designations, voting and other rights and preferences as may be determined from time to time by the Board. The Company has designated 2,800,000 shares of its authorized preferred stock as Series A Preferred Stock. At September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company had 2,778,111 shares of Series A Preferred Stock outstanding. The par value of the Series A Preferred Stock is $0.0001 per share. Each share of Series A Preferred Stock is convertible at the ~~holder's~~holder’s option, at any time into the number of shares of Common Stock determined as of the date of conversion using a certain conversion formula that takes into account the amount of Liquidation Preference per share as adjusted for accrued but unpaid dividends, as described below. As of September 30, ~~2022,~~2023, after taking into account the effect of the Reverse Stock Split, each outstanding share of Series A Preferred Stock was convertible into ~~0.0256~~0.00014 shares of Common Stock using this conversion formula. Accordingly, as of September 30, ~~2022, 71,256~~2023, 393 shares of Common Stock were issuable upon conversion of ~~the remaining~~ 2,778,111 shares of outstanding Series A Preferred Stock.

Holders of the Series A Preferred Stock are entitled to receive cumulative dividends at a rate per annum of 10% of the dollar amount of per share liquidation preference (plus accumulated but unpaid dividends, the “Series A Liquidation Preference”) per share of Series A Preferred Stock, paid or accrued quarterly in arrears on the 15^th day of each March, June, September and December. From the issue date through September 30, ~~2022~~2023, the amount of all accrued but unpaid dividends on the Series A Preferred Stock have been added to the Series A Liquidation Preference. The Company shall add the amount of all accrued but unpaid dividends on each quarterly dividend payment date to the Series A Liquidation Preference, except to the extent the Company elects to make all or any portion of such payment in cash on

~~Table of Contents~~

or prior to the applicable dividend payment date, in which case, the amount of the accrued but unpaid dividends that is added to the Series A Liquidation Preference shall be reduced on a dollar-for-dollar basis by the amount of any such cash payment. The Company is not required to make any payment or allowance for unpaid dividends, whether or not in arrears, on converted shares of Series A Preferred Stock or for dividends on the shares of Common Stock issued upon conversion of such shares. The gross dividend accumulation for the three and nine months ended September 30, ~~2022~~2023 was ~~$0.9~~$1.0 million and ~~$2.6~~$2.9 million, respectively. The gross dividend accumulation for the three ~~months ended September 30, 2021 was $0.8 million. However, as a result of 511,939 shares of Series A Preferred Stock being converted into 11,199 shares of Common Stock during the~~and nine months ended September 30, ~~2021, accumulated dividend of $1.8~~2022 was $0.9 million ~~was reversed, resulting in a net dividend accumulation of $0.7~~and $2.6 million, ~~for the nine months ended September 30, 2021.~~respectively. As of September 30, ~~2022,~~2023, the total accumulated but unpaid dividends on the Series A Preferred Stock since inception on July 12, 2017 ~~is $15.0~~was $18.8 million. The per share average of cumulative preferred dividends for the three and nine months ended September 30, ~~2022 is $0.33~~2023 was $0.36 and ~~$0.95,~~$1.05, respectively. The per share average of cumulative preferred dividends for ~~each of~~ the three and nine months ended September 30, ~~2021 is $0.3.~~2022 was $0.33 and $0.95, respectively.

In addition, holders of the Series A Preferred Stock will participate in any dividend or distribution of cash or other property paid in respect of the Common Stock pro rata with the holders of the Common Stock (other than certain dividends or distributions that trigger an adjustment to the conversion rate, as described in the Certificate of Designations), as if all shares of Series A Preferred Stock had been converted into Common Stock immediately prior to the date on which such holders of the Common Stock became entitled to such dividend or distribution.

Series B Preferred Stock and Tandem Preferred Stock

~~In two separate exchange offers made on February 24, 2022 (the “First Share Exchange Offer”) and May 2, 2022 (the “Second Share Exchange Offer”), the~~The Company offered its common stockholders the opportunity to exchange shares of Common Stock for its Series B Preferred Stock, par value $0.0001 per share, with each one shares of Common Stock being exchangeable for one share of Series B Preferred Stock having a liquidation preference of $25.00 per share. On March 11, 2022, the Companyhas designated ~~5,000,000~~8,100,000 shares of its authorized and unissued preferred stock as Series B Preferred Stock and filed a Certificate of Designation of Series B Preferred Stock of Exela Technologies Inc., or the Series B Certificate of Designation. The First Share Exchange Offer expired on March 10, 2022, and 900,328 shares of Common Stock were validly tendered for exchange. On March 11, 2022, the Company issued a total of 900,328 shares of Series B Preferred Stock in exchange of all such tendered and accepted shares of Common Stock. The Second Share Exchange Offer expired on May 17, 2022, and 2,129,572 shares of Common Stock were validly tendered for exchange. On May 18, 2022, the Company issued a total of 2,129,572 shares of Series B Preferred Stock in exchange of all such tendered and accepted shares of Common Stock. The tendered and accepted shares of Common Stock were cancelled. The Series B Preferred Stock are listed on the Nasdaq under the symbol “XelaP”.

At September 30, 2023 and December 31, 2022, the Company had 3,029,900 shares of Series B Preferred Stock outstanding. The par value of the Series B Preferred Stock is $0.0001 per share. Each share of Series B Preferred Stock is convertible at the ~~holder's~~holder’s option, at any time into the number of shares of Common Stock determined as of the date of conversion using a certain conversion formula that takes into account the amount of liquidation preference per share as adjusted for accrued but unpaid dividends, as described below. As of September 30, ~~2022,~~2023, after taking into account the effect of the Reverse Stock Split and payment of the accrued dividend, each outstanding share of Series B Preferred Stock was convertible into 0.00531 of one share of Common Stock using this conversion formula. Accordingly, as of September 30, ~~2022, 3,029,900~~2023, 16,079 shares of Common Stock were issuable upon conversion of 3,029,900

Table of Contents

shares of outstanding Series B Preferred Stock. The shares of Series B Preferred Stock are listed on the Nasdaq under the symbol “XELAP.”

Holders of the Series B Preferred Stock are entitled to receive cumulative dividends at a rate per annum of 6% of the dollar amount of per share liquidation preference (plus accumulated but unpaid dividends, the “Series B Liquidation Preference”) per share of Series B Preferred Stock, paid or accrued quarterly in arrears on the last day of each of March, June, September and December. The Company shall add the amount of all accrued but unpaid dividends on each quarterly dividend payment date to the Series B Liquidation Preference, except to the extent the Company elects to make all or any portion of such payment in cash on or prior to the applicable dividend payment date, in which case, the amount of the accrued but unpaid dividends that is added to the Series B Liquidation Preference shall be reduced on a dollar-for-dollar basis by the amount of any such cash payment. The Company is not required to make any payment or allowance for unpaid dividends, whether or not in arrears, on converted shares of Series B Preferred Stock or for

~~Table of Contents~~

dividends on the shares of Common Stock issued upon conversion of such shares. The gross dividend accrued for the three and nine months ended September 30, ~~2022 is $1.1~~2023 was $1.2 million and ~~$2.5~~$3.5 million, respectively. The ~~per share average of~~gross dividend accrued ~~preferred dividends~~ for the three and nine months ended September 30, 2022 ~~is $0.38~~was $1.1 million and ~~$0.83,~~$2.5 million, respectively. During the nine months ended September 30, 2022, the Company paid accumulated dividend of $2.5 million. As of September 30, ~~2022, there were no~~2023, the total accumulated but unpaid dividends on the Series B Preferred ~~Stock.~~Stock since inception on March 23, 2022 was $4.6 million. The per share average of accrued preferred dividends for the three and nine months ended September 30, 2023 was $0.39 and $1.16, respectively. The per share average of accrued preferred dividends for the three and nine months ended September 30, 2022 was $0.38 and $0.83, respectively.

In addition, holders of the Series B Preferred Stock will participate in any dividend or distribution of cash or other property paid in respect of the Common Stock pro rata with the holders of the Common Stock (other than certain dividends or distributions that trigger an adjustment to the conversion rate, as described in the Certificate of Designations), as if all shares of Series B Preferred Stock had been converted into Common Stock immediately prior to the date on which such holders of the Common Stock became entitled to such dividend or distribution. Holders of Series B Preferred Stock also have rights to vote for the election of one additional director to serve on the Board, if dividends on Series B Preferred Stock are in arrears for eight or more consecutive quarters, until all unpaid and accumulated dividends on the Series B Preferred Stock have been paid or declared and a sum sufficient for payment is set aside for such payment.

On May 17, 2022, the Company issued one share of tandem preferred stock, par value $0.0001 per share (the “Tandem Preferred Stock”), as a dividend on its existing shares of outstanding Series B Preferred Stock. Any issuance of Series B Preferred Stock after this date shall be automatically accompanied by an equal number of shares of Tandem Preferred Stock. Tandem Preferred Stock are embedded in the Series B Preferred Stock and they provide voting rights to the existing shares of Series B Preferred Stock. Each share of Series B Preferred Stock disclosed in the ~~Condensed Consolidated Balance Sheet,~~condensed consolidated balance sheet, the ~~Condensed Consolidated Statements~~condensed consolidated statements of ~~Stockholders’ Deficit~~stockholders’ deficit and the ~~Notes~~notes to the ~~Condensed Consolidated Financial Statements~~condensed consolidated financial statements embeds one share of Tandem Preferred Stock.

On all matters submitted to a vote of the stockholders of the Company, the holders of the Series B Preferred Stock through their holdings of Tandem Preferred Stock will be entitled to vote with the holders of the Common Stock as a single class. Each share of Tandem Preferred Stock entitles the holder to 1one vote per share, subject to adjustment for issuance of any shares of Common Stock pursuant to any dividend or distribution on shares of Common Stock, share split or share combination or other transactions as specified in the Certificate of Designation of Tandem Preferred Stock.

Shares of Tandem Preferred Stock are not entitled to receive dividends of any kind. In the case of a transfer of the underlying Series B Preferred Stock by a holder to any transferee, the Tandem Preferred Stock shall be automatically transferred simultaneously to such transferee without any further action by such Holder. Upon the redemption of a holder’s shares of Series B Preferred Stock or the conversion of shares of Series B Preferred Stock into Common Stock, an equal number of such holder’s shares of Tandem Preferred Stock shall, without any further action required by the holder, be automatically transferred to the Company for cancellation without the payment of any additional consideration by the Company. In the event of any liquidation, winding-up or dissolution of the Company each holder of the Tandem Preferred Stock shall be entitled to receive and to be paid out of the assets of the Company available for

Table of Contents

distribution to its stockholders an amount in cash equal to the par value of such Tandem Preferred Stock with respect to each share of Tandem Preferred Stock held by such holder.

Treasury Stock

AsThe Company had 612 shares of ~~September 30, 2022, the Company has 46,452 shares repurchased and~~Common Stock held as treasury stock, 232 shares of which were repurchased under a prior expired share buyback ~~program authorized on November 8, 2017. During the first quarter of 2020, 76,179~~and 380 shares ~~of Common Stock~~that were returned to the Company ~~in connection with the Appraisal Action. These shares are also included in treasury stock.~~pursuant to a contractual obligation. The Company ~~records~~recorded treasury stock using the cost method. On September 30, 2023, the Company retired all of 612 shares of the Common Stock held as treasury stock and charged the excess of the repurchase cost over the par value of the shares to accumulated deficit.

Warrants

At September 30, ~~2022,~~2023, there were warrants outstanding to purchase ~~486,591~~2,433 shares of our Common Stock, consisting of 9,731,819 warrants to purchase ~~one-twentieth~~one-four thousandth of one share of Common Stock from the private placement that was completed in March 2021.

~~Table of Contents~~

Private Placement of Unregistered Shares and Warrants

On March 15, 2021, the Company, entered into a securities purchase agreement with certain accredited institutional investors pursuant to which the Company issued and sold to ten accredited institutional investors in a private placement an aggregate of ~~486,591~~2,433 unregistered shares of the ~~Company’s~~ Common Stock at a price of ~~$55.00~~$11,000.00 per share and an equal number of warrants, generating gross proceeds to the Company of $26.8 million. Cantor Fitzgerald acted as ~~underwriter~~placement agent in connection with such sale of unregistered securities and received a placement fee of 5.5% of gross proceeds in connection with such service. In selling the shares without registration, the Company relied on exemptions from registration available under Section 4(a)(2) of the Securities Act ~~of 1933~~ and Rule 506 promulgated thereunder. The Company filed a registration statement on Form S-3 on May 3, 2021 that registered for resale of these shares and the shares underlying these private placement warrants.

Each private placement warrant entitles the holder to purchase ~~one-twentieth~~one-four thousandth of one share of Common Stock, at an exercise price of ~~$80.00~~$16,000.00 per share and will expire on September 19, 2026. The private placement warrants are not listed or traded as of September 30, ~~2022~~2023, and are not subject to mandatory redemption by the Company.

12. Related-Party Transactions

Relationship with HandsOn Global Management

The Company incurred reimbursable travel expenses to HOVS LLC and HandsOn Fund 4 I, LLC (collectively, and together with certain of their affiliated entities managed by HandsOn Global Management LLC, including such entity, “HGM”) of $0 and less than $0.1 million for the three months ended September 30, 2023 and 2022, respectively, and less than $0.1 million for each of the ~~three and~~ nine months ended September 30, ~~2022~~2023 and ~~2021.~~2022. Certain members of our Board, including our Executive Chairman, Par Chadha, Sharon Chadha, Ron Cogburn, and James Reynolds are or have been ~~or may be deemed to be~~ affiliated with HGM. Our Executive Chairman, Par Chadha and his wife, Sharon Chadha, are currently affiliated with HGM. Messrs. Cogburn and Reynolds were affiliated with HGM until 2020.

Pursuant to a master agreement dated January 1, 2015 between Rule 14, LLC ~~a portfolio company of HGM,~~ and a subsidiary of the Company, the Company incurs marketing fees to Rule 14, ~~LLC.~~LLC, a portfolio company of HGM. Similarly, the Company is party to ten master agreements with entities affiliated with HGM’s managed funds, each of which were entered into during 2015 and 2016. Each master agreement provides the Company with use of certain technology and includes a reseller arrangement pursuant to which the Company is entitled to sell these services to third parties. Any revenue earned by the Company in such third-party ~~sales~~sale is shared 75%/25% with each of HGM’s venture affiliates in favor of the Company. The brands Zuma, Athena, Peri, BancMate, Spring, Jet, Teletype, CourtQ and Rewardio are part of the HGM managed

Table of Contents

funds. The Company has the license to use and resell such brands, as described ~~in the master agreements.~~therein. The Company incurred fees of ~~$1.5~~$2.2 million and $1.5 million relating to these agreements for ~~each of~~ the three months ended September 30, 2023 and 2022, ~~and 2021.~~respectively. The Company incurred fees of ~~$4.6~~$6.7 million and ~~$4.2~~$4.6 million relating to these agreements for the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively.

Certain operating companies lease their operating facilities from HOV RE, LLC and HOV Services Limited, which are affiliates under common control with HGM. The rental expense for these operating leases was less than $0.1 million and $0.1 million for ~~each of~~ the three and the nine months ended September 30, ~~2022~~2023, respectively, and ~~2021,~~$0.1 million and $0.2 million for ~~each of~~the three and the nine months ended September 30, 2022, ~~and 2021.~~respectively. In addition, HOV Services, Ltd. provides the Company data capture and technology services. The expense recognized for these services was approximately ~~$0.4~~$0.5 million and ~~$0.3~~$0.4 million for the three months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively, and ~~$1.0~~$1.3 million and $1.1 million for ~~each of~~ the nine months ended September 30, 2023 and 2022, ~~and 2021.~~respectively. These expenses are included in cost of revenue in the condensed consolidated statements of operations.

~~Table of Contents~~

Consulting Agreement

The Company receives services from Oakana Holdings, Inc. The Company and Oakana Holdings, Inc. are related through a family relationship between our Executive Chairman and the president of Oakana Holdings, Inc. ~~There~~The expense recognized for these services was $0 and an expense reversal of less than $0.1 million for the three months ended September 30, 2023 and 2022, respectively, and ~~the expense recognized for these services was~~ less than $0.1 million for ~~the three months ended September 30, 2021. The expense recognized for these services was less than $0.1 million and $0.1 million for~~each of the nine months ended September 30, ~~2022~~2023 and ~~2021, respectively.~~2022.

Subscription Agreements

During the year ended December 31, 2021, the Company entered into separate subscription agreements with five of its directors. Pursuant to these subscription agreements, the Company issued and sold 3,125, 7,936, 3,174, 3,968 and 1,984 shares of Common Stock of the Company to Sharon Chadha, Par Chadha, Martin Akins, J. Coley Clark and John Rexford, respectively, for a purchase price of $0.1 million, $0.2 million, less than $0.1 million, $0.1 million and less than $0.1 million, respectively.

On July 21, 2022, the Company entered into a subscription agreement with its Executive Chairman. Pursuant to this subscription agreement, on August 11, 2022, the Company issued and sold ~~70,921~~355 shares of Common Stock ~~of the Company~~ to Par Chadha for aan aggregate purchase price of $0.1 million.

~~Subscription, Voting and Redemption Agreement~~

On May 19, 2022, the Company issued 1,000,000 shares of special voting preferred stock, par value $0.0001 per share (“Redeemable Special Voting Preferred Stock”) at par value of $100 to GP-HGM LLC, an entity affiliated to the Executive Chairman of the Company, pursuant to a certain subscription, voting and redemption agreement (the “Subscription, Voting and Redemption Agreement”). The Company designated 1,000,000 shares of its authorized and unissued preferred stock as special voting preferred stock and filed a certificate of designations, preferences, rights and limitations for the special voting preferred stock. The Executive Chairman of the Company was the designated manager of GP-HGM LLC. As a sole holder of the Redeemable Special Voting Preferred Stock, GP-HGM LLC was entitled to 20,000 votes per share, to be voted together and in proportion with the holders of the Company’s voting capital stock as a single class at the Company’s 2022 annual meeting of the stockholders on two specific proposals: (a) approval of the adoption of an amendment to the Company’s certificate of incorporation to effect a reverse split of its outstanding Common Stock (the “Reverse Stock Split Proposal”) and (b) approval of an amendment to the Company’s certificate of incorporation to increase the number of authorized shares of preferred stock from 20,000,000 shares to 40,000,000 shares (the “Preferred Stock Increase Proposal”). The Redeemable Super Voting Preferred Stock were redeemed at par on June 28, 2022.

Payable and Receivable/~~Prepayment~~Prepaid Balances with Affiliates

Payable and receivable/~~prepayment~~prepaid balances with affiliates as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 were as follows:



	September 30, 2022				December 31, 2021				September 30, 2023				December 31, 2022
	Receivables and Prepaid Expenses		Payables		Receivables and Prepaid Expenses		Payables		Receivables and Prepaid Expenses		Payables		Receivables and Prepaid Expenses		Payables
HOV Services, Ltd	$	402	$	—	$	708	$	—	$	50	$	—	$	412	$	—
Rule 14		—		1,698		—		1,483		—		2,499		—		2,473
HGM		102		—		7		—		67		—		347		—
Oakana		—		—		—		1
	$	504	$	1,698	$	715	$	1,484	$	117	$	2,499	$	759	$	2,473

~~Table of Contents~~

13. Segment and Geographic Area Information

ITPS: The ITPS segment provides a wide range of solutions and services designed to aid businesses in information capture, processing, decisioning and distribution to customers primarily in the financial services, commercial, public sector and legal industries.

Table of Contents

HS: The HS segment operates and maintains an outsourcing business specializing in both the healthcare provider and payer markets.

LLPS: The LLPS segment provides a broad and active array of legal services in connection with class action, labor claims adjudication and employment and other legal matters.

The chief operating decision maker reviews segment profit to evaluate operating segment performance and determine how to allocate resources to operating segments. “Segment profit” is defined as revenue less cost of revenue (exclusive of depreciation and amortization). The Company does not allocate selling, general, and administrative expenses, depreciation and amortization, interest expense, net and sundry expenses (income), net. The Company manages assets on a total company basis, not by operating segment, and therefore asset information and capital expenditures by operating segments are not presented. A reconciliation of segment profit to net loss before income taxes is presented below.


	Three months ended September 30, 2023
	ITPS		HS		LLPS		Total
Revenue	$	172,150	$	62,090	$	18,885	$	253,125
Cost of revenue (exclusive of depreciation and amortization)		141,808		45,430		11,212		198,450
Segment profit		30,342		16,660		7,673		54,675
Selling, general and administrative expenses (exclusive of depreciation and amortization)								35,367
Depreciation and amortization								14,398
Related party expense								2,845
Interest expense, net								24,708
Debt modification and extinguishment costs (gain), net								(571)
Sundry expense, net								298
Other income, net								(1,069)
Net loss before income taxes							$	(21,301)


	Three months ended September 30, 2022
	ITPS		HS		LLPS		Total
Revenue	$	185,309	$	60,955	$	17,774	$	264,038
Cost of revenue (exclusive of depreciation and amortization)		157,269		48,316		12,257		217,842
Segment profit		28,040		12,639		5,517		46,196
Selling, general and administrative expenses (exclusive of depreciation and amortization)								44,369
Depreciation and amortization								17,737
Impairment of goodwill and other intangible assets								29,565
Related party expense								2,016
Interest expense, net								40,897
Debt modification and extinguishment costs (gain), net								(4,696)
Sundry expense, net								781
Other income, net								(1,115)
Net loss before income taxes							$	(83,358)

3634

Table of Contents


	Three months ended September 30, 2021									Nine months ended September 30, 2023
	ITPS		HS		LLPS		Total		ITPS		HS		LLPS		Total
Revenue	$	208,304	$	53,995	$	16,930	$	279,229	$	550,848	$	188,740	$	60,095	$	799,683
Cost of revenue (exclusive of depreciation and amortization)		157,721		41,945		12,065		211,731		450,353		139,182		37,441		626,976
Segment profit		50,583		12,050		4,865		67,498		100,495		49,558		22,654		172,707
Selling, general and administrative expenses (exclusive of depreciation and amortization)								43,244								111,774
Depreciation and amortization								19,094								45,848
Related party expense								2,744								8,696
Interest expense, net								41,757								113,980
Debt modification and extinguishment costs (gain), net								(28,070)								(16,129)
Sundry expense, net								136								2,546
Other expense, net								366
Other income, net																(1,583)
Net loss before income taxes							$	(11,773)							$	(92,425)


		Nine months ended September 30, 2022
	ITPS		HS		LLPS		Total
Revenue	$	580,320	$	173,940	$	55,946	$	810,206
Cost of revenue (exclusive of depreciation and amortization)		477,559		140,767		40,297		658,623
Segment profit		102,761		33,173		15,649		151,583
Selling, general and administrative expenses (exclusive of depreciation and amortization)								137,604
Depreciation and amortization								53,942
Impairment of goodwill and other intangible assets								29,565
Related party expense								6,189
Interest expense, net								122,928
Debt modification and extinguishment costs (gain), net								4,305
Sundry expense, net								347
Other expense, net								12,419
Net loss before income taxes							$	(215,716)

Nine months ended September 30, 2021


ITPS

HS

LLPS

Total
Revenue

$
657,438

$
161,292

$
53,564

$
872,294
Cost of revenue (exclusive of depreciation and amortization)

499,892

116,736

36,770

653,398
Segment profit

157,546

44,556

16,794

218,896
Selling, general and administrative expenses (exclusive of depreciation and amortization)

121,519
Depreciation and amortization

58,113
Related party expense

7,199
Interest expense, net

127,755
Debt modification and extinguishment costs (gain), net

(28,070)
Sundry income, net

(438)
Other expense, net

1,169
Net loss before income taxes

$
(68,351)

~~Table of Contents~~

14. Subsequent Events

The Company has evaluated all events that occurred after the balance sheet date through the date when these condensed consolidated financial statements were issued to determine if they must be reported.

Special Voting Preferred Stock

~~Common Stock At-The-Market Sales Program~~

~~During~~On October ~~1, 2022 through November 14, 2022, we issued~~9, 2023, the Company entered into the Subscription, Voting and Redemption Agreement with GP-HGM LLC (“GP-HGM”), an entity controlled by our Executive Chairman, pursuant to which GP-HGM purchased 1,000,000 shares of a new class of preferred stock designated as “Special Voting Stock” for an aggregate purchase price of ~~42,150,362~~$100 and agreed to vote all of the shares of Special Voting Stock at the annual meeting of stockholders, scheduled for December 5, 2023 (the “Annual Meeting"), in proportion to the votes cast at the Annual Meeting. Each share of Special Voting Stock is entitled to 20,000 votes per share. The Company has further agreed to redeem the shares of Special Voting Stock for an aggregate price of $100 on the first business day following the date on which the voting on the Amendment to Series B Certificate of Designations Proposal has concluded.

Table of Contents

At the Annual Meeting, stockholders will be asked to approve an amendment to the Certificate of Designations of the Company’s Series B Preferred Stock to allow the Company to have the ability to (a) pay dividends in shares of Common Stock, ~~under~~(b) pay less than all of the ~~Common ATM Program–4 at a weighted average price~~accrued dividends, and (c) pay dividends on any date designated by the Company’s board of ~~$0.281 per share, generating gross proceeds~~directors for the payment of ~~$11.8 million and net proceeds~~dividends.

Completion of ~~$11.4 million, after offering expenses.~~the Merger

~~Repayments~~On November 29, 2023, the Company completed the merger of its European business with CFFE. The combined company now operates as XBP Europe and, beginning on ~~BRCC Facility~~

~~During October 1, 2022 through~~ November ~~14, 2022, we repaid $5.3 million of outstanding principal amount~~30, 2023, XBP Europe shares started trading on the Nasdaq Stock Market under the ~~BRCC Term Loan.~~ticker symbol “XBP” and its warrants started trading on the Nasdaq Stock Market under the ticker symbol “XBPEW”.

The business combination will be accounted for as a reverse capitalization in accordance with FASB’s ASC Topic 805, Business Combinations (“ASC 805”). Under this method of accounting, CFFE will be treated as the “acquired” company for financial reporting purposes with XBP Europe surviving as a direct wholly-owned subsidiary of CFFE.

Insurance Claim

~~Divestiture~~The Company received an insurance claim settlement amount of $10.0 million in December 2023 under the business interruption claim filed for the cyber security incident which occurred during the second half of 2022.

On October 10, 2022, we announced the execution of a definitive merger agreement to merge our European business with CF Acquisition Corp. VIII (“CFFE”), a special purpose acquisition company, to form a new publicly-traded company which will be called XBP Europe Holdings, Inc. Exela will indirectly own a majority of the outstanding capital stock of XBP Europe Holdings, Inc. The Board of the Company has approved the transaction. The transaction is subject to customary closing conditions, several of which are outside the control of the parties, and there can be no assurance as to whether or when a closing will occur.

3836

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis together with our condensed consolidated financial statements and the related notes included elsewhere in this Form 10-Q. Among other things, the condensed consolidated financial statements include more detailed information regarding the basis of presentation for the financial data than included in the following discussion. Amounts in thousands of United States dollars.

~~Restatement~~

As described in additional detail in the Explanatory Note to its 2021 Form 10-KA, the Company restated its audited consolidated financial statements in the 2021 Form 10-K for the year ended December 31, 2021. Previously filed quarterly reports on Form 10-Q for the first two fiscal quarters in the fiscal year ended December 31, 2022 have not been amended for the restated consolidated balance sheet as of December 31, 2021 as affected by the restatement. See Note 21, Restatement of Previously Issued Financial Statements, of the Notes to the consolidated financial statements in the 2021 Form 10-KA for the impact of the restatement. These condensed consolidated financial statements include restated consolidated balance sheet as of December 31, 2021.

Forward Looking Statements

Certain statements included in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this quarterly report are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for Exela, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties regarding Exela’s businesses and actual results may differ materially. The factors that may affect our results include, among others: the impact of political and economic conditions on the demand for our services; ~~the impact of the COVID-19 pandemic; the impact of the 2022 network outage,~~ cyber incidents such as a data or security breach; the impact of competition or alternatives to our services on our business pricing and other actions by competitors; our ability to address technological development and change in order to keep pace with our industry and the industries of our customers; the impact of terrorism, natural disasters or similar events on our business; the effect of legislative and regulatory actions in the United States and internationally; the impact of operational failure due to the unavailability or failure of third-party services on which we rely; the effect of intellectual property infringement; and other factors discussed in this quarterly report and our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2021 ending December 31, 2021~~2022 (as amended, the ~~“Annual Report”~~“2022 Form 10-K”) under the heading “Risk Factors”, and otherwise identified or discussed in this quarterly report. You should consider these factors carefully in evaluating forward-looking statements and are cautioned not to place undue reliance on such statements, which speak only as of the date of this quarterly report. It is impossible for us to predict new events or circumstances that may arise in the future or how they may affect us. We undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this quarterly report. We are not including the information provided on any websites that may be referenced herein as part of, or incorporating such information by reference into, this quarterly report. In addition, forward-looking statements provide our expectations, plans or forecasts of future events and views as of the date of this quarterly report. We anticipate that subsequent events and developments may cause our assessments to change. These forward-looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of this quarterly report.

Overview

Exela Technologies, Inc. (“Exela”, the “Company”, “we”, “our” or “us”) is a business process automation leader leveraging a global footprint and proprietary technology to help turn the complex into the simple through user friendly software platforms and solutions that enable our customers’ digital transformation. We have decades of expertise earned

~~Table of Contents~~

from serving more than 4,000 customers worldwide, including many of the world’s largest enterprises and over 60% of the Fortune® 100, in many mission critical environments across multiple industries, including banking, healthcare, insurance and manufacturing. Our technology-enabled solutions allow global organizations to address critical challenges resulting from the massive amounts of data obtained and created through their daily operations. Our solutions address the life cycle of transaction processing and enterprise information management, from enabling payment gateways and data exchanges across multiple systems, to matching inputs against contracts and handling exceptions, to ultimately depositing payments and distributing communications. Through cloud-enabled platforms, built on a configurable stack of automation modules, and approximately ~~16,500~~15,000 employees operating in 21 countries, Exela rapidly deploys integrated technology and operations as an end-to-end digital journey partner.

Table of Contents

We believe our process expertise, information technology capabilities and operational insights enable our customers’ organizations to more efficiently and effectively execute transactions, make decisions, drive revenue and profitability, and communicate critical information to their employees, customers, partners, and vendors. Our solutions are location agnostic, and we believe the combination of our hybrid hosted solutions and global work force in the Americas, EMEA and Asia offers a meaningful differentiation in the industries we serve and services we provide.

History

We are a former special purpose acquisition company that completed an initial public offering on January 22, 2015. In July 2017, Exela, formerly known as Quinpario Acquisition Corp. 2 (“Quinpario”), completed its acquisition of SourceHOV Holdings, Inc. (“SourceHOV”) and Novitex Holdings, Inc. (“Novitex”) pursuant to ~~the~~a business combination agreement dated February 21, 2017 (“Novitex Business Combination”). In conjunction with the completion of the Novitex Business Combination, Quinpario was renamed Exela Technologies, Inc.

The Novitex Business Combination was accounted for as a reverse merger for which SourceHOV was determined to be the accounting acquirer. Outstanding shares of SourceHOV were converted into shares of our common stock (“Common Stock”), presented as a recapitalization, and the net assets of Quinpario were acquired at historical cost, with no goodwill or other intangible assets recorded. The acquisition of Novitex was treated as a business combination under ASC 805 and was accounted for using the acquisition method. The strategic combination of SourceHOV and Novitex formed Exela, which is one of the largest global providers of information processing solutions based on revenues.

On ~~July 25, 2022,~~May 12, 2023, we effected a ~~one-for-twenty~~one-for-two hundred reverse stock split (the “Reverse Stock Split”) of our issued and outstanding shares of our Common Stock. At the effective time of the ~~reverse split,~~Reverse Stock Split, every ~~twenty (20)~~two hundred (200) shares of Common Stock issued and outstanding were automatically combined into one (1) share of issued and outstanding Common Stock, without any change in the par value per share. Our Common Stock began trading on The Nasdaq Capital Market on a Reverse Stock Split-adjusted basis on ~~July 26, 2022.~~May 15, 2023. There was no change in our ticker symbol as a result of the Reverse Stock Split. All information related to Common Stock, stock options, restricted stock units, warrants and earnings per share have been retroactively adjusted to give effect to the Reverse Stock Split for all periods presented.

Merger Agreement

On October 9, 2022, the Company entered into a definitive merger agreement to merge its European business with CF Acquisition Corp. VIII (“CFFE”), a special purpose acquisition company, to form a new publicly-traded company which will be called XBP Europe, Inc. (“XBP Europe”). Following the closing of the transaction, which occurred on November 29, 2023, we indirectly own a majority of the outstanding capital stock of the combined company, which now operates as XBP Europe. The shares and warrants of XBP Europe are listed on the Nasdaq Stock Market under the ticker symbols “XBP” and “XBPEW,” respectively.

Sale of Non-core Assets

On June 8, 2023, the Company completed the sale of the high-speed scanner business, which was a part of its Information & Transaction Processing Solutions segment, for a purchase price of approximately $30.1 million, subject to final working capital adjustments. This transaction resulted in a pre-tax gain of $7.2 million.

Our Segments

Our three reportable segments are Information & Transaction Processing Solutions (“ITPS”), Healthcare Solutions (“HS”), and Legal & Loss Prevention Services (“LLPS”). These segments are comprised of significant strategic business units that align our transaction processing and enterprise information management products and services with how we manage our business, approach our key markets and interact with our customers based on their respective industries.

Table of Contents

ITPS: Our largest segment, ITPS, provides a wide range of solutions and services designed to aid businesses in information capture, processing, decisioning and distribution to customers primarily in the financial services, commercial, public sector and legal industries. Our major customers include many leading banks, insurance companies, and utilities, as well as hundreds of federal, state and local government entities. Our ITPS offerings enable companies to increase availability of working capital, reduce turnaround times for application processes, increase regulatory compliance and enhance consumer engagement.

~~Table of Contents~~

HS: HS operates and maintains an outsourcing business specializing in both the healthcare provider and payer markets. We serve the top healthcare insurance payers and hundreds of healthcare providers.

LLPS: Our LLPS segment provides a broad and active array of support services in connection with class action, labor claims adjudication and employment and other legal matters. Our customer base consists of corporate counsel, government attorneys, and law firms.

Revenues

ITPS revenues are primarily generated from a transaction based pricing model for the various types of volumes processed, licensing and maintenance fees for technology sales, and a mix of fixed management fee and transactional revenue for document logistics and location services. HS revenues are primarily generated from a transaction based pricing model for the various types of volumes processed for healthcare payers and providers. LLPS revenues are primarily based on time and materials pricing as well as through transactional services priced on a per item basis.

People

We draw on the business and technical expertise of our talented and diverse global workforce to provide our customers with high-quality services. Our business leaders bring a strong diversity of experience in our industry and a track record of successful performance and execution.

As of September 30, ~~2022,~~2023, we had approximately ~~16,500~~15,000 employees globally, with ~~54%~~53% located in the Americas and EMEA, and the remainder located primarily in India, ~~the~~ Philippines and China.

Costs associated with our employees represent the most significant expense for our business. We incurred personnel costs of ~~$136.0~~$121.9 million and ~~$130.4~~$136.0 million for the three months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. We incurred personnel costs of ~~$405.5~~$376.5 million and ~~$395.7~~$405.5 million for the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The majority of our personnel costs are variable and incurred only while we are providing our services.

Key Performance Indicators

We use a variety of operational and financial measures to assess our performance. Among the measures considered by our management are the following:

●

Revenue by segment;

●

EBITDA; and

●

Adjusted EBITDA

Revenue by segment

We analyze our revenue by comparing actual monthly revenue to internal projections and prior periods across our operating segments in order to assess performance, identify potential areas for improvement, and determine whether our segments are meeting management’s expectations.

Table of Contents

EBITDA and Adjusted EBITDA

We view EBITDA and Adjusted EBITDA as important indicators of performance of our consolidated operations. We define EBITDA as net income, plus taxes, interest expense, and depreciation and amortization. We define Adjusted EBITDA as EBITDA plus optimization and restructuring charges, including severance and retention expenses; transaction and integration costs; other non-cash charges, including non-cash compensation, (gain) or loss

~~Table of Contents~~

from sale or disposal of assets, and impairment charges; and management fees and expenses. See “—Other Financial Information (Non-GAAP Financial Measures)” for more information and a reconciliation of EBITDA and Adjusted EBITDA to net loss, the most directly comparable financial measure calculated and presented in accordance with GAAP.

Results of Operations

Three Months Ended September 30, ~~2022 Compared~~2023 compared to Three Months Ended September 30, ~~2021:~~2022:


	Three Months Ended September 30,								Three Months Ended September 30,
	2022		2021		Change		% Change		2023		2022		Change		% Change
Revenue:
ITPS	$	185,309	$	208,304	$	(22,995)		(11.04)%	$	172,150	$	185,309	$	(13,159)		(7.10)%
HS		60,955		53,995		6,960		12.89%		62,090		60,955		1,135		1.86%
LLPS		17,774		16,930		844		4.99%		18,885		17,774		1,111		6.25%
Total revenue		264,038		279,229		(15,191)		(5.44)%		253,125		264,038		(10,913)		(4.13)%
Cost of revenue (exclusive of depreciation and amortization):
ITPS		157,269		157,721		(452)		(0.29)%		141,808		157,269		(15,461)		(9.83)%
HS		48,316		41,945		6,371		15.19%		45,430		48,316		(2,886)		(5.97)%
LLPS		12,257		12,065		192		1.59%		11,212		12,257		(1,045)		(8.53)%
Total cost of revenues		217,842		211,731		6,111		2.89%		198,450		217,842		(19,392)		(8.90)%
Selling, general and administrative expenses (exclusive of depreciation and amortization)		44,369		43,244		1,125		2.60%		35,367		44,369		(9,002)		(20.29)%
Depreciation and amortization		17,737		19,094		(1,357)		(7.11)%		14,398		17,737		(3,339)		(18.83)%
Impairment of goodwill and other intangible assets		29,565		—		29,565		100.00%		—		29,565		(29,565)		100.00%
Related party expense		2,016		2,744		(728)		(26.53)%		2,845		2,016		829		41.12%
Operating profit (loss)		(47,491)		2,416		(49,907)		(2065.69)%		2,065		(47,491)		49,556		(104.35)%
Interest expense, net		40,897		41,757		(860)		(2.06)%		24,708		40,897		(16,189)		(39.58)%
Debt modification and extinguishment costs (gain), net		(4,696)		(28,070)		23,374		(83.27)%		(571)		(4,696)		4,125		(87.84)%
Sundry expense, net		781		136		645		474.26%		298		781		(483)		(61.84)%
Other expense (income), net		(1,115)		366		(1,481)		(404.64)%
Other income, net										(1,069)		(1,115)		46		(4.13)%
Net loss before income taxes		(83,358)		(11,773)		(71,585)		608.04%		(21,301)		(83,358)		62,057		(74.45)%
Income tax expense		(1,924)		(1,441)		(483)		33.52%		(1,807)		(1,924)		117		(6.08)%
Net loss	$	(85,282)	$	(13,214)	$	(72,068)		545.39%	$	(23,108)	$	(85,282)	$	62,174		(72.90)%

Revenue

For the three months ended September 30, ~~2022,~~2023, our revenue on a consolidated basis decreased by ~~$15.2~~$10.9 million, or ~~5.4%,~~4.1% to ~~$264.0~~$ 253.1 million ~~as compared to $279.2~~from $264.0 million for the three months ended September 30, ~~2021.~~2022. We experienced revenue decline in ~~our~~the ITPS segment ~~of $23.0 million~~ and revenue ~~increases~~growth in ~~our~~the HS and LLPS ~~segments of $7.0 million and $0.8 million respectively.~~segments. Our ITPS, HS, and LLPS segments constituted ~~70.2%~~68.0%%, ~~23.1%,~~24.5% and ~~6.7%~~7.5% of total revenue, respectively, ~~compared to 74.6%, 19.3%, and 6.1%~~ for the three months ended September 30, ~~2021.~~2023, compared to 70.2%, 23.1%, and 6.7%, respectively, for the three months ended September 30, 2022. The revenue changes by reporting segment were as follows:

ITPS— For the three months ended September 30, ~~2022,~~2023, revenue attributable to our ITPS segment decreased by ~~$23.0~~$13.2 million, or ~~11.0%~~7.1% compared to the same period in the prior year. This revenue decline is attributable to exiting contracts and statements of work with certain customers that we believe was unpredictable, non-recurring and were not a strategic fit to Company’s long-term success or unlikely to achieve the Company’s long-term target margins (“transition revenue”) and other customer losses. In addition, staffing shortages and network outage from prior quarter impacted revenue during the quarter. The reported ITPS segment revenue decline was also impacted by $7.0 million from currency conversion attributable to the depreciation of the Euro and U.K. pound sterling against the U.S. dollar during the three months ended September 30, 2022, compared to the three months ended September 30, 2021.lower volumes,

4240

Table of Contents

transition revenue and other customer losses. The reported ITPS segment revenue benefited by $2.3 million from currency conversion during the three months ended September 30, 2023, compared to the three months ended September 30, 2022.

HS— For the three months ended September 30, ~~2022,~~2023, revenue attributable to our HS segment increased by ~~$7.0~~$1.1 million, or ~~12.9%~~1.9 % compared to the same period in the prior year primarily ~~driven by~~due to higher volumes from our existing healthcare ~~payer~~ customers.

LLPS— For the three months ended September 30, ~~2022,~~2023, revenue attributable to our LLPS segment increased by ~~$0.8~~$1.1 million, or ~~5.0%~~6.3 % compared to the same period in the prior year primarily due to an increase in project based engagements in legal claims administration services.

Cost of Revenue

For the three months ended September 30, ~~2022,~~2023, our ~~direct costs increased~~cost of revenue decreased by ~~$6.1~~$19.4 million, or ~~2.9%~~8.9%, compared to the three months ended September 30, ~~2021.~~2022. Costs in our ITPS segment decreased by ~~$0.5~~$15.5 million, or ~~0.3%~~9.8%, primarily attributable to the corresponding decline in revenues ~~offset by higher wage inflation.~~and cost savings flow through. HS segment ~~costs increased~~cost of revenue decreased by ~~$6.4~~$2.9 million, or ~~15.2% primarily due to increases in employee-related cost on account of higher headcount in HS (bench costs) to meet our customer forecasts.~~6.0 %. LLPS segment cost of revenue ~~increased~~decreased by ~~$0.2~~$1.0 million, or ~~1.6%.~~8.5 %.

The ~~increase~~decrease in cost of revenues on a consolidated basis was primarily due to ~~an increase~~decrease in employee-related costs of ~~$4.6 million, higher pass through costs of $3.9~~$11.7 million, lower infrastructure and maintenance costs of ~~$1.2~~$1.9 million, lower travel costs of $0.1 million and lower pass through costs of $6.0 million which is offset by operating costs of ~~$1.5~~$0.3 million.

Cost ~~of revenue as a percentage~~ of revenue for the three months ended September 30, ~~2022~~2023 was ~~82.5%~~78.4% of revenue compared to the ~~75.8%~~82.5% for the comparable same period in the prior year.

Selling, General and Administrative Expenses

SG&A expenses ~~increased~~decreased by ~~$1.1~~$9.0 million, or ~~2.6%~~20.3%, to $35.4 million for the three months ended September 30, 2023, compared to $44.4 million for the three months ended September 30, ~~2022, compared~~2022. The decrease was primarily attributable to ~~$43.2~~a pre-tax gain of $0.7 million recorded for the three months ended September 30, ~~2021. The increase was primarily attributable to higher~~2023 on the sale of the high-speed scanner business, lower employee related costs by ~~$2.5~~$2.9 million, ~~higher infrastructure and other costs of $1.2 million, higher~~lower travel costs of ~~$0.5~~$0.3 million, ~~offset by~~ lower ~~legal~~infrastructure, maintenance and operating costs of $1.5 million and lower professional and legal fees of ~~$3.1~~$1.3 million. and lower other SG&A expenses ~~increased~~of $2.3 million. SG&A expenses decreased as a percentage of revenues to 14.0 % for the three months ended September 30, 2023 as compared to 16.8% for the three months ended September 30, ~~2022 as compared to 15.5% for the three months ended September 30, 2021.~~2022.

Depreciation & Amortization

Total depreciation and amortization expense was ~~$17.7~~$14.4 million and ~~$19.1~~$17.7 million for the three months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The decrease in total depreciation and amortization expense by ~~$1.4~~$3.3 million was primarily due to a reduction in depreciation expense as a result of the expiration of the ~~depreciated~~ lives of assets acquired in prior periods and decrease in intangibles amortization expense due to end of useful lives for certain intangible assets during the three months ended September 30, ~~2022~~2023 compared to the three months ended September 30, ~~2021.~~2022.

Impairment of Goodwill and Other Intangible Assets

Impairment of goodwill and other intangible assets for the three months ended September 30, 2022 was $29.6 million. During the three months ended September 30, 2022, the Company made an evaluation based on factors such as changes in the Company’s growth rate and recent trends in the Company’s market capitalization, and concluded that a triggering event for an interim impairment analysis had occurred induring the ~~third quarter of~~three months ended September 30, 2022. As a result of the interim impairment analysis at September 30, 2022, the Company recorded an impairment charge of $29.6 million, including taxes to goodwill relating to ITPS.

~~Related Party Expenses~~

~~Related party expense was $2.0 million and $2.7 million for the three months ended September 30, 2022 and 2021, respectively.~~

4341

Table of Contents

~~Interest Expense~~Related Party Expenses

~~Interest~~Related party expense was ~~$40.9 million and $41.8~~$2.8 million for the three months ended September 30, ~~2022~~2023 compared to $2.0 million for the three months ended September 30, 2022.

Interest Expense

Interest expense was $24.7 million for the three months ended September 30, 2023 compared to $40.9 million for the three months ended September 30, 2022. The decrease in total interest expense by $16.2 million was primarily due to amortization of debt exchange premium during the three months ended September 30, 2023 compared to the three months ended September 30, 2022.

Debt modification and ~~2021, respectively.~~extinguishment costs (gain), net

Debt modification and extinguishment gain was $0.6 million for the three months ended September 30, 2023 compared to a gain of $4.7 million for the three months ended September 30, 2022. In July 2023, the Company recorded a debt extinguishment gain of $0.6 million when the Company fully repaid and discharged the remaining outstanding balance of $48.4 million of the 2023 Term Loans by making a cash payment of $44.8 million and by issuance of $3.0 million principal amount of New Notes (as defined and described further in the description of “Indebtedness” below) in an exchange transaction.

Sundry Expense, net

~~The~~Sundry expense, net ~~change in~~was $0.3 million for the three months ended September 30, 2023 compared to sundry expense, net of ~~$0.6~~$0.8 million for the three months ended September 30, 2022. The change over the prior year period was primarily attributable to exchange rate fluctuations on foreign currency transactions.

Other ~~Expense (Income),~~Income, net

Other income, net was $1.1 million for the three months ended September 30, ~~2022~~2023 compared to other ~~expense,~~income, net of ~~0.4~~$1.1 million for the three months ended September 30, ~~2021.~~2022. For the three months ended September 30, 2022, the expenses were primarily attributable to remeasurement of our true-up guarantee obligation under the Revolver Exchange (as defined below) and accrual of true-up liability based on the market price for the 2026 Notes.

Income Tax Expense

~~We had~~The company recorded income tax expense of $1.8 million for the three months ended September 30, 2023 and an income tax expense of $1.9 million for the three months ended September 30, ~~2022 compared with an income~~2022. The tax expense ~~of $1.4 million~~is primarily impacted by permanent tax adjustments, state and local current expense, foreign operations and valuation allowances. The tax expense for three months ended September 30, 2023 is comparable to the three months ended September 30, ~~2021. The change in income taxes was primarily attributable to our change in judgment in 2022 related to the realizability of deferred tax assets in certain state and foreign jurisdictions.~~

~~Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021:~~

Nine Months Ended September 30,


2022

2021

Change

% Change
Revenue:








ITPS

$
580,320

$
657,438

$
(77,118)

(11.73)%
HS

173,940

161,292

12,648

7.84%
LLPS

55,946

53,564

2,382

4.45%
Total revenue

810,206

872,294

(62,088)

(7.12)%
Cost of revenue (exclusive of depreciation and amortization):








ITPS

477,559

499,892

(22,333)

(4.47)%
HS

140,767

116,736

24,031

20.59%
LLPS

40,297

36,770

3,527

9.59%
Total cost of revenues

658,623

653,398

5,225

0.80%
Selling, general and administrative expenses (exclusive of depreciation and amortization)

137,604

121,519

16,085

13.24%
Depreciation and amortization

53,942

58,113

(4,171)

(7.18)%
Impairment of goodwill and other intangible assets

29,565

—

29,565

100.00%
Related party expense

6,189

7,199

(1,010)

(14.03)%
Operating profit (loss)

(75,717)

32,065

(107,782)

(336.14)%
Interest expense, net

122,928

127,755

(4,827)

(3.78)%
Debt modification and extinguishment costs (gain), net

4,305

(28,070)

32,375

(115.34)%
Sundry expense (income), net

347

(438)

785

(179.22)%
Other expense, net

12,419

1,169

11,250

962.36%
Net loss before income taxes

(215,716)

(68,351)

(147,365)

215.60%
Income tax expense

(5,721)

(3,430)

(2,291)

66.79%
Net loss

$
(221,437)

$
(71,781)

$
(149,656)

208.49%

2022.

4442

Table of Contents

Nine months ended September 30, 2023 compared to Nine months ended September 30, 2022:


	Nine Months Ended September 30,
	2023		2022		Change		% Change
Revenue:
ITPS	$	550,848	$	580,320	$	(29,472)		(5.08)%
HS		188,740		173,940		14,800		8.51%
LLPS		60,095		55,946		4,149		7.42%
Total revenue		799,683		810,206		(10,523)		(1.30)%
Cost of revenue (exclusive of depreciation and amortization):
ITPS		450,353		477,559		(27,206)		(5.70)%
HS		139,182		140,767		(1,585)		(1.13)%
LLPS		37,441		40,297		(2,856)		(7.09)%
Total cost of revenues		626,976		658,623		(31,647)		(4.81)%
Selling, general and administrative expenses (exclusive of depreciation and amortization)		111,774		137,604		(25,830)		(18.77)%
Depreciation and amortization		45,848		53,942		(8,094)		(15.01)%
Impairment of goodwill and other intangible assets		—		29,565		(29,565)		100.00%
Related party expense		8,696		6,189		2,507		40.51%
Operating profit (loss)		6,389		(75,717)		82,106		(108.44)%
Interest expense, net		113,980		122,928		(8,948)		(7.28)%
Debt modification and extinguishment costs (gain), net		(16,129)		4,305		(20,434)		(474.66)%
Sundry expense, net		2,546		347		2,199		633.72%
Other expense (income), net		(1,583)		12,419		(14,002)		(112.75)%
Net loss before income taxes		(92,425)		(215,716)		123,291		(57.15)%
Income tax expense		(7,005)		(5,721)		(1,284)		22.44%
Net loss	$	(99,430)	$	(221,437)	$	122,007		(55.10)%

Revenue

For the nine months ended September 30, ~~2022,~~2023, our revenue on a consolidated basis decreased by ~~$62.1~~$10.5 million, or ~~7.1%~~1.3% , to ~~$810.2~~$799.7 million from ~~$872.3~~$810.2 million for the nine months ended September 30, ~~2021.~~2022. We experienced revenue decline in ~~the~~ ITPS segment and revenue growth in ~~the~~ HS and LLPS segments. Our ITPS, HS, and LLPS segments constituted ~~71.6%~~68.9%, ~~21.5%~~23.6%, and ~~6.9%~~7.5% of total revenue, respectively, for the nine months ended September 30, ~~2022,~~2023, compared to ~~75.4%~~71.6%, ~~18.5%~~21.5%, and ~~6.1%~~6.9%, respectively, for the nine months ended September 30, ~~2021.~~2022. The revenue changes by reporting segment were as follows:

ITPS— For the nine months ended September 30, ~~2022,~~2023, revenue attributable to our ITPS segment decreased by ~~$77.1~~$29.5 million, or ~~11.7%~~5.1% compared to the same period in the prior year. ~~This~~The majority of this revenue decline is attributable to exiting contracts and statements of work from certain customers with revenue that we believe was unpredictable, non-recurring and were not a strategic fit to Company’s long-term success or unlikely to achieve the Company’s long-term target margins (“transition ~~revenue and other customer losses.~~revenue”). In addition, lower volumes and staffing shortages during the nine months ended September 30, ~~2022 and continued impact from the network outage during June 2022~~2023 impacted revenue ~~for~~during the period. ~~The reported~~ ITPS segment revenue ~~decline~~ was also impacted adversely by ~~$16.9~~$1.3 million ~~from currency conversion~~ attributable to the depreciation of the Euro and U.K. pound sterling against the U.S. dollar during the nine months ended September 30, ~~2022,~~2023, compared to the nine months ended September 30, ~~2021.~~2022

HS— For the nine months ended September 30, ~~2022,~~2023, revenue attributable to our HS segment increased by ~~$12.6~~$14.8 million, or ~~7.8%~~8.5% compared to the same period in the prior year primarily due to higher volumes from our new and existing healthcare customers.

Table of Contents

LLPS— For the nine months ended September 30, ~~2022,~~2023, revenue attributable to our LLPS segment increased by ~~$2.4~~$4.1 million, or ~~4.4%~~7.4% compared to the same period in the prior year primarily due to an increase in project based engagements in legal claims administration services.

Cost of Revenue

For the nine months ended September 30, ~~2022,~~2023, our cost of revenue ~~increased~~decreased by ~~$5.2~~$31.6 million, or ~~0.8%~~4.8%, compared to the nine months ended September 30, ~~2021.~~2022. Costs in our ITPS segment decreased by ~~$22.3~~$27.2 million, or ~~4.5%~~5.7%, primarily attributable to the corresponding decline in ~~revenues offset by wages inflation.~~revenues. HS segment costs ~~increased~~decreased by ~~$24.0~~$1.6 million, or ~~20.6%~~1.1% primarily due to ~~increases~~decrease in employee-related ~~costs on account of higher headcount in HS (bench costs) to meet our customer forecasts.~~cost. LLPS segment cost of revenue ~~increased~~decreased by ~~$3.5~~$2.9 million, or ~~9.6%. Higher costs~~7.1% primarily due to ~~inflationary pressure during the nine months ended September 30, 2022~~higher margin project engagements and ~~idle production costs due to the network outage~~saving in ~~June impacted both ITPS and HS segments during the nine months ended September 30, 2022.~~other operating costs.

The ~~increase~~decrease in cost of revenues on a consolidated basis was primarily due to ~~an increase~~a decrease in employee-related costs of ~~$1.8~~$21.8 million, ~~higher~~lower infrastructure and maintenance costs of $5.8 million and lower other operating costs of $3.6 million, lower pass through costs of $0.6 million and higher travel costs of ~~$0.5 million offset by lower pass through costs of $0.5 million and lower infrastructure and maintenance costs of~~ $0.2 million.

Cost of revenue for the nine months ended September 30, ~~2022~~2023 was ~~81.3%~~78.4% of revenue compared to the ~~74.9%~~81.3% for the comparable same period in the prior year.

Selling, General and Administrative Expenses

SG&A expenses ~~increased $16.1~~decreased $25.8 million, or ~~13.2%~~18.8%, to $111.8 million for the nine months ended September 30, 2023, compared to $137.6 million for the nine months ended September 30, ~~2022, compared~~2022. The decrease was primarily attributable to ~~$121.5~~a gain of $7.2 million on sale of the high-speed scanner business, lower employee related costs by $9.4 million, lower travel costs of $0.8 million, lower infrastructure, maintenance and operating costs of $3.6 million, lower legal and professional fees of $5.3 million and higher other SG&A expenses of $0.4 million. SG&A expenses decreased as a percentage of revenues to 14.0% for the nine months ended September 30, ~~2021. The increase was primarily attributable~~2023 as compared to higher employee related costs by $10.8 million, higher travel costs of $1.7 million, higher infrastructure, maintenance and operating costs of $4.5 million, higher legal and professional fees of $4.1 million offset by lower other SG&A expenses of $5.0 million. SG&A expenses increased as a percentage of revenues to 17.0%16.8% for the nine months ended September 30, ~~2022 as compared to 13.9% for the nine months ended September 30, 2021.~~2022.

~~Table of Contents~~

Depreciation & Amortization

Total depreciation and amortization expense was ~~$53.9~~$45.8 million and ~~$58.1~~$53.9 million for the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The decrease in total depreciation and amortization expense by ~~$4.2~~$8.1 million was primarily due to a reduction in depreciation expense as a result of the expiration of the lives of assets acquired in prior periods and decrease in intangibles amortization expense due to end of useful lives for certain intangible assets during the nine months ended September 30, ~~2022~~2023 compared to the nine months ended September 30, ~~2021.~~2022.

Impairment of Goodwill and Other Intangible Assets

Impairment of goodwill and other intangible assets for the nine months ended September 30, 2022 was $29.6 million. During the three months ended September 30, 2022, the Company made an evaluation based on factors such as changes in the Company’s growth rate and recent trends in the Company’s market capitalization, and concluded that a triggering event for an interim impairment analysis had occurred induring the ~~third quarter of~~three months ended September 30, 2022. As a result of the interim impairment analysis at September 30, 2022, the Company recorded an impairment charge of $29.6 million, including taxes to goodwill relating to ITPS.

Related Party Expenses

Related party expense was $8.7 million for the nine months ended September 30, 2023 compared to $6.2 million for the nine months ended September 30, ~~2022 compared to $7.2~~2022.

Table of Contents

Interest Expense

Interest expense was $114.0 million for the nine months ended September 30, ~~2021.~~

~~Interest Expense~~

~~Interest expense was~~2023 compared to $122.9 million for the nine months ended September 30, ~~2022 compared~~2022. The decrease in total interest expense by $8.9 million was primarily due to ~~$127.8 million for~~amortization of debt exchange premium during the nine months ended September 30, ~~2021.~~2023 compared to the nine months ended September 30, 2022.

Debt modification and extinguishment costs (gain), net

Debt modification and extinguishment ~~cost~~gain was $16.1 million for the nine months ended September 30, 2023 compared to a loss of $4.3 million for the nine months ended September 30, ~~2022 compared to a gain of $28.1 million for the nine months ended September 30, 2021.~~2022. During the nine months ended September 30, ~~2022,~~2023, we repurchased $13.8 million principal amount of 2023 Notes for a cash consideration of $4.4 million. The gain on early extinguishment of debt for the Company recorded a debt extinguishment cost of $9.0 million in connection with partial prepayment of $50.0 million in cash on the $100.0 million senior secured revolving facility maturing July 12, 20222023 Notes during the nine months ended September 30, ~~2022~~2023 totaled $9.9 million and is inclusive of less than $0.1 million write off of original issue discount and debt issuance costs. During the nine months ended September 30, 2023, we repurchased $15.1 million principal amount of the 2023 Term Loans outstanding under the Credit Agreement for a cash consideration of $8.0 million. The gain on early extinguishment of debt for the 2023 Term Loans repurchases during the nine months ended September 30, 2023 totaled $7.1 million and is inclusive of less than $0.1 million write off of original issue discount and debt issuance costs. In July 2023, the Company recorded an additional debt extinguishment gain of $0.6 million when the Company fully repaid and discharged the remaining outstanding balance of $48.4 million under the 2023 Term Loans by making a cash payment of $44.8 million and by issuance of $3.0 million principal amount of New Notes in an exchange transaction. During the nine months ended September 30, 2023, we paid $1.6 million of exit fees ~~paid~~ on the partial prepayment of the BRCC Term Loan (as defined and described further in the description of “Indebtedness” below) which was treated as a debt extinguishment cost offset by gain on extinguishment of debt of $5.3 million related to the notes that was part of the revolver exchange transaction. The Company recorded a gain on early extinguishment of debt of $28.1 million in connection with the repurchase of the Notes and Senior Secured Term Loan for a total of $89.6 million for the nine months ended September 30, 2021.cost.

Sundry Expense, ~~(Income),~~ net

~~Sundry~~The increase in sundry expense, net ~~was $0.3~~by $2.2 million ~~for the nine months ended September 30, 2022 compared to sundry income, net of 0.4 million for the nine months ended September 30, 2021. The change~~ over the prior year period was primarily attributable to exchange rate fluctuations on foreign currency transactions.

Other Expense (Income), net

Other income, net was $1.6 million for the nine months ended September 30, 2023 compared to other expense, net ~~was~~of $12.4 million for the nine months ended September 30, ~~2022 compared to other expense, net of 1.2 million for the nine months ended September 30, 2021. The increase in expense was primarily attributable to remeasurement~~2022. Remeasurement of our true-up guarantee obligation under the Revolver Exchange ~~(as defined below) and accrual of true-up liability based on the market price~~ for the 2026 Notes ~~in Other~~was the primary driver of the net expense ~~net.~~for the nine months ended September 30, 2022.

~~Table of Contents~~

Income Tax Expense

The Company recorded income tax expense of $7.0 million for the nine months ended September 30, 2023 and an income tax expense of $5.7 million for the nine months ended September 30, ~~2022 and an income tax expense of $3.4 million for the nine months ended September 30, 2021.~~2022. The tax expense for the nine months ended September 30, ~~2022~~2023 is higher than the nine months ended September 30, ~~2021~~2022 largely due to ~~year-over-year increase~~improvement in ~~profitability in non-US jurisdictions.~~operating perfomance.

Other Financial Information (Non-GAAP Financial Measures)

We view EBITDA and Adjusted EBITDA as important indicators of performance. We define EBITDA as net income, plus taxes, interest expense, and depreciation and amortization. We define Adjusted EBITDA as EBITDA plus optimization and restructuring charges, including severance and retention expenses; transaction and integration costs; other non-cash charges, including non-cash compensation, (gain) or loss from sale or disposal of assets, and impairment charges; and management fees and expenses. We add back certain expenses, costs and charges in determining Adjusted EBITDA under our secured debt agreements which is used thereunder in determining various calculations. We have reported on these items in a consistent manner since our business combination in 2017.

Table of Contents

We present EBITDA and Adjusted EBITDA because we believe they provide useful information regarding the factors and trends affecting our business in addition to measures calculated under GAAP.

Note Regarding Non-GAAP Financial Measures

EBITDA and Adjusted EBITDA are not financial measures presented in accordance with GAAP. We believe that the presentation of these non GAAP financial measures will provide useful information to investors in assessing our financial performance and results of operations as our Board of Directors (the “Board”) and management use EBITDA and Adjusted EBITDA to assess our financial performance, because it allows them to compare our operating performance on a consistent basis across periods by removing the effects of our capital structure (such as varying levels of interest expense), asset base (such as depreciation and amortization) and items outside the control of our management team. Net loss is the GAAP measure most directly comparable to EBITDA and Adjusted EBITDA. Our non GAAP financial measures should not be considered as alternatives to the most directly comparable GAAP financial measure. Each of these non GAAP financial measures ~~has~~have important limitations as analytical tools because they exclude some but not all items that affect the most directly comparable GAAP financial measures. These non GAAP financial measures are not required to be uniformly applied, are not audited and should not be considered in isolation or as substitutes for results prepared in accordance with GAAP. Because EBITDA and Adjusted EBITDA may be defined differently by other companies in our industry, our definitions of these non GAAP financial measures may not be comparable to similarly titled measures of other companies, thereby diminishing their utility.

Three Months Ended September 30, ~~2022 Compared~~2023 compared to the Three Months Ended September 30, ~~2021~~2022

The following table presents a reconciliation of EBITDA and Adjusted EBITDA to our net loss, the most directly comparable GAAP measure, for the three months ended September 30, ~~2022~~2023 and ~~2021.~~2022.

Three Months Ended September 30,

2022

2021
Net Loss

$
(85,282)

$
(13,214)
Taxes

1,924

1,441
Interest expense

40,897

41,757
Depreciation and amortization

17,737

19,094
EBITDA

(24,724)

49,078
Optimization and restructuring expenses (1)

6,252

4,695
Transaction and integration costs (2)

4,139

1,928
Non-cash equity compensation (3)

(142)

539
Other charges including non-cash (4)

16,479

8,011
Loss/(Gain) on sale of assets (5)

54

(164)
Debt modification and extinguishment costs (gain), net

(4,696)

(28,070)
Loss/(Gain) on derivative instruments

(1,091)

—

~~Table of Contents~~

Contract costs (6)		5,986		358

					Three Months Ended September 30,
					2023		2022
Net Loss					$	(23,108)	$	(85,282)
Taxes						1,807		1,924
Interest expense						24,708		40,897
Depreciation and amortization						14,398		17,737
EBITDA						17,805		(24,724)
Optimization and restructuring expenses (1)						5,440		6,252
Transaction and integration costs (2)						3,221		4,139
Non-cash equity compensation (3)						252		(142)
Other charges including non-cash (4)						7,034		16,479
Loss/(gain) on sale of assets (5)						208		54
Loss/(gain) on business disposals (6)						(750)		—
Debt modification and extinguishment costs (gain), net						(571)		(4,696)
Loss/(gain) on derivative instruments						—		(1,091)
Contract costs (7)						3,444		5,986
Impairment of goodwill and other intangible assets		29,565		—		—		29,565
Adjusted EBITDA	$	31,822	$	36,375	$	36,083	$	31,822

(1)

Adjustment represents net salary and benefits associated with positions, current vendor expenses and existing lease contracts that are part of the on-going savings and productivity improvement initiatives in process transformation and customer ~~transformation and post-merger or acquisition integration.~~transformation.

(2)

Represents costs incurred related to transactions for completed or contemplated transactions during the period.

(3)

Represents the non-cash charges related to restricted stock units and ~~options that vested under the 2018 Stock Incentive Plan.~~options.

(4)

Represents fair value adjustments to ~~deferred revenue and deferred rent accounts established as part~~guaranteed true up of ~~purchase accounting~~settlement notes, accelerated ASC 842 amortization of operating lease right-of-use asset and other non-cash charges. Other charges include severance, retention bonus, facility consolidation, relocation and recruitment costs, loss contracts, network outage related costs and other transition costs.

(5)

Represents a loss/(gain) recognized on the disposal of property, plant, and equipment and other assets.

Table of Contents

(6)

Represents a loss/(gain) recognized on the sale of high-speed scanner business in the second quarter of 2023.

(7)

Represents costs incurred on new projects, contract start-up costs and project ramp costs.

Nine months ended September 30, ~~2022 Compared~~2023 compared to the Nine months ended September 30, ~~2021~~2022

The following table presents a reconciliation of EBITDA and Adjusted EBITDA to our net loss, the most directly comparable GAAP measure, for the nine months ended September 30, ~~2022~~2023 and ~~2021.~~2022.


	Nine Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2023		2022
Net Loss	$	(221,437)	$	(71,781)	$	(99,430)	$	(221,437)
Taxes		5,721		3,430		7,005		5,721
Interest expense		122,928		127,755		113,980		122,928
Depreciation and amortization		53,942		58,113		45,848		53,942
EBITDA		(38,846)		117,517		67,403		(38,846)
Optimization and restructuring expenses (1)		19,659		14,990		17,739		19,659
Transaction and integration costs (2)		16,466		7,927		11,282		16,466
Non-cash equity compensation (3)		703		1,519		565		703
Other charges including non-cash (4)		54,509		20,417		24,341		54,509
Loss/(Gain) on sale of assets (5)		576		(2,604)
Loss/(Gain) on business disposals (6)		—		1,296
Loss/(gain) on sale of assets (5)						1,146		576
Loss/(gain) on business disposals (6)						(7,223)		—
Debt modification and extinguishment costs (gain), net		4,305		(28,070)		(16,129)		4,305
Loss/(Gain) on derivative instruments (7)		(1,091)		(125)
Loss/(gain) on derivative instruments						—		(1,091)
Contract costs ~~(8)~~(7)		18,563		1,812		12,688		18,563
Litigation reserve		—		(925)
Impairment of goodwill and other intangible assets		29,565		—		—		29,565
Adjusted EBITDA	$	104,409	$	133,754	$	111,812	$	104,409

(1)

(2)

Represents costs incurred related to transactions for completed or contemplated transactions during the period.

(3)

Represents the non-cash charges related to restricted stock units and ~~options that vested during the year under the 2018 Stock Incentive Plan.~~options.

(4)

(5)

Represents a loss/(gain) recognized on the disposal of property, plant, and equipment and other assets.

(6)

Represents a loss/(gain) recognized on the ~~disposal~~sale of ~~noncore-business assets.~~high-speed scanner business in the second quarter of 2023.

(7)

~~Represents the impact of changes in the fair value of an interest rate swap entered into during the fourth quarter of 2017.~~

~~Table of Contents~~

~~(8)~~

Represents costs incurred on new projects, contract start-up costs and project ramp costs.

Liquidity and Capital Resources

Overview

Under ASC Subtopic 205-40, Presentation of Financial Statements—Going Concern (“ASC 205-40”), the Company has the responsibility to evaluate whether conditions and/or events raise substantial doubt about its ability to meet its future financial obligations as they become due within one year after the date that the financial statements are issued. The following conditions raised substantial doubt about our ability to continue as a going concern: a history of net losses, net operating cash outflows, working capital deficits and significant cash payments for interest on our long-term debt. The Company has undertaken and completed several plans and actions to improve our available cash balances, liquidity or cash generated from operations, over the twelve month period from the date these financial statements are issued.accumulated deficit. Going concern matters are more fully discussed in Note 1, ~~General.~~

~~At September 30, 2022, cash and cash equivalents totaled $44.8 million, including restricted cash~~ General of ~~$34.4 million. We also had borrowing capacity of up to $31.0 million under our $51.0 million BRCC Revolver which,~~ the ~~Company anticipates, will become fully available in the course of 2022, of which $20.0 million was drawn by the Company as of September 30, 2022.~~condensed consolidated financial statements.

Liquidity is the availability of adequate amounts of cash with an enterprise to meet its needs for cash requirements. At September 30, 2023, cash, restricted cash, and cash equivalents totaled $45.5 million, including

Table of Contents

restricted cash of $39.4 million. As of September 30, ~~2022,~~2023, our working capital deficit amounted to ~~$243.3~~$195.4 million, ~~an increase~~a decrease of ~~$23.3~~$124.1 million as compared to working capital deficit of ~~$220.0~~$319.5 million as of December 31, ~~2021.~~2022. This ~~increase~~decrease in working capital deficit is primarily a result of decreases in ~~accounts receivables due to~~ the ~~sale~~current portion of ~~accounts receivables~~long-term debts and ~~increases~~an increase in ~~accrued interest, accounts payable, and obligation for claim payment.~~restricted cash.

In the ordinary course of business, we enter into contracts and commitments that obligate us to make payments in the future. These obligations include borrowings, interest obligations, purchase commitments, operating and finance lease commitments, employee benefit payments and taxes. Specifically, ~~$55.8 million of BRCC Term Loan and $20.0~~$25.9 million outstanding under the BRCC Revolver ~~both mature~~(as defined and described further in ~~June 2023. Also, maturing~~the description of “Indebtedness” below) is payable in ~~July~~eleven (11) monthly installments of $2.0 million commencing October 31, 2023, ~~are $22.8~~with the remaining outstanding principal balance of $3.9 million ~~aggregate principal amount~~payable on September 30, 2024. The current maturities of the ~~2023 Notes~~Senior Secured Term Loan and ~~$77.8~~the other debts are $2.0 million ~~aggregate principal amount of the Term Loans. The Company’s Term Loans also require us to make periodic principal repayments.~~and $20.3 million, respectively. See Note 5 - – Long-Term Debt and Credit Facilities, Note 7 - – Employee Benefit Plans, and Note 8- 8 – Commitments and Contingencies, to our condensed consolidated financial statements herein for further information on material cash requirements from known contractual and other obligations.

We currently expect to spend approximately ~~$15.0~~$10.0 to ~~$20.0~~$15.0 million on total capital expenditures over the next twelve months. We will continue to evaluate additional capital expenditure needs that may arise due to changes in the business model. Our future cash requirements will depend on many factors, including our rate of revenue growth, our investments in strategic initiatives, applications or technologies, operation centers and acquisition of complementary businesses, which may require the use of significant cash resources and/or additional financing.

~~On March 26, 2020,~~ We may be required to seek additional equity or debt financing. In the ~~Delaware Court of Chancery entered a judgment against one of~~event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. If we are unable to raise additional capital when desired, our ~~subsidiaries in the amount of $57.7 million inclusive of costs~~business, operating results and interest arising out of the petition for appraisal pursuant to 8 Del. C. § 262 in the Delaware Court of Chancery, captioned Manichaean Capital, LLC, et al. v. SourceHOV Holdings, Inc., C.A. No. 2017 0673 JRS (pursuant to which former stockholders of SourceHOV sought, among other things, a determination of the fair value of their 10,304 SourceHOV shares at the time of the Novitex Business Combination) (the “Appraisal Action”). On December 31, 2021, we agreed to settle the Appraisal Action along with a separate case brought by the same plaintiffs for $63.4 million. Accordingly as of December 31, 2021, the Company accrued a liability of $63.4 million for these matters, all of which had been paid as of September 30, 2022.financial condition would be adversely affected.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, includes provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative

~~Table of Contents~~

minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. The Company has implemented favorable provisions of the CARES Act, including the refundable payroll tax credits and the deferment of employer social security payments. At the end of 2021, the Company paid a portion of the deferred employer social security due as per ~~IRS~~Internal Revenue Services guidance. The remaining balance of deferred employer social security taxes will be paid by ~~the end of~~ fiscal ~~2022.~~year 2024. The Company has similarly utilized COVID-19 relief measures in various European jurisdictions, including permitted deferrals of certain payroll, social security and value added taxes. At the end of 2021, the Company paid a portion of these deferred payroll taxes, social security and value added taxes. The remaining balance of European deferred payroll taxes, social security and value added taxes will be paid by ~~the end of~~ fiscal ~~2022~~year 2025 as per deferment timeline.

With an objective to increase free cash flows and in order to maintain sufficient liquidity to support profitable growth, the Company is pursuing further reduction in debt and repricing of existing debt. The Company will continue to pursue the sale of certain non-core businesses that are not central to the Company’s long-term strategic vision and invest in the acquisition of businesses that enhance the value proposition. The Company also plans to take further action to raise additional funds in the debt and equity capital markets. Based on our experience with the at-the-market programs and our knowledge of the Company and the financial market, we believe that we will be able to raise those additional funds. There can be no assurances, however, that any of these initiatives will be consummated or will achieve its desired result.

On December 17, 2020, certain subsidiaries of the Company entered into a $145.0 million securitization facility with a five year term (the “Securitization Facility”). On December 17, 2020 the Company made the initial borrowing of approximately $92.0 million under the Securitization Facility and used a portion of the proceeds to repay previous securitization facility, which terminated on such date. The Company used the remaining proceeds for general corporate purposes. On June 17, 2022, the Company repaid in full the loans outstanding under the Securitization Facility. The aggregate outstanding principal amount of loans under the Securitization Facility as of such date was approximately $91.9 million.

On June 17, 2022, the Company entered into an amended and restated receivables purchase agreement (the “Amended Receivables Purchase Agreement”) under the Securitization Facility among certain of the Company's subsidiaries, its wholly-owned, “bankruptcy remote” special purpose subsidiaries (“SPEs”) and certain global financial institutions (“Purchasers”). The Amended Receivables Purchase Agreement extends the term of the securitization facility such that the SPE may sell certain receivables to the Purchasers until June 17, 2025. Under the Amended Receivables Purchase Agreement, transfers of accounts receivable from the SPEs are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the accounts receivable to the Purchasers. As of September 30, 2022, the Company has sold $90.2 million of its accounts receivable. Unsold accounts receivable of $42.1 million were pledged by the SPEs as collateral to the Purchasers as of September 30, 2022.

On March 15, 2021, the Company, entered into a securities purchase agreement with certain accredited institutional investors pursuant to which the Company issued and sold to ten accredited institutional investors in a private placement an aggregate of 486,591 unregistered shares of the Company’s Common Stock at a price of $55.00 per share and an equal number of warrants, generating gross proceeds to the Company of $26.8 million. Cantor Fitzgerald acted as underwriter in connection with such sale of unregistered securities and received a placement fee of 5.5% of gross proceeds in connection with such service. In selling the shares without registration, the Company relied on exemptions from registration available under Section 4(a)(2) of the Securities Act of 1933 and Rule 506 promulgated thereunder. Each private placement warrant entitles the holder to purchase one share of Common Stock, will be exercisable at an exercise price of $80.00 per share beginning on September 19, 2021 and will expire on September 19, 2026.

On May 27, 2021, the Company entered into an At Market Issuance Sales Agreement (“First ATM Agreement”) with B. Riley Securities, Inc. (“B. Riley”) and Cantor Fitzgerald & Co. (“Cantor”), as distribution agents under which the Company may offer and sell shares of the ~~Company’s~~ Common Stock from time to time through the Distribution Agents, acting as sales agent or principal. On September 30, 2021, the Company entered into a second At Market Issuance Sales Agreement with B. Riley, BNP Paribas Securities Corp., Cantor, Mizuho Securities USA LLC

~~Table of Contents~~

and Needham & Company, LLC, as distribution agents (together with the First ATM Agreement, the “ATM Agreement”).

Sales of the shares of Common Stock under the ATM Agreement, ~~will be~~have been in “at the market offerings” as defined in Rule 415 under the Securities Act, including, without limitation, sales made directly on or through the Nasdaq or on any other existing trading market for the Common Stock, as applicable, or to or through a market maker or any other method permitted by law, including, without limitation, negotiated transactions and block trades. Shares of Common Stock sold under the ATM Agreement ~~are~~have been offered pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-255707), filed with the SEC on May 3, 2021 and declared effective on May 12, 2021, ~~(the “2021 Registration Statement”),~~ and the ~~prospectus dated May 12, 2021 included in the 2021~~Company’s Registration Statement on Form S-3 (File No. 333-263909), filed with the SEC on March 28, 2022 and

Table of Contents

declared effective on May 10, 2022, and the prospectuses and related prospectus supplements included therein for sales of shares of Common Stock as follows:



Supplement	Period	Number of Shares Sold	Weighted Average Price Per Share	Gross Proceeds	Net Proceeds	Period	Number of Shares Sold	Weighted Average Price Per Share	Gross Proceeds	Net Proceeds
Prospectus supplement dated May 27, 2021 with an aggregate offering price of up to $100.0 million (“Common ATM Program–1”)	May 28, 2021 through July 1, 2021	2,471,185	$40.164	$99.3 million	$95.7 million	May 28, 2021 through July 1, 2021	12,356	$8,032.74	$99.3 million	$95.7 million
Prospectus supplement dated June 30, 2021 with an aggregate offering price of up to $150.0 million (“Common ATM Program–2”)	June 30, 2021 through September 2, 2021	2,879,023	$52.069	$149.9 million	$144.4 million	June 30, 2021 through September 2, 2021	14,395	$10,413.79	$149.9 million	$144.4 million
Prospectus supplement dated September 30, 2021 with an aggregate offering price of up to $250.0 million (“Common ATM Program–3”)	October 6, 2021 through March 31, 2022	16,743,797	$14.931	$250.0 million	$241.0 million	October 6, 2021 through March 31, 2022	83,719	$2,986.18	$250.0 million	$241.0 million
Prospectus supplement dated May 23, 2022 with an aggregate offering price of up to $250.0 million (“Common ATM Program–4”)(1)	May 24, 2022 through September 30, 2022	58,283,108	$2.159	$125.8 million	$122.0 million	May 24, 2022 through March 31, 2023	6,262,182	$36.15	$226.4 million	$219.3 million

(1)

Due to the late filing of the 2022 Form 10-K, the Company lost eligibility to use Form S-3 (and thereby the ability to conduct at the market offerings and one of its sources of liquidity). As a result of subsequent delinquent quarterly reports on Form 10-Q, including for the period ended September 30, 2023 (the “Q3 Form 10-Q”), the Company will not regain eligibility to use Form S-3 until twelve full calendar months following the date the Q3 Form 10-Q was due. Any future delinquency with respect to the filing of a Form 10-K, Form 10-Q, or certain Form 8-Ks will cause the Company to lose Form S-3 eligibility for at least 12 calendar months from the due date of the delinquent filing.

The Amended Receivables Purchase Agreement (as defined and described further in the description of “Indebtedness” below) entered into on June 17, 2022 provides us access to liquidity through the sale of receivables. Under the Amended Receivables Purchase Agreement, transfers of accounts receivable are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the accounts receivable to the purchasers of the receivables. The Company de-recognized $408.9 million of accounts receivable under this agreement during the year ended December 31, 2022. The amount remitted to the Purchasers during fiscal year 2022 was $308.7 million. The Company de-recognized $119.3 million and $382.2 million of accounts receivable under this agreement during the three and nine months ended September 30, 2023, respectively. The amount remitted to the Purchasers during the three and nine months ended September 30, 2023 was $119.0 million and $385.5 million, respectively. Unsold accounts receivable of $47.1 million and $46.5 million were pledged by the SPEs as collateral to the Purchasers as of September 30, 2023 and December 31, 2022, respectively.

On August 10, 2022, the Company’s board of directors (the “Board”) authorized a share buyback program (the “2022 Share Buyback Program”), pursuant to which the Company ~~was~~is authorized to repurchase, from time to time, up to ~~10,000,000~~50,000 shares of ~~its~~ Common Stock over ~~next~~the following two-year period through various means, including, open market transactions and privately negotiated transactions. The 2022 Share Buyback Program does not obligate the Company to repurchase any shares. The decision as to whether to repurchase any shares and the timing of repurchases will be based on the price of the ~~Company’s~~ Common Stock, general business and market conditions and other investment considerations and factors. ~~During the three months ended September 30, 2022, the Company~~No shares were repurchased ~~and concurrently retired 357,461 shares of Common Stock at an average share price of $1.348 per share~~ under the 2022 Share Buyback Program during the nine months ended September 30, 2023. As of September 30, 2023, we had repurchased and concurrently retired a total of 1,787 shares of Common Stock pursuant to the 2022 Share Buyback Program.

Table of Contents

Cash Flows

The following table summarizes our cash flows for the periods indicated:


	Nine Months Ended September 30,						Nine Months Ended September 30,
	2022		2021		Change		2023		2022		Change
Net cash used in operating activities	$	(86,951)	$	(73,588)	$	(13,363)	$	(29,220)	$	(86,951)	$	57,731
Net cash used in investing activities		(16,739)		(3,649)		(13,090)
Net cash provided by (used in) investing activities								21,259		(16,739)		37,998
Net cash provided by financing activities		101,487		177,995		(76,508)		8,441		101,487		(93,046)
Subtotal		(2,203)		100,758		(102,961)	$	480		(2,203)	$	2,683
Effect of exchange rates on cash		(1,054)		(78)		(976)
Net increase (decrease) in cash and cash equivalents		(3,257)		100,680		(103,937)
Effect of exchange rates on cash, restricted cash and cash equivalents								(53)		(1,054)		1,001
Net increase in cash, restricted cash and cash equivalents							$	427	$	(3,257)	$	3,684

~~Table of Contents~~

Analysis of Cash Flow Changes between the nine months ended September 30, ~~2022~~2023 and September 30, ~~2021~~2022

Operating Activities—The ~~increase~~decrease of ~~$13.0~~$57.7 million in net cash used in operating activities for the nine months ended September 30, ~~2022~~2023 was primarily due to lower cost of revenue, ~~higher~~lower selling, general and administrative expenses and other expenses, improvement in operating cycle for accounts payable and accrued liabilities and prepaid exepense. This increase in cash ~~outflow on employees-related investments on account of higher headcount (bench costs) to meet our customer forecasts and $63.4 million payment for the Appraisal Action made~~generated in operating activities was partially offset by lower realization from accounts receivable during the nine months ended September 30, 2022. This increase in cash used in operating activities was partially offset by cash inflow from sale of accounts receivable, reduction in cash outflow from accounts payable and accrued liabilities and reduction in cash outflow for interest payments.2023.

Investing Activities—The increase of ~~$13.1~~$38.0 million in net cash ~~used in~~provided by investing activities for the nine months ended September 30, ~~2022~~2023 was primarily due to ~~higher~~$29.4 million of net cash proceeds from sale of the high-speed scanner business and lower additions to property, plant and equipment and patents ~~and development of internal software~~ in ~~2022~~2023 offset by ~~cash proceeds received from asset sales. Property~~higher additions ~~were primarily related~~ to ~~a purchase of the Company’s Irish headquarters in Dublin, Ireland.~~internally developed software.

Financing Activities— Cash provided by financing activities during the nine months ended September 30, 2023 was $8.4 million, primarily as a result of $67.0 million of net proceeds from equity offerings, $31.5 million of proceeds from the Second Lien Note, $9.6 million of proceeds from borrowings under the BRCC Revolver which is offset by debt issuance costs of $8.3 million, repayments on the BRCC Facility, senior secured term loans and other loans of $80.0 million and cash outflow of $11.9 million for debt repurchases (all as defined and described further in the description of “Indebtedness” below).

Cash provided by financing activities during the nine months ended September 30, 2022 was $101.5 million, primarily as a result of $236.5 million of net proceeds from equity offerings, $75.0 million of net proceeds from the issuance of 2026 Notes offset by net repayments of our senior secured revolving facility, Securitization Facility, BRCC Facility, ~~and~~ senior secured term loans and other loans of $203.4 million and debt repurchases of $4.7 ~~million.~~

~~Cash provided by financing activities during~~million (all as defined and described further in the ~~nine months ended September 30, 2021 was $178.0 million, primarily as a result~~description of ~~$265.2 million of net proceeds from equity offerings offset by repayments of our term and other loans and debt repurchases of $87.1 million.~~“Indebtedness” below).

Indebtedness

~~In connection with~~Following is a description of the Company’s key credit facilities since the Novitex Business Combination, when we acquired debt facilities and issued notes totaling $1.4 billion. Proceeds from the indebtedness were initially used to pay off credit facilities existing immediately before the Novitex Business Combination.

~~Senior Credit Facilities~~2023 Term Loans

On July ~~12, 2017,~~13, 2018, subsidiaries of the Company ~~entered into~~refinanced a $343.4 million of term loans then outstanding under that certain First Lien Credit Agreement, dated July 12, 2017, with Royal Bank of Canada, Credit Suisse AG, Cayman Islands Branch, Natixis, New York Branch and KKR Corporate Lending LLC (the “Credit Agreement”) providing Exela Intermediate LLC, a wholly owned subsidiary of the Company, upon the terms and subject to the conditions set forth in the Credit Agreement, (i) a $350.0 million senior secured term loan maturing July 12, 2023 with an original issue discount of $7.0 million, and (ii) a $100.0 million senior secured revolving facility that matured on July 12, 2022 (the “Revolving Credit Facility”).

~~On July 13, 2018, we were able to refinance the $343.4 million of term loans then outstanding under the Credit Agreement (the~~ “Repricing Term Loans”) and borrowed an additional $30.0 million pursuant to incremental term loans (the “2018 Incremental Term Loans”). ~~The proceeds of the 2018 Incremental Term Loans were used by the Company for general corporate purposes and to pay related fees and expenses.~~

On April 16, 2019, subsidiaries of the Company borrowed a further $30.0 million pursuant to incremental term loans (the “2019 Incremental Term Loans”, and, together with the 2018 Incremental Terms Loans and Repricing Term Loans, the “Term Loans”). The proceeds of the 2019 Incremental Term Loans were used to replace cash spent for acquisitions, pay related fees, expenses and related borrowings for general corporate purposes.

The Term Loans bear interest at a rate per annum of, at the borrower’s option, either (a) a LIBOR rate determined by reference to the costs of funds for Eurodollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs, subject to a 1.0% floor, or (b) a base rate determined by reference to the highest of (i) the federal funds rate plus 0.5%, (ii) the prime rate and (iii) the one-month adjusted LIBOR plus 1.0%, in each case

5250

Table of Contents

~~plus an applicable margin~~referred to herein as the “2023 Term Loans”). The subsidiaries of ~~6.5% for LIBOR loans~~the Company made periodic interest and ~~5.5% for base rate loans. The~~principal repayments on the 2023 Term ~~Loans will mature on July 12, 2023. As of September 30, 2022, the interest rate applicable for the first lien senior secured term loan was 8.8%.~~

~~The Term Loans are jointly and severally, irrevocably and unconditionally guaranteed by the certain of Company’s U.S. subsidiaries, as primary obligors and not merely as sureties.~~

The borrower may voluntarily repay the Term Loans at any time, without prepayment premium or penalty, subject to customary “breakage” costs with respect to LIBOR rate loans. Other than as described above, the terms, conditions and covenants applicable to the Incremental Term Loans are consistent with the terms, conditions and covenants that were applicable to the Repricing Term LoansLoan under the ~~Credit Agreement.~~term of the loan agreements.

On May 18, 2020, we amended the Credit Agreement to, among other things, extend the time for delivery of its audited financial statements for the year ended December 31, 2019 and its financial statements for the quarter ended March 31, 2020. Pursuant to the amendment, we also agreed to amend the Credit Agreement to, among other things: restrict the borrower and its subsidiaries’ ability to designate or invest in unrestricted subsidiaries; incur certain debt; create certain liens; make certain investments; pay certain dividends or other distributions on account of its equity interests; make certain asset sales or other dispositions (or utilize the proceeds of certain asset sales to reinvest in the business); or enter into certain affiliate transactions pursuant to the negative covenants under the Credit Agreement. In addition, pursuant to the amendment, the borrower under the Credit Agreement was required to maintain minimum Liquidity (as defined in the amendment) of $35.0 million.

On December 9, 2021, in a ~~separate~~private exchange transaction, ~~referred to here as the “Private Exchange” (as distinguished from the “Public Exchange” described below),~~ subsidiaries of the Company ~~agreed with three (3) of their Term Loan lenders to exchange~~exchanged $212.1 million of 2023 Term Loans ~~under the Credit Agreement~~ for $84.3 million in cash and in $127.8 million principal amount of new 11.500% First-Priority Senior Secured Notes ~~due~~scheduled to mature July 12, 2026 (the “2026 Notes”)~~. In connection with~~ issued by Exela Intermediate LLC and Exela Finance Inc., wholly-owned subsidiaries of the ~~Private Exchange,~~Company (together, the exchanging lenders provided consents to amend the Credit Agreement to (i) eliminate all affirmative covenants, (ii) eliminate all negative covenants and (iii) eliminate certain events of default (other than events of default relating to payment obligations)“Issuers”).

As a result of the ~~Private Exchange,~~private exchange, repurchases (as discussed below) and periodic principal repayments, ~~$77.8~~$48.4 million aggregate principal amount of the 2023 Term Loans ~~maturing July 12, 2023 remains~~were outstanding as of ~~September 30, 2022.~~

~~Revolving Credit Facility; Letters of Credit~~

~~As of December 31, 2021, our $100 million Revolving Credit Facility was~~July 11, 2023, the date the Company fully ~~drawn taking into account letters of credit issued thereunder. As of December 31, 2021, there were~~repaid and discharged the remaining outstanding irrevocable letters of credit totaling approximately $0.5 million under the Revolving Credit Facility. As of September 30, 2022, the Revolving Credit Facility had been prepaid and terminated as described below.

~~On March 7, 2022, subsidiaries~~balance of the ~~Company entered into~~2023 Term Loans by making a ~~Revolving Loan Exchange and Prepayment Agreement with Royal Bank~~cash payment of Canada, Credit Suisse AG, Cayman Islands Branch, KKR Corporate Lending LLC, Granite State Capital Master Fund LP, Credit Suisse Loan Funding LLC and Revolvercap Partners Fund LP exchanging $100.0 million of outstanding Revolving Credit Facility owed by Exela Intermediate LLC, upon the terms and subject to the conditions set forth in the Revolver Exchange agreement, for (i) $50.0 million in cash, and (ii) $50.0 million of 2026 Notes (such exchange, the “Revolver Exchange” and such 2026 Notes, the “Exchange Notes”).

The Exchange Notes were subject to a guarantee in the form of a true-up mechanism whereby the Company was responsible to make a payment to the holders of the Exchange Notes if holders of the Exchange Notes sold their notes at a price below certain agreed thresholds during agreed periods in 2022. During the third quarter of 2022, the Company settled the true-up obligation with cash payments of $9.9$44.8 million and by ~~permitting the holders~~issuance of ~~the Exchange Notes to keep the $21.0~~$3.0 million of principal amount of new 11.500% First-Priority Senior Secured Notes scheduled to mature April 15, 2026 ~~Notes previously placed as Collateral Notes constituting an issuance. In addition, $9.0 million of principal amount of 2026 Notes, which had been placed as~~

~~Table of Contents~~

~~Collateral Notes with the holders of the Exchange Notes, were sold~~(the “New Notes”) issued by the ~~holders for a net proceeds of $2.6 million which was applied against the true-up obligation.~~Issuers in exchange transaction (as discussed below).

~~Senior Secured~~ 2023 Notes

~~Upon the closing of the Novitex Business Combination on~~On July 12, 2017, subsidiaries of the Company issued $1.0 billion in aggregate principal amount of 10.0% First Priority Senior Secured Notes due 2023 (the “2023 Notes”). The 2023 Notes ~~bear~~are guaranteed by nearly all U.S. subsidiaries of Exela Intermediate LLC. The 2023 Notes bore interest at a rate of 10.0% per year. WeThe issuers pay interest on the 2023 Notes on January 15 and July 15 of each year, commencing on January 15, 2018. The 2023 Notes are jointly and severally guaranteed by certain U.S. subsidiaries of the Company. The 2023 Notes mature on July 15, 2023. As a result of the Public Exchange and repurchases (as discussed below), $22.8 million aggregate principal amount of the 2023 Notes remains outstanding as of September 30, 2022.

On October 27, 2021, we launched an offer to exchange (the “Public Exchange”) up to $225.0 million in cash and new 11.500% First-Priority Senior Secured Notes due 2026 (the “2026 Notes”) issued by subsidiaries of the Company’s for the outstanding 2023 Notes. The Public Exchange was for $900 in cash per $1,000 principal amount of 2023 Notes tendered subject to proration. The maximum amount of cash to be paid was $225.0 million and the offer was not subject to any minimum participation condition. In case of oversubscription to the cash offer, tendered 2023 Notes would be accepted for cash on a pro rata basis (as a single class). The balance of any tendered 2023 Notes not accepted for cash would be exchanged into 2026 Notes on the basis of $1,000 principal amount of new 2026 Notes for each $1,000 principal amount of outstanding 2023 Notes tendered.

~~In conjunction with the Public Exchange, we also solicited consents to amend certain provisions in the indenture governing the 2023 Notes (“Notes Amendments”). On December 1, 2021, on receipt~~$912.7 million principal amount of the requisite consents to the Notes Amendments, the Company, and Wilmington Trust, National Association, as trustee (the “2023 Notes Trustee”), entered into a third supplemental indenture (the “Third Supplemental Indenture”) to the indenture, dated as of July 12, 2017 (as amended and supplemented by (i) the first supplemental indenture, dated as of July 12, 2017 and (ii) the second supplemental indenture, dated as of May 20, 2020, the “2023 Notes Indenture”) governing the outstanding 2023 Notes. The ~~Third Supplemental Indenture amends~~Company concluded that the public exchange of notes represented modification of debt under ASC 470-50.

As a result of the 2021 public exchange and repurchases (as discussed below), $9.0 million aggregate principal amount of the 2023 Notes ~~Indenture~~remained outstanding as of July 11, 2023, the date the Company fully repaid and discharged the remaining outstanding balance of the 2023 Notes to eliminate substantially all of the restrictive covenants, eliminate certain events of default, modify covenants regarding mergers and consolidations and modify or eliminate certain other provisions, including certain provisions relating to future guarantors and defeasance, contained in ~~the 2023 Notes Indenture and the 2023 Notes. In addition, all of the collateral securing the 2023 Notes was released pursuant to the Third Supplemental Indenture.~~cash.

~~Senior Secured~~ 2026 Notes

outstanding. During the nine months ended September 30, ~~2022,~~2023, no 2026 Notes were sold by subsidiaries of the Company sold $150.0 million in aggregate of principal amount of the 2026 Notes generating net proceeds of $75.0 million. On March 18, 2022, subsidiaries of the Company issued $50.0 million of the 2026 Notes to satisfy the exchange obligation under the Revolver Exchange.Company. The 2026 Notes are guaranteed by ~~certain~~nearly all U.S. subsidiaries of ~~the Company.~~Exela Intermediate LLC. The 2026 Notes bear interest at a rate of 11.5% per year. We ~~will~~are required to pay interest on the 2026 Notes on January 15 and July 15 of each year, ~~commencing~~and commenced making such interest payments on July 15, 2022. The 2026 Notes are scheduled to mature on July 12, 2026.

~~Table of Contents~~

~~On or after December 1, 2022, we~~ The Issuers may redeem the 2026 Notes in whole or in part from time to time, at a redemption price of 100%, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date.

On July 11, 2023, the Issuers, certain guarantors and U.S. Bank Trust Company, National Association, as trustee, entered into an indenture (the “New Notes Indenture”) governing the Company’s New Notes and issued approximately $764.8 million aggregate principal amount of the New Notes as consideration for the exchange of $956.0 million aggregate principal amount of the Issuers’ existing 2026 Notes pursuant to a public exchange offer (the “2023 Exchange”). The Company performed an assessment of the 2023 Exchange and determined that it met the criteria to be accounted for as a troubled debt restructuring under ASC 470-60. The undiscounted cash flows associated with the New Notes issued were compared to the carrying value of the exchanged 2026 Notes and since the undiscounted cash flows of the New Notes exceeded the carrying value of the exchanged 2026 Notes, the carrying value of the New Notes was established at the carrying value of the exchanged 2026 Notes and the Company established new effective interest rates based on the carrying value of the exchanged 2026 Notes prior to the 2023 Exchange. The difference between the principal amount of the issued New Notes and their carrying value was recorded as a premium and is included in long-term debt on the Company’s condensed consolidated balance sheets. The Compnay recorded a premium of $142.3 million on the notes exchange, which will be reduced as contractual interest payments are made on the New Notes.

Table of Contents

On July 11, 2023, we entered into a seventh supplemental indenture to the 2026 Notes Indenture which eliminated substantially all of the restrictive covenants, eliminated certain events of default, modified covenants regarding mergers and consolidations and modified or eliminated certain other provisions, including certain provisions relating to future guarantors and defeasance, contained in the 2026 Notes Indenture and the 2026 Notes. In addition, ~~prior~~all of the collateral securing the 2026 Notes was released pursuant to ~~December 1, 2022, we~~the seventh supplemental indenture.

As a result of the 2023 Exchange and repurchases (as discussed below), $24.0 million aggregate principal amount of the 2026 Notes maturing July 12, 2026 remained outstanding as of September 30, 2023.

Senior Secured New Notes

On July 11, 2023, the Issuers issued approximately $767.8 million aggregate principal amount of the New Notes under the New Notes Indenture, which includes (i) $764.8 million aggregate principal amount of the New Notes issued under the 2023 Exchange (as described above) and (ii) $3.0 million aggregate principal amount of the New Notes issued as consideration for the exchange of certain of the Company’s outstanding 2023 Term Loans (as described above).

The New Notes are scheduled to mature on April 15, 2026. Interest on the New Notes will accrue at 11.500% per annum and will be paid semi-annually, in arrears, on January 15 and July 15 of each year, beginning July 15, 2023. Interest will be payable in cash or in kind by issuing additional New Notes (or increasing the principal amount of the outstanding New Notes) (“PIK Interest”) as follows: (A) for the July 15, 2023 interest payment date, such interest was paid in kind as PIK Interest, (B) for each interest payment date from and including the January 15, 2024 interest payment date through and including the July 15, 2024 interest payment date, such interest shall be paid in cash in an amount equal to (i) 50% of such interest plus (ii) an amount not to exceed an amount that, pro forma for such payment, would leave the issuers with Unrestricted Cash (as defined in the New Notes Indenture) of at least $15 million, with the remaining interest paid in kind as PIK Interest, and (C) for interest payment dates falling on or after January 15, 2025, such interest shall be paid in cash.

On July, 15, 2023, the Company issued $44.1 million in aggregate principal amount of the New Notes as a payment for PIK Interest due on July 15, 2023. $811.9 million aggregate principal amount of the New Notes maturing April 15, 2026 remained outstanding as of September 30, 2023.

The Issuers’ obligations under the New Notes and the New Notes Indenture are irrevocably and unconditionally guaranteed, jointly and severally, by the same guarantors (the “Guarantors”) that guarantee the 2026 Notes (other than certain guarantors that have ceased to have operations or assets) and by certain of the Issuers’ other affiliates (“Affiliated Guarantors”). The New Notes and the related guarantees are first-priority senior secured obligations of the Issuers and the Guarantors.

The New Notes Indenture contains covenants that limit the Issuers’ and the Affiliated Guarantors and their respective subsidiaries’ ability to, among other things, (i) incur or guarantee additional indebtedness, (ii) pay dividends or distributions on, or redeem or repurchase, capital stock and make other restricted payments, (iii) make investments, (iv) consummate certain asset sales, (v) engage in certain transactions with ~~respect~~affiliates, (vi) grant or assume certain liens and (vii) consolidate, merge or transfer all or substantially all of their assets. These covenants are subject to a number of important limitations and exceptions. In addition, upon the occurrence of specified change of control events, the Issuers must offer to repurchase the New Notes at 101% of the principal amount, plus accrued and unpaid interest, if any, ~~2026 Note~~to, but excluding, the applicable repurchase date. The New Notes Indenture also provides for events of default, which, if any of them occurs, would permit or require the principal, premium, if any, interest and any other monetary obligations on ~~any applicable redemption date, as determined by us, the greater of: (1) 1%~~all of the then outstanding ~~principal amount~~New Notes to be due and payable immediately.

Table of the 2026 Note; and (2) the excess of: (a) the present value at such redemption date of (i) the redemption price of the 2026 Note, at December 1, 2022 plus (ii) all required interest payments due on the 2026 Note through December 1, 2022 (excluding accrued but unpaid interest), computed using a discount rate equal to the treasury rate as of such redemption date plus 50 basis points; over (b) the then outstanding principal amount of the 2026 Note.Contents

~~$980.0 million aggregate principal amount of 2026 Notes were outstanding as of September 30, 2022.~~

Repurchases

~~During the three and nine months ended September 30,~~ 2022, we repurchased $15.0 million principal amount of ~~Exchange~~the 2026 Notes ~~issued under the Revolver Exchange (as discussed above)~~ for a net cash consideration of $4.7 million. The gain on early extinguishment of debt for the ~~Exchange~~2026 Notes during the three and nine months ended September 30, 2022 totaled $5.3 million and is inclusive of $5.0 million and $0.1 million write off of original issue discount and debt issuance costs, respectively.

BRCC Facility

On November 17, 2021, GP2 XCV, LLC, a subsidiary of the Company (“GP2 XCV”), entered into a borrowing facility with B. Riley Commercial Capital, LLC (which was subsequently assigned to BRF Finance Co., LLC (“BRF Finance”)) pursuant to which the Company was able to borrow an original principal amount of $75.0 million, which was later increased to $115.0 million as of December 7, 2021 (as the same may be amended from time to time, the “BRCC Term Loan”). On March 31, 2022, GP2 XCV ~~entered into an amendment to the borrowing facility with~~and B. Riley Commercial Capital, LLC ~~pursuant~~amended this facility to ~~which the Company will be able~~permit GP2 XCV to borrow up to $51.0 million under a separate revolving loan (the “BRCC Revolver”, collectively with the BRCC Term Loan, the “BRCC Facility”).

The BRCC Facility is secured by a lien on all the assets of GP2 XCV and by a pledge of the equity of GP2 XCV. GP2 XCV is a bankruptcy-remote entity and as such its assets are not available to other creditors of the Company or any of its subsidiaries other than GP2 XCV. The BRCC Facility will mature on June 10, 2023. However, the BRCC Revolver is subject to certain automatic maturity extensions of six months, unless B. Riley Commercial Capital, LLC or the Company notifies the other party about its election not to extend. In such event, the outstanding principal amount of the BRCC Revolver as of the maturity shall be due and payable in 12 equal installments on the last business day of each calendar month thereafter. Interest under the BRCC Facility accrues at a rate of 11.5% per annum (13.5% per annum default rate) and is payable quarterly on the last business day of each March, June, September and December. The purpose of BRCC Term Loan was to fund certain repurchases of ~~our~~the secured indebtedness and to provide funding for ~~the Public Exchange transaction and Private Exchange transaction described above.~~certain debt exchange transactions. The purpose of BRCC Revolver is to fund general corporate purposes.

During the nine months ended September 30, 2023, we borrowed $9.6 million of principal amount under the BRCC Revolver. During the nine months ended September 30, 2023, we repaid $48.5 million and $3.7 million of outstanding principal amount under the BRCC Term Loan and the BRCC Revolver, respectively along with $1.6 million of exit fees on the BRCC Term Loan. The exit fees paid on the prepayment of the BRCC Term Loan were treated as a debt extinguishment cost under ASC 470-50 and reported within debt modification and extinguishment costs (gain), net in our condensed consolidated statements of operations. The BRCC Facility matured on June 10, 2023. As of September 30, 2023, the Company had fully repaid the outstanding balances under the BRCC Term Loan. As of September 30, 2023, there were borrowings of $25.9 million outstanding under the BRCC Revolver. The outstanding principal amount under the BRCC Revolver is payable in eleven (11) monthly installments of $2.0 million commencing October 31, 2023, with the remaining outstanding principal balance of $3.9 million payable on September 30, 2024.

Senior Secured Term Loan

5553

Table of Contents

~~During~~principal amount outstanding from the ~~nine~~date of the Senior Secured Term Loan until repaid, at a rate per annum equal to the Reference Rate plus the Applicable Margin. “Reference Rate” for any period means the greatest of (i) 4.00% per annum, (ii) the federal funds rate plus 0.50% per annum, (iii) the Adjusted Term SOFR (which rate shall be calculated based upon an interest period of 1 month and shall be determined on a daily basis) plus 1.00% per annum, and (iv) the rate last quoted by the Wall Street Journal as the "Prime Rate" in the United States. “Applicable Margin,” with respect to the interest rate of (a) any Reference Rate Loan is 10.39% per annum, and (b) any SOFR Rate Loan is 11.39% per annum. SOFR Rate Loan shall bear interest on the principal amount outstanding, at a rate per annum equal to the Adjusted Term SOFR rate for the Interest Period in effect for the Term Loan plus Applicable Margin. “Adjusted Term SOFR” means the rate per annum equal to Term SOFR for such calculation, plus 0.26161%. “Term SOFR,” for calculation with respect to a SOFR Rate Loan, is the per annum forward-looking term rate based on secured overnight financing rate for a tenor comparable to the applicable interest period on the day that is two business days prior to the first day of such interest period. However, with respect to a Reference Rate Loan, “Term SOFR” means the per annum forward-looking term rate based on secured overnight financing rate for a tenor of three months ~~ended September 30, 2022, we repaid $59.2 million~~on the day that is two business days prior to such day. If Term SOFR as so determined shall ever be less than 4.00%, then Term SOFR shall be deemed to be 4.00%.

The outstanding principal amount ~~under~~of the ~~BRCC~~Senior Secured Term Loan shall be repaid in eleven (11) equal quarterly installments of $0.5 million commencing December 31, 2023, with the remaining outstanding principal amount of $34.5 million payable at maturity along with ~~$1.8 million~~accrued and unpaid interest. The maturity date of ~~exit fees. As of September 30, 2022, there were borrowings of $55.8 million and $20.0 million outstanding under~~ the ~~BRCC~~Senior Secured Term Loan shall be the earlier of July 11, 2026 and ~~BRCC Revolver, respectively, maturing June 10, 2023. There was no availability under~~ the ~~BRCC Revolver as~~date that is 91 days prior to the earliest maturity of ~~September 30, 2022.~~any of the New Notes or the 2026 Notes (after giving effect to any refinancing indebtedness).

The Company may, at any time, prepay the principal of the Senior Secured Term Loan. Each prepayment shall be accompanied by the payment of accrued interest and the applicable premium, if any. Each prepayment shall be applied against the remaining installments of principal due on the Senior Secured Term Loan in the inverse order of maturity. The applicable premium shall be payable in the form of a make-whole amount if prepayment is made within one year of the borrowing date (the “First Period”). If optional prepayment is made between after the year one anniversary of the borrowing date to the date of two-year anniversary (the “Second Period”), the applicable premium shall be an amount equal to 1% times the amount of the principal amount of the Senior Secured Term Loan being paid on such date. The applicable premium shall be zero in case of prepayment after the date of two-year anniversary of the borrowing date. Further, during the Second Period, if the prepayment is because of an event of default or termination of contract for any reason, the applicable premium shall be 1% times the aggregate principal amount of the Senior Secured Term Loan outstanding on such date.

Securitization Facility

On December 17, 2020, certain subsidiaries of the Company ~~closed on Securitization Facility~~entered into a $145.0 million securitization facility with a five year ~~term.~~term (the “Securitization Facility”) with certain lenders and Alter Domus (US), LLC, as administrative agent (the “Securitization Administrative Agent”). The Securitization Facility provided for an initial funding of approximately $92.0 million supported by ~~the~~ receivables, ~~portion of the borrowing base~~ and, subject to contribution, a further funding of approximately $53.0 million to be supported by inventory and intellectual property. On December 17, 2020, weExela Receivables 3, LLC (the “Securitization Borrower”) made the initial borrowing of approximately $92.0 million under the Securitization Facility and used a portion of the proceeds to repay $83.0 million of the aggregate outstanding principal amount of loans as of December 17, 2020 under a previous $160.0 million accounts receivable securitization facility (“A/R Facility”) and used the remaining proceeds for general corporate purposes.

The documentation for the Securitization Facility included (i) a Loan and Security Agreement (the “Securitization Loan Agreement”), dated as of December 10, 2020, by and among Exela Receivables 3, LLC (the “Securitization Borrower”), a wholly-owned indirect subsidiary of the Company, the lenders (each, a “Securitization Lender” and collectively the “Securitization Lenders”), Alter Domus (US), LLC, as administrative agent (the “Securitization Administrative Agent”) and the Company, as initial servicer, pursuant to which the Securitization Lenders will make loans to the Securitization Borrower to be used to purchase receivables and related assets from the Securitization Parent SPE (as defined below), (ii) a First Tier Receivables Purchase and Sale Agreement (the, dated as of December 17, 2020, by and among Exela Receivables 3 Holdco, LLC (the “Securitization Parent SPE”), a wholly-owned indirect subsidiary of the Company, and certain other indirect, wholly-owned subsidiaries of the Company listed therein (collectively, the “Securitization Originators”), and the Company, as initial servicer, pursuant to which each Securitization Originator has sold or contributed and will sell or contribute to the Securitization Parent SPE certain receivables and related assets in consideration for a combination of cash and equity in the Securitization Parent SPE, (iii) a Second Tier Receivables Purchase and Sale Agreement, dated as of December 17, 2020, by and among, the Securitization Borrower, the Securitization Parent SPE and the Company, as initial servicer, pursuant to which Securitization Parent SPE has sold or contributed and will sell or contribute to the Securitization Borrower certain receivables and related assets in consideration for a combination of cash and equity in the Securitization Borrower, (iv) the Sub-Servicing Agreement, dated as of December 17, 2020, by and among the Company and each Securitization Originator, (v) the Pledge and Guaranty, dated as of the December 10, 2020, between the Securitization Parent SPE and the Administrative Agent, and (vi) the Performance Guaranty, dated as of December 17, 2020, between the Company, as performance guarantor, and the Securitization Administrative Agent (and together with all other certificates, instruments, UCC financing statements, reports, notices, agreements and documents executed or delivered in connection with the Securitization Loan Agreement, the “Securitization Agreements”). On April 11, 2021, the Company amended the Securitization ~~Loan Agreement and agreed~~Facility to, among other things, extend the ~~option to contribute~~period during which the Company could access the

Table of Contents

approximately $53.0 million in additional borrowings upon the contribution of inventory and intellectual property to support the borrowing base from April 10, 2021 to September 30, ~~2021 (which did not occur).~~2021.

The Securitization Borrower, Exela Receivables 3 Holdco, LLC (the “Securitization Parent SPE,” and together with the Securitizatin Borrower, the “SPEs”), the Company, and certain of our operating subsidiaries that agreed to sell receivables in connection with the Securitization ~~Parent SPE and the Securitization Originators provide~~

Facillity (the “Securitization Originators”) provided customary representations and covenants under the agreements underlying the Securitization ~~Agreements.~~Factility. The Securitization ~~Loan Agreement provides for~~Facility identified certain events of default upon the occurrence of which the Securitization Administrative Agent may declare the facility’s termination date to have occurred and declare the outstanding Securitization Loan and all other obligations of the Securitization Borrower to be immediately due and payable, however the Securitization Facility does not include an ongoing liquidity covenant like the A/R Facility and aligns reporting obligations with the Company’s other material indebtedness agreements.

The Securitization Borrower and Securitization Parent SPE were formed in December 2020, and are consolidated into the Company’s financial statements. The Securitization Borrower and Securitization Parent SPE are bankruptcy remote entities and as such their assets are not available to creditors of the Company or any of its subsidiaries. Each loan under the Securitization Facility ~~bears~~bore interest on the unpaid principal amount as follows: (i) if a Base Rate Loan, at a rate per annum equal to (x) the greatest of (a) the Prime Rate in effect on such day, (b) the Federal

~~Table of Contents~~

Funds Effective Rate in effect on such day plus 0.50% and (c) the Adjusted LIBOR Rate (as defined in the Securitization Loan Agreement) plus 1.00%, plus (y) 8.75%; or (ii) if a LIBOR Rate Loan, at the Adjusted LIBOR Rate plus 9.75%.

On June 17, 2022, the Company repaid in full the ~~loans outstanding under the Securitization Facility. The aggregate outstanding~~approximately $91.9 million principal amount of loans outstanding under ~~the Securitization Facility as of such date was approximately $91.9 million. The early termination of~~ the Securitization Facility, triggered a prepayment premium of $2.7 million and a required payment of approximately $0.5 million and $1.3 million in respect of accrued interest and fees, respectively. All obligations under the Securitization Facility (other than contingent indemnification obligations that expressly survive termination) terminated upon repayment. The Securitization Facility was replaced by the Amended Receivables Purchase Agreement and related agreements described below.

On June 17, 2022, the Company entered into an amended and restated receivables purchase agreement ~~(the~~(as amended, the “Amended Receivables Purchase Agreement”) under the Securitization Facility among certain of the ~~Company's~~Company’s subsidiaries, ~~its wholly-owned, “bankruptcy remote” special purpose subsidiaries (“SPEs”)~~the SPEs and certain global financial institutions (“Purchasers”). The Amended Receivables Purchase Agreement extends the term of the ~~securitization facility~~Securitization Facility such that the ~~SPE~~SPEs may sell certain receivables to the Purchasers until June 17, 2025. Under the Amended Receivables Purchase Agreement, transfers of accounts receivable from the SPEs are treated as sales and are accounted for as a reduction in accounts receivable, because the agreement transfers effective control over and risk related to the accounts receivable to the Purchasers. The Company and related subsidiaries have no continuing involvement in the transferred accounts receivable, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors of the Company, the Securitization Originators, or ~~the related~~any other relevant subsidiaries. ~~As of September 30,~~

Table of Contents

Second Lien Note

As of September 30, 2023, there were borrowings of $31.5 million outstanding under the Second Lien Note payable at maturity.

Potential Future Transactions

We may, from time to time explore and evaluate possible strategic transactions, which may include joint ventures, as well as business combinations or the acquisition or disposition of assets. In order to pursue certain of these opportunities, additional funds will likely be required. Subject to applicable contractual restrictions, to obtain such financing, we may seek to use cash on hand, ~~borrowings under our revolving credit facility,~~ or we may seek to raise additional debt or equity financing through private placements or through underwritten offerings. There can be no assurance that we will enter into additional strategic transactions or alliances, nor do we know if we will be able to obtain the necessary financing for transactions that require additional funds on favorable terms, if at all. In addition, pursuant to the Registration Rights Agreement that we entered into in connection with the closing of the Novitex Business Combination, certain of our stockholders may have the right to demand underwritten offerings of our Common Stock. We may from time to time in the future explore, with certain of those stockholders the possibility of an underwritten public offering of our Common Stock held by those stockholders. There can be no assurance as to whether or when an offering may be commenced or completed, or as to the actual size or terms of the offering.

Item 3. Quantitative and Qualitative Disclosure About Market Risk

Interest Rate Risk

At September 30, ~~2022,~~2023, we had ~~$1,181.1~~$969.1 million of principal amount of debt outstanding, with a weighted average interest rate of ~~11.1%~~11.7%. Interest is calculated under the terms of our credit agreements based on the greatest of certain specified base rates plus an applicable margin that varies based on certain factors. Assuming no change in the principal amount outstanding, the impact on interest expense of a 1% increase or decrease in the assumed weighted average interest rate would be approximately ~~$11.8~~$9.7 million per year. In order to mitigate interest rate fluctuations with respect to term loan borrowings under the Credit Agreement, in November 2017, we entered into a three year one-month LIBOR interest rate swap contract with a notional amount of $347.8 million, which at the time was the remaining principal balance of the term loan. The swap contract swapped out the floating rate interest risk related to the LIBOR with a fixed interest rate of 1.9275% effective January 12, 2018, but expired in January 2021.

~~Table of Contents~~

The interest rate swap, which was used to manage our exposure to interest rate movements and other identified risks, was not designated as a hedge. As such, changes in the fair value of the derivative were recorded directly to other expense (income), net. Other expense (income), net includes a gain of $0.1 million related to changes in the fair value of the interest rate swap for the nine months ended September 30, 2021.

Foreign Currency Risk

We are exposed to foreign currency risks that arise from normal business operations. These risks include transaction gains and losses associated with intercompany loans with foreign subsidiaries and transactions denominated in currencies other than a location’s functional currency. Our contracts are denominated in currencies of major industrial countries.

Market Risk

We are exposed to market risks primarily from changes in interest rates and foreign currency exchange rates. We do not use derivatives for trading purposes, to generate income or to engage in speculative activity.

Table of Contents

Item 4. ~~Internal~~ Controls and Procedures

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to provide reasonable assurance that material information required to be disclosed in our reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Executive Chairman and Interim Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Executive Chairman and Interim Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based upon that evaluation, our Executive Chairman and Interim Chief Financial Officer concluded that our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting that are described in ~~our Annual Report.~~the 2022 Form 10-K.

Notwithstanding such material weaknesses in internal control over financial reporting, our management, including our Executive Chairman and Interim Chief Financial Officer, has concluded that our condensed consolidated financial statements present fairly, in all material respects, our financial position, results of our operations and our cash flows for the periods presented in this ~~Quarterly Report,~~quarterly report, in conformity with U.S. generally accepted accounting principles.

Remediation

As previously described in Part II—Item 9A – Controls and Procedures of ~~our Annual Report,~~the 2022 Form 10-K, we continue to implement a remediation plan to address the material weaknesses mentioned above. The material weaknesses will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

~~Table of Contents~~

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting during the ~~quarter-ended~~quarter ended September 30, ~~2022,~~2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

5957

Table of Contents

PART IIII. OTHER INFORMATION

Item 1. Legal Proceedings

Class Action

On March 23, 2020, the Plaintiff, Bo Shen, filed a putative class action against the Company, Ronald Cogburn, the Company’s former Chief Executive Officer, and James Reynolds, the Company’s former Chief Financial ~~Officer.~~Officer and current member of the Board. Plaintiff ~~claimed~~claims to behave been a holder of 674,000 shares of Company stock, purchased on October 4, 2019 at ~~$80.40 per share.~~$1.34/share (in the case of the number of shares and share price without adjusting for any of the reverse stock splits occurring after that date). Plaintiff asserts two claims covering the purported class period of March 16, 2018 to March 16, 2020: (1) a violation of Section 10(b) and Rule 10b-5 of the Exchange Act against all defendants; and (2) a violation of Section 20(a) of the Exchange Act against Mr. Cogburn and Mr. Reynolds. The allegations stem from the Company’s press release, dated March 16, 2020 (announcing the postponement of the earnings call and delay in filing of its annual report on Form 10-K for the fiscal year ended December 31, 2019), and press release and related SEC filings, dated March 17, 2020 (announcing its intent to restate its financial statements for 2017, 2018 and interim periods through September 30, 2019) and certain other matters. On July 27, 2023, the parties submitted a settlement agreement to the Court that, if approved, will result in the dismissal of the action with prejudice in exchange for a settlement payment of $5.0 million, which the Company anticipates will be funded by the Company’s insurance carrier to the extent the payment exceeds any remaining deductible under the applicable insurance policy. The ~~Company moved to dismiss~~settlement agreement was preliminary approved by the ~~case~~Court on August 21, 2023 and the ~~Company’s motion was~~final approval hearing took place on December 7, 2023. The court granted the settlement in ~~its entirety on June 24, 2021. Plaintiffs filed an amended complaint by~~full and entered a final judgment of dismissal and final orders approving the ~~Court’s deadline on August 5, 2021,~~plan of allocation and plaintiffs’ attorneys’ fee award, which will be paid entirely out of the Company moved to dismiss this amended complaint on September 3, 2021, which dismissal was denied on January 21, 2022, permitting the case to move forward. At this time, it is not practicable to render an opinion about whether an unfavorable outcome is probable or remote with respect to this matter; however, the Company believes it has meritorious defenses and will continue to vigorously assert them.existing settlement fund.

Derivative ~~Action~~Actions

On July 8, 2020, Plaintiff Gregory McKenna filed a shareholder derivative action asserting the following claims against current and former directors and officers of Exela: (1) Violations of Section 14(a) of the Exchange Act; (2) Violations of Section 10(b) and Rule 10b-5 of the Exchange Act; (3) Violations of Section 20(a) of the Exchange Act; (4) breach of fiduciary duty; (5) unjust enrichment; and (6) waste of corporate assets. On December 21, 2020, Plaintiffs Richard W. Moser and Jonathan Gonzalez filed a substantially similar shareholder derivative action, which has been consolidated with the McKenna action. The claims stem from substantially the same factual allegations set forth in the Shen securities class action lawsuit, described above. At this time, it is not practicable to render an opinion about whether an unfavorable outcome is probable or remote with respect to this matter; however, the Company believes it has meritorious defenses and will continue to vigorously assert them.

~~Inquiry~~

Since May 2020, the Company has received and been responding to various document and information requests from the staff of the SEC in connection with an inquiry relating to the Company’s accounting treatment of the Appraisal Action, as well as the Company’s identification, classification and disclosure of certain related party transactions, both of which were the subject of the above described restatement. In June 2022, the Company reached an agreement in principle with the SEC Staff to resolve the matter. Under the terms of the settlement, the Company would consent, without admitting or denying the SEC’s allegations, to the entry of a cease-and-desist order for violations of Sections 13(a), 13(b)(2)(A), and 13(b)(2)(B) of the Exchange Act and Rules 13a-1, 13a-13 and 13a-15 thereunder, and the payment of a $175,000 penalty. In addition, the Company’s former Chief Financial Officer would consent, without admitting or denying the SEC’s allegations, to the entry of a cease-and-desist order for causing certain of the Company’s violations of Section 13(a) of the Exchange Act, and the payment of a $10,000 penalty. These settlements are subject to finalization and then approval by the SEC, and there can be no assurance that any settlement will be agreed or approved.

Other

We are, from time to time, involved in other legal proceedings, inquiries, claims and disputes, which arise in the ordinary course of business. Although our management cannot predict the outcomes of these matters, our management believes these actions will not have a material, adverse effect on our financial position, results of operations or cash flows.

~~Table of Contents~~

Item 1A. Risk Factors.

~~Except as~~In addition to the other information set forth ~~below and as previously reported~~ in ~~the “Risk Factors” section of our prospectus supplement~~ ~~filed with the SEC on May 23, 2022 and our~~this quarterly report, ~~on Form 10-Q filed with the SEC on August 12, 2022, there have been no material changes to~~you should carefully consider the risk factors ~~previously~~ described in Part I, “Item 1A. Risk Factors” in the 2022 Form 10‑K, which could materially affect our ~~Annual Report.~~business, financial condition and/or operating results. The risks described in those Risk Factors ~~and below~~ are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.

~~Our Common Stock may be delisted from Nasdaq.~~

Our Common Stock is currently listed for trading on the Nasdaq, and the continued listing of our Common Stock on the Nasdaq is subject to our compliance with a number of listing standards, including the $1.00 minimum bid price requirement for continued listing on the Nasdaq under Rule 5550(a)(2) of the Nasdaq Listing Rules and Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the SEC. We currently do not meet the requirement that our minimum bid price exceed $1.00 for at least 30 consecutive business days and received a letter from Nasdaq regarding the infraction on October 12, 2022. There can be no assurance that we will remedy and continue to satisfy this and other continuing listing requirements and remain listed on the Nasdaq, and in order to do so we may have to effect one or more additional reverse stock splits. If our Common Stock were no longer listed on the Nasdaq, investors might only be able to trade on one of the over-the-counter markets. This would impair the liquidity of our Common Stock not only in the number of shares that could be bought and sold at a given price, which might be depressed by the relative illiquidity, but also through delays in the timing of transactions and reduction in media coverage. In addition, we could face significant material adverse consequences, including: a limited availability of market quotations for our securities; a limited amount of news and analyst coverage for us; and a decreased ability to issue additional securities or obtain additional financing.

~~We restated certain of our previously issued consolidated financial statements, which resulted in unanticipated costs and may affect investor and customer confidence and raise reputational issues.~~

As discussed in the Explanatory Note in the Annual Report, we restated our consolidated financial statements and related disclosures for the year ended December 30, 2021. As a result, we incurred unanticipated costs for accounting and legal fees in connection with or related to the restatement, and have become subject to a number of additional risks and uncertainties, which may affect investor and customer confidence in the accuracy of our financial disclosures and may raise reputational issues for our business.

If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired.

As a public company, we are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act of 2002, as amended (the "Sarbanes-Oxley Act"), and the listing standards of the Nasdaq. We expect that the requirements of these rules and regulations will continue to increase our legal, accounting and financial compliance costs, make some activities more difficult, time consuming and costly, and place significant strain on our personnel, systems and resources. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we will file with the SEC is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that information required to be disclosed in reports under the Exchange Act is accumulated and communicated to our principal executive and financial officers. We are also continuing to improve our internal control over financial reporting. In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal control over financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and significant management oversight.

6158

Table of Contents

Our current controls and any new controls that we develop may become inadequate because of changes in conditions in our business. Further, weaknesses in our disclosure controls or our internal control over financial reporting may be discovered in the future. Any failure to develop or maintain effective controls, or any difficulties encountered in their implementation or improvement, could harm our operating results or cause us to fail to meet our reporting obligations and may result in a restatement of our financial statements for prior periods. Any failure to implement and maintain effective internal control over financial reporting also could adversely affect the results of management evaluations of our internal control over financial reporting that we are required to include in our periodic reports that we file with the SEC. Ineffective disclosure controls and procedures and internal control over financial reporting could also cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of our Common Stock. In addition, if we are unable to meet these requirements, we may not be able to remain listed on the Nasdaq.

Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2021 and based on its assessment, our management, including our Executive Chairman and Chief Financial Officer, has concluded that our internal control over financial reporting was not effective as of December 31, 2021 due to material weaknesses in our internal control over financial reporting. Further, in connection with the Restatement, the Company’s management also reassessed the effectiveness of its disclosure controls and procedures for the periods affected by the Restatement. As a result of that reassessment, the Company’s management determined that its disclosure controls and procedures as of December 31, 2021 were not effective due to the material weaknesses with respect to compiling information to prepare our financial statements in accordance with U.S. GAAP. The material weaknesses are due to the going concern assessment. For more information, see Part II—Item 9A—Controls and Procedures of the Annual Report.

Any failure to maintain effective disclosure controls and internal control over financial reporting could have a material and adverse effect on our business and operating results and cause a decline in the price of our Common Stock.

~~Internal control matters are more fully discussed in Part II—Item 9A—Controls and Procedures of the Annual Report.~~

Item 2. Unregistered Sales of Equity Securities and Use of ~~Proceeds.~~Proceeds, and Issuer Purchases of Equity Securities.

On August 10, 2022, the ~~Company’s board of directors~~Board authorized a share buyback program (the “2022 Share Buyback Program”), pursuant to which the Company was authorized to repurchase, from time to time, up to ~~10,000,000~~50,000 shares of ~~its~~the Common Stock over a two-year period through various means, including, open market transactions and privately negotiated transactions. The 2022 Share Buyback Program does not obligate the Company to repurchase any shares. The decision as to whether to repurchase any shares and the timing of repurchases will be based on the price of the ~~Company’s~~ Common Stock, general business and market conditions and other investment considerations and factors. ~~During three~~No shares were repurchased under the 2022 Share Buyback Program during the nine months ended September 30, ~~2022, the Company~~2023. As of September 30, 2023, we had repurchased and concurrently retired ~~357,461~~a total of 1,787 shares of Common Stock ~~at an average share price of $1.348 per share under~~pursuant to the 2022 Share Buyback Program.

The table below sets forth information with respect to purchases made by or on behalf of us or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934) of shares of our Common StockShare repurchase activity during the ~~period of August 10, 2022 through the quarter~~three months ended September 30, ~~2022:~~2023 was as follows::

Period
Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
August 2022
357,461
1.3480
357,461
9,642,539
September 2022
—
—
—
—
Total
357,461
1.3480
357,461
9,642,539


				Total Number	Maximum
				of Shares	Number of
				Purchased as	Shares that
				Part of	May Yet Be
		Average		Publicly	Purchased
	Number	Price		Announced	Under the
	of Shares	Paid per		Plans or	Plans or
Period	Purchased	Share		Programs	Programs
July 1 – July 31, 2023	—	$	—	1,787	48,213
August 1 – August 31, 2023	—		—	1,787	48,213
September 1 – September 30, 2023	—	$	—	1,787	48,213
Total	—

~~Table of Contents~~

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

~~Not applicable.~~None.

6359

Table of Contents

Item 6. Exhibits.

~~Item 6.Exhibits.~~ Exhibit No.		Description
3.1		Restated Certificate of Incorporation, dated July 12, 2017. (1)
3.2		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Exela Technologies, Inc., effective January 25, 2021. (2)
3.3		Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Exela Technologies, Inc., effective July 25, 2022. (6)
3.4		Third Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Exela Technologies, Inc., effective May 12, 2023. (4)
3.5		Certificate of Designations, Preferences, Rights and Limitations of Series A Perpetual Convertible Preferred Stock. (1)
3.6		Certificate of Decrease of Series A Perpetual Convertible Preferred Stock. (3)
3.7		Certificate of Designations, Preferences, Rights and Limitations of Series B Cumulative Convertible Perpetual Preferred Stock, dated March 10, 2022. (5)
3.8		Certificate of Increase of Authorized Number of Shares of Series B Cumulative Convertible Perpetual Preferred Stock of Exela Technologies, Inc., effective July 25, 2022. (6)
3.9		Certificate of Decrease of Series B Perpetual Convertible Preferred Stock. (7)
3.1		Certificate of Designations, Preferences, Rights and Limitations of Tandem Preferred Stock. (3)
3.11		Certificate of Increase of Authorized Number of Shares of Tandem Preferred Stock of Exela Technologies, Inc., effective July 25, 2022. (6)
3.12		Certificate of Decrease of Tandem Preferred Stock. (7)
3.13		Certificate of Designations, Preferences, Rights and Limitations of Special Voting Preferred Stock. (3)
3.14		Certificate of Elimination of Special Voting Preferred Stock of Exela Technologies, Inc., effective July 25, 2022. (6)
3.15		Certificate of Designations, Preferences, Rights and Limitations of Special Voting Preferred Stock. (7)
3.16		Certificate of Elimination of Special Voting Preferred Stock of Exela Technologies, Inc., effective May 12, 2023. (4)
3.17		Certificate of Designations, Preferences, Rights and Limitations of Special Voting Preferred Stock. (8)
4.1		Indenture, dated as of July 11, 2023, by and among Exela Intermediate LLC and Exela Finance Inc., as Issuers, the guarantors party thereto from time to time and U.S. Bank Trust Company, National Association, as trustee. (9)
4.2		Seventh Supplemental Indenture, dated as of July 11, 2023, by and among Exela Intermediate LLC, Exela Finance Inc., U.S. Bank Trust Company, National Association, as trustee, and Wilmington Savings Fund Society, FSB, as collateral agent. (9)
10.1		Subscription, Voting and Redemption Agreement, dated as of October 9, 2023, by and between Exela Technologies, Inc. and GP-HGM LLC. (8)
31.1^*		Certification of the Principal Executive Officer required by Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
31.2^*		Certification of the Principal Financial and Accounting Officer required by Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
32.1^**		Certification of the Principal Executive Officer required by 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
32.2^**		Certification of the Principal Financial and Accounting Officer required by 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH		Inline XBRL Taxonomy Extension Schema
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase

Table of Contents

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase
104		Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)

^*Filed herewith.

^** Furnished herewith.

(1)	Incorporated by reference to the Registrants’ Current Report on Form 8-K, filed on July 18, 2017.

(2)	Incorporated by reference to the Registrants’ Current Report on Form 8 K, filed on January 25, 2021.

(3)	Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on May 19, 2022.

(4)	Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on May 12, 2023.

(5)	Incorporated by reference from Exhibit (a)(1)(N) to Amendment No. 11 to Schedule TO, filed by the Company with the Securities and Exchange Commission on March 11, 2022.

(6)	Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on July 26, 2022.

(7)	Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on March 13, 2023.

(8)	Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on October 10, 2023.

(9)	Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on July 17, 2023.

6461

Table of Contents

SIGNATURES

Pursuant to the requirements of the Section 13 or 15 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 145^th day of ~~November 2022.~~January 2024.


	EXELA TECHNOLOGIES, INC.

	By:	/s/ Par Chadha
		Par Chadha
		Executive Chairman (Principal Executive Officer)


	By:	/s/ ~~Shrikant Sortur~~Matthew T. Brown
		~~Shrikant Sortur~~Matthew T. Brown
		Interim Chief Financial Officer (Principal Financial and Accounting Officer)

6562


Period	Number of Shares Purchased	Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
August 2022	357,461	1.3480	357,461	9,642,539
September 2022	—	—	—	—
Total	357,461	1.3480	357,461	9,642,539